{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {},
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert, Sandra Spalek, and Charles Tapley Hoyt",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns"
    },
    "namespaces_uncached": [],
    "path": "tau/boland2018.bel",
    "pybel_version": "0.13.3-dev"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The heterotrimeric serine/threonine kinase 5ʹ‑AMP‑ activated protein kinase (AMPK) and mammalian target of rapamycin complex 1 (mTORC1) trigger autophagy and repress mitophagy 3,10,20–23   (BOX 2; FIG. 3) .",
      "key": "cf135c27b28d459ecea23d86dc28add35eb5694a8668a967534771c950f9fd419969592025d5d011fd494adac87431eb6e2b923fe1b07ed04bd9f02b36a86d89",
      "line": 74,
      "relation": "increases",
      "source": 96,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The di-glucose derivative trehalose inhibits the sol- ute carrier 2A (SLC2A) family of glucose transporters to promote AMPK-induced autophagy and reduce neurotoxic protein load, although it also exerts other actions downstream in the ALN 4,120 . ",
      "key": "dc1b5e9c1d3f1b33af11680c9aabebf99a917a3e3a4df7a14187f17a26f36d363ffdf6bc23e9fc7babf6dcb831b8348d3ae3ace299a7ae0d5c0b49d9ac80c9ce",
      "line": 586,
      "relation": "increases",
      "source": 96,
      "subject": {
        "modifier": "Activity"
      },
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " In addition, calcitriol (the active metabolite of vitamin D 3 ) elicited AMPK-dependent autophagy in a neurochemical lesion-induced model of PD 129.",
      "key": "b073361598135a6e367decff8f61de9da54dcbad73641a77378767081b0676f80131f00f94e6f70d420ba1e7e4d2edad96d070ba144e85944a7032fdea2cd342",
      "line": 649,
      "relation": "increases",
      "source": 96,
      "subject": {
        "modifier": "Activity"
      },
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The heterotrimeric serine/threonine kinase 5ʹ‑AMP‑ activated protein kinase (AMPK) and mammalian target of rapamycin complex 1 (mTORC1) trigger autophagy and repress mitophagy 3,10,20–23   (BOX 2; FIG. 3) .",
      "key": "c9b51c61556b1184b4c85af05941512107edf08f6ffae791835b52dcc02bced528525062a8b1155d9cb51f928692652dabf78c7b46a0187f35ea1f91d54a65c9",
      "line": 76,
      "relation": "decreases",
      "source": 96,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "AMPK is central to several mechanisms that trigger autophagy — most importantly, activating phosphoryla- tion of ULK1 (Ser317 and Ser777) and inhibitory phos- phorylation of mTORC1  (REFS21,31) .",
      "key": "eadf8451f4244c20be2d80c16b1e8bd16e416fef1f0e5151ccdcec3b0ddc3788dd54af2de54bf91a1f70306c561869f2342a2964ca2f79822276348ffa966de1",
      "line": 106,
      "relation": "increases",
      "source": 96,
      "target": 189
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "AMPK is central to several mechanisms that trigger autophagy — most importantly, activating phosphoryla- tion of ULK1 (Ser317 and Ser777) and inhibitory phos- phorylation of mTORC1  (REFS21,31) .",
      "key": "ae1ec98ab6d67757edae6e4754442bb4c88c497c8bd35def4c07e0e753fa177ebefc3b63e3563fb2d21a2b7bd4f70a37488779ea329069db9c9b776ae4b971de",
      "line": 107,
      "relation": "increases",
      "source": 96,
      "target": 191
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "AMPK is central to several mechanisms that trigger autophagy — most importantly, activating phosphoryla- tion of ULK1 (Ser317 and Ser777) and inhibitory phos- phorylation of mTORC1  (REFS21,31) .",
      "key": "efc2d1168451cab69a7573a024272519da31dc9abe71e43ef481dcdc99449c2c0f8a4dafafb77fc92aea949edae2a99817796072d526e856a43e5340aec14324",
      "line": 110,
      "relation": "increases",
      "source": 96,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " SIRT1 is activated by AMPK- mediated increases in nicotinamide, and it drives the ALN by inhibiting mTORC1, inducing FOXO1 and FOXO3 and activating key regulatory proteins such as ATG5, ATG7 and LC3.",
      "key": "a0f9ce16088539c657d24f228a981ea5caaecb2df79b253ca430aaa72c4720b5fc341ede652ea7844efd1f6755565a9954058856d6cfa145a8bb18f9ebe7045f",
      "line": 154,
      "relation": "increases",
      "source": 96,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The aminoimidazole derivative 5-aminoimidazole- 4-carboxamide ribonucleotide (AICAR) undergoes intra- cellular transformation to an AMP analogue that triggers AMPK-mediated autophagy 21,108 .",
      "key": "a5f8e9f8407b3162eaa1741a733df4f012b9d292c597713f55446b9372f6084ecac7afc74bcd6d528cca8810198b7376cb56c522fe981f5dfab00b61a462ad27",
      "line": 512,
      "relation": "increases",
      "source": 96,
      "subject": {
        "modifier": "Activity"
      },
      "target": 72
    },
    {
      "key": "e37f3889e99c4df1fec71e9589a4e0975b04bcba1171611fd0212393e337317878284ca02199e891f875e84a293763c683c20bbf8fa771b236a43516287fb52b",
      "relation": "hasVariant",
      "source": 96,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Resveratrol can stimulate SIRT1 via AMPK (see above), and it also possesses an AMPK-independent mode of SIRT1 recruitment that participates in blunting the neurotoxicity of Aβ25–35 fragments in PC12 cells 160 . ",
      "key": "10bc1e33639947517e578854266b0860fd00dd5fde156edcada94dcf54eafa49f5da6ef7d77dc38bdbdf9118b349784f215930f7b72fc5a3555b27865b8ecac2",
      "line": 785,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 96,
      "subject": {
        "modifier": "Activity"
      },
      "target": 175
    },
    {
      "key": "877cf903be8923d5edca628511104c94501949866c10352a90b228f7e9949e39850462681d20000c5b5966b12350d94195218c2f845582d7e8b2dd771732d524",
      "relation": "hasVariant",
      "source": 96,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Moreover, the flavonol fisetin stimulated auto- phagic degradation of phosphorylated tau in cortical neu- rons via mTORC1-dependent activation of TFEB and the cytoprotective transcription factor nuclear factor eryth- roid 2-related factor 2 (NFE2L2) 149 . Fisetin also reduced Aβ accumulation in an APP/PS1 mouse model of AD 150 . ",
      "key": "1cf73f244611d1b1ca0149ae93a0c7286b09dbf05ddfce58f91025da56a6c1c45ec92ee876945f77f3db494ede4d8474a5bd7281371545fa84c6307d8cf0b53a",
      "line": 740,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 74,
      "target": 156
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The heterotrimeric serine/threonine kinase 5ʹ‑AMP‑ activated protein kinase (AMPK) and mammalian target of rapamycin complex 1 (mTORC1) trigger autophagy and repress mitophagy 3,10,20–23   (BOX 2; FIG. 3) .",
      "key": "65c0638fdb9a2c1f028d5bb0260a6cd5f9f0fbbc86ffc73f68c2a529bc4c7010064c24716f837699e4ac15473e02c9bf8e5c170816998d454e0a8dbf343d9290",
      "line": 75,
      "relation": "increases",
      "source": 104,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "mTORC1 also restrains autophagy by preventing nuclear translo- cation of TFEB 20 .",
      "key": "34d09540a7b37de9620b6677f26811caecb82e4f7c57e7a4a16f284f84a604e9d7defe3fd66efd6fb57ae18465a5acce76aead5d348c898be06c89ab946672d2",
      "line": 127,
      "relation": "decreases",
      "source": 104,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "One major strategy for promoting autophagy is the relief of its repression by mTORC1.",
      "key": "2e5d603d1f6bbfea2d599eaefcd16a2f4f884c69fc5859942b6303b6720091f24d6e9a85f083f5900328ccc55434460ac87b617d6d0def5e47ccbad594bb21e4",
      "line": 656,
      "relation": "decreases",
      "source": 104,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Sestrin 2 over expression also prompted mTORC1-dependent autophagy in cortical neurons in a presenilin-knockout model of AD.",
      "key": "9532c1d19269472800087b602261c96e1963eb1befbba4cf2641132c61bf65d543df0af3601a1e10a2b180994a737e0535a71daf01fbfb93baa1d3bcfcd9664e",
      "line": 1096,
      "relation": "increases",
      "source": 104,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The heterotrimeric serine/threonine kinase 5ʹ‑AMP‑ activated protein kinase (AMPK) and mammalian target of rapamycin complex 1 (mTORC1) trigger autophagy and repress mitophagy 3,10,20–23   (BOX 2; FIG. 3) .",
      "key": "442184af4cdb3bbf7f173c55e932b138eefcebd1a8e6c6f190c505ffdbaf9c40816d73c11a93f9c613ead33a92a63a4346ad46258a699374485109c823108fd3",
      "line": 77,
      "relation": "decreases",
      "source": 104,
      "target": 76
    },
    {
      "key": "b99a8da0f2caed27174bafd6dc6fb80f9afa1a0d557f6d74977a64a72edfdf25d2ad3cd0fd29066f1a9c625a7fad395c9ba458526f3228601a2edee4c444ee79",
      "relation": "hasVariant",
      "source": 104,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Conversely, mTORC1 inhibits ULK1 by Ser757 phosphorylation 3,4,31 .",
      "key": "e78ab7fe830b6f953e54c67d06c70ed090103e344018bee28381dd9ef811856d6fc7cc6e7bc9644219ab3bd6df16991cc5756fe05bf8e61f91fcfaaef5af439a",
      "line": 117,
      "relation": "increases",
      "source": 104,
      "target": 190
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "mTORC1 also restrains autophagy by preventing nuclear translo- cation of TFEB 20 .",
      "key": "0bdf12a246556fc2ecca0039d8e696ba675dd9540c0836bfec48b2f2781cc4dde10419293b589f2b7f493d599519180d61185353b7ab1e90a55bcffda48fa837",
      "line": 125,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytoplasm",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 104,
      "target": 187
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Moreover, the flavonol fisetin stimulated auto- phagic degradation of phosphorylated tau in cortical neu- rons via mTORC1-dependent activation of TFEB and the cytoprotective transcription factor nuclear factor eryth- roid 2-related factor 2 (NFE2L2) 149 . Fisetin also reduced Aβ accumulation in an APP/PS1 mouse model of AD 150 . ",
      "key": "8f91139c15dd5085a6940500cdd5bd7987299b2822f07c4de06a4e16b3cff2b6e824e0c1e37bb673a7039bb63b8ec917d418091179ad1b56ffc5718f03e3afab",
      "line": 742,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 104,
      "subject": {
        "modifier": "Activity"
      },
      "target": 187
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Moreover, the flavonol fisetin stimulated auto- phagic degradation of phosphorylated tau in cortical neu- rons via mTORC1-dependent activation of TFEB and the cytoprotective transcription factor nuclear factor eryth- roid 2-related factor 2 (NFE2L2) 149 . Fisetin also reduced Aβ accumulation in an APP/PS1 mouse model of AD 150 . ",
      "key": "51926b5c15517e0da1a05f5687ffd7896b16639c0b16ba9175f9eefdfef9d811d46b035685a7d66e7d3fcfd08bb72a3e3e8f13602f5eb14798f1ffc7126aa6ba",
      "line": 743,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 104,
      "subject": {
        "modifier": "Activity"
      },
      "target": 163
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Finally, mirroring its inhibitory influence on the ALN, mTORC1 suppresses the UPS by impeding the formation and assembly of proteasomal subunits. ",
      "key": "9b939cd1687659150386de99d64fbde5919b9bba7af5c4f0af407f9033b0b5dfb71313baf600c778c2919d967744514a7d2dd684eaecc18bbcba6401fc56ef0e",
      "line": 1056,
      "relation": "decreases",
      "source": 104,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Finally, mirroring its inhibitory influence on the ALN, mTORC1 suppresses the UPS by impeding the formation and assembly of proteasomal subunits. ",
      "key": "b9b1ffa36eeb048d9cabadb031524c9c448571ef7b78688f8f10a689f6d90a6b680d30d7d08ff0826da34fabc63e0507300daf15b8c7747780ae45616a310c08",
      "line": 1057,
      "relation": "decreases",
      "source": 104,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, genetic mutations and anomalies of presenilin 1, a dominant negative gene linked to AD, are associated with reduced lysosomal v-ATPase-mediated acidifica- tion 40,63 , a compromised ALN and deficient mitophagy 64 . ",
      "key": "c2b032388f7e90d240ecb605f48cd52df424587727d8fe2f7875f858236241a757857c6d410a0d73b1104f3cfedc7db921043d33475bdba9b9df2d5d42023d0e",
      "line": 252,
      "relation": "negativeCorrelation",
      "source": 76,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Unc-51-like kinase 1 (ULK1) is primarily an autophagy-initiating protein 3,10,19 , as is the mTORC1- suppressed transcrip- tion factor EB (TFEB), which orchestrates the synthesis of lysosomal and other proteins critical for maintaining ALN flux 20–23 .",
      "key": "0ba4e3317a98154ba3d12a1337839bd2f54f90c7ce7199cf6a9866a3608bf9da05bbfee155891aafebfb22353f7620871b7ac26690aceef4f7d1ac17e8c060b9",
      "line": 87,
      "relation": "increases",
      "source": 188,
      "target": 74
    },
    {
      "key": "781ffcf50b9a824737278bdeebb201baa6ff983fe469009fbd737c9859061c4776c5848af0a8f737b69a82538a681016cdbc6ccbac4cdfcf7a02f93fe8517dd1",
      "relation": "hasVariant",
      "source": 188,
      "target": 189
    },
    {
      "key": "fd7e80fe3160a96773221589870374238a4fd4bb2993b3190e09a21f44e6b4ae1adc4484f88c616cb88850a38a3e45045dafb0e60bc7a4ae66119d009dac36d9",
      "relation": "hasVariant",
      "source": 188,
      "target": 191
    },
    {
      "key": "831e04fd0515c51116495ca15de86d56afeed26e18c62c5393e3f87c29a1c89e21faf7486bb0aa768776fdb3ca0e2a2e71e9c53b0a7cbf12b3577dec6aaac3b2",
      "relation": "hasVariant",
      "source": 188,
      "target": 190
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Activation of ULK1 triggers autophagosome nucleation through activating phospho- rylation of AMBRA and beclin 1 within the autophagy- specific PIK3C3 complex 10   (FIG. 3) .",
      "key": "c524f7414b12a8de0eddf083862dd27dfb25e0997cd8c62e906bc2d308cc6a5e13d70e0c8c42d9a33137f97dc6b6ccd32499c49c07960859a30d469c5e652f7d",
      "line": 170,
      "relation": "increases",
      "source": 188,
      "subject": {
        "modifier": "Activity"
      },
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Activation of ULK1 triggers autophagosome nucleation through activating phospho- rylation of AMBRA and beclin 1 within the autophagy- specific PIK3C3 complex 10   (FIG. 3) .",
      "key": "bc80e98db5c46a12f92d49eedd37c4a3cacdc5d628b21ecffb9ab4b849f9c271b77b5b837480a0da4c2ae3e7d227658747571589cbc216ed4b308997752a9e7a",
      "line": 171,
      "relation": "increases",
      "source": 188,
      "subject": {
        "modifier": "Activity"
      },
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Activation of ULK1 triggers autophagosome nucleation through activating phospho- rylation of AMBRA and beclin 1 within the autophagy- specific PIK3C3 complex 10   (FIG. 3) .",
      "key": "759bbefbd7a0875c1cc3730e536ff196a8de464e365b96f022cb20bed3054ad749b9b20e5618922eb175f76c26451449d7507fbf5b2f59a4e3734ec2c88f13f7",
      "line": 174,
      "relation": "increases",
      "source": 188,
      "subject": {
        "modifier": "Activity"
      },
      "target": 121
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Unc-51-like kinase 1 (ULK1) is primarily an autophagy-initiating protein 3,10,19 , as is the mTORC1- suppressed transcrip- tion factor EB (TFEB), which orchestrates the synthesis of lysosomal and other proteins critical for maintaining ALN flux 20–23 .",
      "key": "4c59da16bf0a5da3553fb0167b1c6b5240b3c4c65518b257a2a29727de05ce868b909fe1c5f9b31a020fe90ac09c71bd6f0fb7cc95424fe500e1dde4d864d230",
      "line": 88,
      "relation": "increases",
      "source": 187,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "mTORC1 also restrains autophagy by preventing nuclear translo- cation of TFEB 20 .",
      "key": "eec10d6842811f98460f74f3fe0aa8aa5620c0ec25cef1b5c7d18c0344dfbb650dbf0df453351779c407e5586e6ec5890b06bb21d69a170977dffd44942b4da1",
      "line": 126,
      "relation": "increases",
      "source": 187,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Cytoplasm",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Indeed, TFEB over- expression reduced amyloid plaques in a APP/PS1 mouse model 148 . ",
      "key": "6c5d32657e29de30ebc4003e8f61d9b02ec6a83b611b86157afe427f98fdfdb38cafee4d9037f7774b758123702e1890902a6a027ef2f70b83ad1440a9cbf302",
      "line": 729,
      "relation": "decreases",
      "source": 187,
      "target": 199
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Because the class III deacetylase NAD- dependent protein deacetylase sirtuin 1 (SIRT1) requires nicotinamide adenine dinucleotide (NAD) to sustain its activity, this positive regulator of autophagy may also be considered a sensor 24 .",
      "key": "dce4611c07df6186aabdcf95c56f8737a6da4e6ecd7a9016cc80ff062c2f82a22427ecaa9ead5cef93df40c58e3a7ecd7bbc9480e42a85c85f9db70c15fd988e",
      "line": 97,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 3,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " SIRT1 is activated by AMPK- mediated increases in nicotinamide, and it drives the ALN by inhibiting mTORC1, inducing FOXO1 and FOXO3 and activating key regulatory proteins such as ATG5, ATG7 and LC3.",
      "key": "b77bb81a2f368484916d9ad7cc403105f1a18aa1572f16adb424797d13312fdcb5d0f11d8504550f20100153426feddcda19169cb400692b718754a90908941f",
      "line": 155,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 3,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " SIRT1 is activated by AMPK- mediated increases in nicotinamide, and it drives the ALN by inhibiting mTORC1, inducing FOXO1 and FOXO3 and activating key regulatory proteins such as ATG5, ATG7 and LC3.",
      "key": "43679b3e1abcfd0bb910b41f9e6292e08768dcd35719ac56864af382d5f300f45fcbc1e4a6be5baaa9c1aff8f642740e0d8a774062dbe94233dd3f30cefa3388",
      "line": 156,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 175,
      "subject": {
        "modifier": "Activity"
      },
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " SIRT1 is activated by AMPK- mediated increases in nicotinamide, and it drives the ALN by inhibiting mTORC1, inducing FOXO1 and FOXO3 and activating key regulatory proteins such as ATG5, ATG7 and LC3.",
      "key": "f5fe23b406cecdec45822ff9e85ce8f792e6a0fced95dba869c5fd38d8bdbb5ff6efce9dafb555fb1236a56badad5446679516e627390fceb17f8df6d9302f17",
      "line": 157,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 175,
      "subject": {
        "modifier": "Activity"
      },
      "target": 133
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " SIRT1 is activated by AMPK- mediated increases in nicotinamide, and it drives the ALN by inhibiting mTORC1, inducing FOXO1 and FOXO3 and activating key regulatory proteins such as ATG5, ATG7 and LC3.",
      "key": "77f4f6d7f8bd303a176904cc9bded538b8bfce4a872ee040d7a79e0a707dbbbf6a848ef465b1a5f6e78026e858f545dbc22f359cd359f663bdcdf321cccc93b1",
      "line": 158,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 175,
      "subject": {
        "modifier": "Activity"
      },
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " SIRT1 is activated by AMPK- mediated increases in nicotinamide, and it drives the ALN by inhibiting mTORC1, inducing FOXO1 and FOXO3 and activating key regulatory proteins such as ATG5, ATG7 and LC3.",
      "key": "caea3e049bae408bac61715ee86dbdaff80aa54822da223b8cb7b897604031ad1d15b8bb1cbf6252968aa3db1e6619a9a16c29b0e4514475c61172416b735e6e",
      "line": 159,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 175,
      "subject": {
        "modifier": "Activity"
      },
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " SIRT1 is activated by AMPK- mediated increases in nicotinamide, and it drives the ALN by inhibiting mTORC1, inducing FOXO1 and FOXO3 and activating key regulatory proteins such as ATG5, ATG7 and LC3.",
      "key": "98fd375c604aa583e09536565128eb247c85ac2d9f0bb931aa6ce8d1b00cac15b3207d7755c3c3a870b2f356a4effe86a799b19d72dbfd4288a2885af8a3d945",
      "line": 160,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 175,
      "subject": {
        "modifier": "Activity"
      },
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " SIRT1 is activated by AMPK- mediated increases in nicotinamide, and it drives the ALN by inhibiting mTORC1, inducing FOXO1 and FOXO3 and activating key regulatory proteins such as ATG5, ATG7 and LC3.",
      "key": "fc6f444adad99ae3de63276a8f3c9b36d43ab6cc01a086db9d91c006194c7ee55015154194cf655623e1377e038905e05f3f9dc5e254ff9ead025b01d97045e9",
      "line": 162,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 175,
      "subject": {
        "modifier": "Activity"
      },
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Activity of the deacetylase SIRT1 declines with age, partially owing to limited availability of its co fac- tor, nicotinamide 24,56,156 . ",
      "key": "66b4d5ef248a2e12cb5a586462ad247cbe6c67f60ea77ee7cb0c9e844d556cfca76b575f958eff582a41556a21687c7c7f0fa044963697cf6cb6dcb6c3f53273",
      "line": 775,
      "relation": "negativeCorrelation",
      "source": 175,
      "subject": {
        "modifier": "Activity"
      },
      "target": 71
    },
    {
      "key": "fd0c132704017a1cd684efdbc8d4e4c0694041303aca0ca619d62fb6219a2b7fc42b9aac752fb24e63b14a96cfe7813e0d059209d9a50d2a3fc38ea07532ec09",
      "relation": "hasComponent",
      "source": 85,
      "target": 3
    },
    {
      "key": "36057e3bb16afb8eebde31f71be0e3ab39080faf17b1aed3c687c89da3a70f690c8cff33d26cd13b246938ff6a41e84fdde025ec4e072f1def9d6635330f9244",
      "relation": "hasComponent",
      "source": 85,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Because the class III deacetylase NAD- dependent protein deacetylase sirtuin 1 (SIRT1) requires nicotinamide adenine dinucleotide (NAD) to sustain its activity, this positive regulator of autophagy may also be considered a sensor 24 .",
      "key": "3e06b474791e9c2460dd322b28fd51bb3bff2035f51fd3d12a7c7ab7855b860f8efbfe5a78cca98d33de77917d91fe941ec05bcd49e47df85dc35f64c5f492eb",
      "line": 98,
      "relation": "increases",
      "source": 85,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "AMPK is central to several mechanisms that trigger autophagy — most importantly, activating phosphoryla- tion of ULK1 (Ser317 and Ser777) and inhibitory phos- phorylation of mTORC1  (REFS21,31) .",
      "key": "ca56825fd8ec13fbdf472b35427982f07938c16d4de714362d7995e5d4c9ac9e1f6c0ee21e06c1bfbbaa2980b7f7b799e40a5b0a33a7d42c917ab754e3eca6fc",
      "line": 108,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 189,
      "target": 188
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "AMPK is central to several mechanisms that trigger autophagy — most importantly, activating phosphoryla- tion of ULK1 (Ser317 and Ser777) and inhibitory phos- phorylation of mTORC1  (REFS21,31) .",
      "key": "b7bc5a1beadd93c3c197f4042d78e6467d9dc410197b21b090025922041ee5b19761a1776daab4f806269ffad22d5eb0368bea0b31cf60b6890bce9285c3b285",
      "line": 109,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 191,
      "target": 188
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "AMPK is central to several mechanisms that trigger autophagy — most importantly, activating phosphoryla- tion of ULK1 (Ser317 and Ser777) and inhibitory phos- phorylation of mTORC1  (REFS21,31) .",
      "key": "5b46c2e3c450df3f36bdb2c8e54612ffed1c2545ead894cfeea5cdf49caf6bae7a6269f96fa6f27e0e5b031e46ee4c0c8f2312dd1dff0d61a8227b0d6333ff0c",
      "line": 111,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 105,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Conversely, mTORC1 inhibits ULK1 by Ser757 phosphorylation 3,4,31 .",
      "key": "6d255a628ba719f7dec2f6ab4d52a5f4e28cadf767eb4f826e0b6a94e6d2cce15d71342c2b1a4241499ce68ed00c465a7f881ac6b928e26f14aeb83f33865bc2",
      "line": 118,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 190,
      "target": 188
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Other transcription factors that posi- tively regulate autophagy include forkhead box protein O1 (FOXO1) and FOXO3  (REF.22) . ",
      "key": "1f9ce084ac1f53540d01f383fb25952e04b4c31bde528594f9577bc35b761982644bba46b6836d2388b7de4f3b9dd904548fa49d6cebcc847b35e1399dadd4f4",
      "line": 134,
      "relation": "increases",
      "source": 133,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Other transcription factors that posi- tively regulate autophagy include forkhead box protein O1 (FOXO1) and FOXO3  (REF.22) . ",
      "key": "1918715f09d332e441cc0a84d4ccf267a15c17a796597aaec8f1d99742054d755f340c063898be0e1dd07358fcb3959fff87141045b50b9e399b9fb5b9b19639",
      "line": 135,
      "relation": "increases",
      "source": 134,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Conversely, repression is effected by signal transducer and activator of transcrip- tion 3 (STAT3) and possibly zinc-finger protein with KRAB and SCAN domains 3 (ZKSCAN3), although its role has been disputed 22,32 .",
      "key": "8e6f455b55f2cee2b4afbe7fdaac3cfc1c99bf8457fb02275e99deeed4af1b5042a09bdb3e4d34c5f065b81b5c98a40ea9fa8bc01635267189693a9154053d4a",
      "line": 144,
      "relation": "decreases",
      "source": 183,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Conversely, repression is effected by signal transducer and activator of transcrip- tion 3 (STAT3) and possibly zinc-finger protein with KRAB and SCAN domains 3 (ZKSCAN3), although its role has been disputed 22,32 .",
      "key": "bcaa11b73ac9367b735913adf5b8a2ba13d87501ac157d357425d4e9d0fae08961f271dbc0932a9939251e0fc9472486cdcf96a7660931ea9ca31f9207adef85",
      "line": 145,
      "relation": "decreases",
      "source": 192,
      "target": 74
    },
    {
      "key": "29a4c50b5ee569fdf732c0f06455d6c383086d29ad53ca86c61524833ed22b8987b6f59b0597bf4dd8893eceac83d31f21f5f783333e4acb7f153946341c6c66",
      "relation": "hasVariant",
      "source": 114,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Activation of ULK1 triggers autophagosome nucleation through activating phospho- rylation of AMBRA and beclin 1 within the autophagy- specific PIK3C3 complex 10   (FIG. 3) .",
      "key": "6714b7a8c21c54c300f582f27bc7b5a4dfa63e8f166c191abb9db8a930a427fb8465c7f5aa667347e4da6057b81d11eeed71bfe57876227a28ed75d842cfafdc",
      "line": 172,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 110,
      "target": 109
    },
    {
      "key": "7de18fbdf06d3171ed0329af4f40a502cfc77eb27bccf540104ee3305aef66ed9220a9fc694ba8e418c89d857ca1efdc0279ed1ff918946e7256b699d0d0d6ac",
      "relation": "hasVariant",
      "source": 109,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Activation of ULK1 triggers autophagosome nucleation through activating phospho- rylation of AMBRA and beclin 1 within the autophagy- specific PIK3C3 complex 10   (FIG. 3) .",
      "key": "8150d3842d3e6008adc6f93e1d80b951dabf02b6176c8a9e6bb66d29ea2766faf81a6a53feb85afa45c466964351160220d15e0693993f15dba233ad126b4c18",
      "line": 173,
      "relation": "increases",
      "source": 109,
      "subject": {
        "modifier": "Activity"
      },
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Activation of ULK1 triggers autophagosome nucleation through activating phospho- rylation of AMBRA and beclin 1 within the autophagy- specific PIK3C3 complex 10   (FIG. 3) .",
      "key": "c47fcf92e082437ffaa6099f4e7db9e9ff56db884b2208c94f6b816d828b4ffd3e1ff6155da4f51369a0f71f0c595f1ac3ba4d2f3590d9e758f77ddd3d6de267",
      "line": 175,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 121,
      "target": 119
    },
    {
      "key": "62371c5803e59637b8d61e7048382715746a32acfbb9ba36682506a6f8e42014071222964d34de763d52bd02e8502a8b746d2242d3e2f52f5503890a5861d2f5",
      "relation": "hasVariant",
      "source": 119,
      "target": 121
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Activation of ULK1 triggers autophagosome nucleation through activating phospho- rylation of AMBRA and beclin 1 within the autophagy- specific PIK3C3 complex 10   (FIG. 3) .",
      "key": "83216ca03429003b7f265375185f50819427289408992b89ba218dbf32291ee1a0b51c2d8f9db7788a83603b0d9d6dce5e7b2032c6dcb3f3a64ad3fab6915586",
      "line": 176,
      "relation": "increases",
      "source": 119,
      "subject": {
        "modifier": "Activity"
      },
      "target": 59
    },
    {
      "key": "e7d32b10d5a3d30db8ebab9e15eb6baf420f297d676a7b9c6520c08d924d08b3d19a3b4694836dd16871da4c496da319f51a1927522fce891d7767e58ffc296f",
      "relation": "hasVariant",
      "source": 119,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tau, α-synuclein and TDP43 are substrates for CMA degradation, as are amyloid precursor protein (APP) but not amyloid-β fragment 42 (Aβ42) itself 3,45–47,48 . ",
      "key": "f9d4b7798e56ff291dab6e5af8ca8a268676c93a7280c462de6f7ae91abfd99287f78d1a034d86ea5df6194780a10d6a0242b808e2ff88af684a4d98028a72e0",
      "line": 183,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 61,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Finally, while physiological tau possesses KFERQ motifs and is degraded by CMA, aggregates, mutant forms and frag- ments interfere with CMA 45,47 .",
      "key": "867b057faed5147b9014c0a198412784cb44d6a4ddc0566e7588255fcd2d2be26f90c8ca1a9460b853a39daeda96c933321dbcdaacffbeb18c513df384730ce0",
      "line": 300,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 61,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tau, α-synuclein and TDP43 are substrates for CMA degradation, as are amyloid precursor protein (APP) but not amyloid-β fragment 42 (Aβ42) itself 3,45–47,48 . ",
      "key": "78573e193d94dcfa5703b45023202a850c5dff7437eab06625b249bc07c59205a096d1020f112faf83a5db7201d12da7360096f62cb04c0cac2508faa9127ff2",
      "line": 184,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 61,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " CMA dysfunction in PD favours the accumulation of α- synuclein and leads to inactivation of the dopaminergic neuron survival factor, myocyte-specific enhancer factor 2D (MEF2D) 2,45,47,55 .",
      "key": "bc7d15ec8d2c6ac5acf8f27312b8640dac326e30947515336ba0b81f88610ff6295305c3980050a4d9a101f9bd16372933d33ea77cde98f3e9ca4dd003f29ce7",
      "line": 388,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 61,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tau, α-synuclein and TDP43 are substrates for CMA degradation, as are amyloid precursor protein (APP) but not amyloid-β fragment 42 (Aβ42) itself 3,45–47,48 . ",
      "key": "bbf5feb70d2d5b2102a93ed93f055cd9985bfe09a61caea20174b66e91d820e2ae452e31e152ad6ef701556bae9b4253b95180e30e65990be89a17c38d299b06",
      "line": 185,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 61,
      "target": 184
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tau, α-synuclein and TDP43 are substrates for CMA degradation, as are amyloid precursor protein (APP) but not amyloid-β fragment 42 (Aβ42) itself 3,45–47,48 . ",
      "key": "fef22b4cce30ee294fd1039b620039e289f6082d7da3c5980ba63dff72b5b0d24564090de9abcc06b4139a59de94d7ac9f4c05f9cf6c33c80f584f367dd0a8d7",
      "line": 186,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 61,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tau, α-synuclein and TDP43 are substrates for CMA degradation, as are amyloid precursor protein (APP) but not amyloid-β fragment 42 (Aβ42) itself 3,45–47,48 . ",
      "key": "9239abae9a3df56678f302d8bdeaca89aad121553350cd8052f4ec5e201f70780a3bf042b45694b670f5f99b0064234201466b3b5a7f298866348d6e25eba29b",
      "line": 187,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "causesNoChange",
      "source": 61,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Htt is not efficiently cleared by CMA, and the same appears to hold for its fragments and mutant and post- translationally modified forms, although the precise role of CMA in Htt elimination remains to be more fully defined 2,45–47 .",
      "key": "4c7ca7497e0c46da80008d12eec52d2d2824cef70e09dedab6a6bcda53cae006b261595547ac59adb68dc3a375bf3317185698ead906f7fe49130cc4e27a03d4",
      "line": 196,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "causesNoChange",
      "source": 61,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Htt is not efficiently cleared by CMA, and the same appears to hold for its fragments and mutant and post- translationally modified forms, although the precise role of CMA in Htt elimination remains to be more fully defined 2,45–47 .",
      "key": "26c2ec4bfa6e29ddcb2335699c4738c5acf65823d4ac8fff3fd226aa16b50531b35c0ced1b1b4a773fac5fbd255dd2e52369eafa72b95de94315b977e592e512",
      "line": 197,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "causesNoChange",
      "source": 61,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Htt is not efficiently cleared by CMA, and the same appears to hold for its fragments and mutant and post- translationally modified forms, although the precise role of CMA in Htt elimination remains to be more fully defined 2,45–47 .",
      "key": "78bd09e35245a63ebf38f8c13c8e0fa26347a9a07f776da0ee9e20d69f535364542b63cbd10ac3ae674b8a9de034264948802b22d209d76592d0a72e236c6efa",
      "line": 198,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "causesNoChange",
      "source": 61,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " CMA dysfunction in PD favours the accumulation of α- synuclein and leads to inactivation of the dopaminergic neuron survival factor, myocyte-specific enhancer factor 2D (MEF2D) 2,45,47,55 .",
      "key": "7863b9f98074729f69526744d3e212159d77e70b017cc4a6953532e0441d3d5d04a3f51a03428bfac76dda681a7b8ae632ae542cd0674aa2fd1cb76a2f1d4de8",
      "line": 389,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 61,
      "target": 159
    },
    {
      "key": "70ef61f3b89c9d067ea1526d4e1b6316726a30a092af7a3cd65b88c1f4270b584582b4f195016b21fdbae19bff824fa458f3e8e3df83d35ad7544379cf31feda",
      "relation": "hasVariant",
      "source": 153,
      "target": 154
    },
    {
      "key": "1f9bd7c2867036707fe963649511c37811b9c55d8f86d32aaf19a2b9ae43692126867debd9355b90aee88e793e854340f6276fe41c9492d1abb3c766f366e2e5",
      "relation": "hasVariant",
      "source": 153,
      "target": 157
    },
    {
      "key": "9fbd9218812f1cd82827e2d73f3b6af04acbe1f408aaedcdc53c6fc17a36272c67cdcc254874f5473ba4443fa19971fe4877420e735c04f4f7353480d8e1f8b2",
      "relation": "hasVariant",
      "source": 153,
      "target": 155
    },
    {
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48",
      "relation": "hasVariant",
      "source": 153,
      "target": 156
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The UPS and CMA are disrupted by neurotoxic proteins like Aβ42 and tau, hence, their early and preventive reinforcement prior to Aβ42 and tau accumulation may be critical.",
      "key": "99883f6ec7260b3aac460fc53958bbf0ef067eb6d7e3c38d5cd04629cbf2e7210b7810f72073d720d2996407490126b31e16d811480dfeab6115af448bcdaa03",
      "line": 1076,
      "relation": "decreases",
      "source": 153,
      "target": 68
    },
    {
      "key": "892d371737b8a859289caced4c4d763309650497f2e73b58bc379b64d1f7a3a19962c0ee817a361a6bbbcfb96d11c59e50167d5baa9b2fe04a181b6576d47322",
      "relation": "hasVariant",
      "source": 177,
      "target": 179
    },
    {
      "key": "be326115b03b23c8f9535c21a847d21c9d71e9ca0a6e59ec5908fdafce0eaeeec33010beead981cf64164710a885bfd84590f8605663c0c087fcfebbf7ab6580",
      "relation": "hasVariant",
      "source": 177,
      "target": 180
    },
    {
      "key": "8b33ffc00ae7c4456651a2f54c7d222899d0cce3ef452d990817774cf5ea992aa398bc0bf62f1ad8ae6704ff66ffc417aefeb74486233db9a2782aac366b9334",
      "relation": "hasVariant",
      "source": 177,
      "target": 178
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Sixth, Aβ42 compro- mises the function of AMPK to impede initiation of the ALN 67 . ",
      "key": "22aa336c6d4db64b4c800f9012a196c6c83463fbc2a614ea3574006a5db670ec3648b0c1a6225e68d82a482a4c11b89a7f52588ddbc25950d1d96f9b04d6ee0b",
      "line": 270,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Sixth, Aβ42 compro- mises the function of AMPK to impede initiation of the ALN 67 . ",
      "key": "49b32a37e334bbf452478075a1be74c29272e0411e4a1a3337a66e488781e1a32580ffd1cf0d5e2fa0626aa5f1313d27517b7727084bfdb4b5babb8b636a75b6",
      "line": 271,
      "relation": "decreases",
      "source": 5,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Seventh, Aβ42 obstructs the UPS and CMA 47,68 . ",
      "key": "c4044cca63424a553d1f193a847840d32a65e7bca2521ba32290423779fb2bdc3c99a76e2fad4cb233439410fefbaeff0d0e5902382be0b1456394d91bb23569",
      "line": 276,
      "relation": "decreases",
      "source": 5,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Seventh, Aβ42 obstructs the UPS and CMA 47,68 . ",
      "key": "a68b2deaff3a828994f2a2a9595f41621c88dab1861dc16b88927c7cb430f32040280818a51d80d1541e3745ef8acb45d01c090c435d4c31be91477f2496798b",
      "line": 277,
      "relation": "decreases",
      "source": 5,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The UPS and CMA are disrupted by neurotoxic proteins like Aβ42 and tau, hence, their early and preventive reinforcement prior to Aβ42 and tau accumulation may be critical.",
      "key": "70c7ec092f56817e39ba24d9d872446a484dfe75c18b68e9864ea9089b5c72619312fa9428f5848b4ff016c707c8888d3404b12a9420ddd1bb519dc3a73c19ae",
      "line": 1074,
      "relation": "decreases",
      "source": 5,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The microtubule stabilizers paclitaxel and epothilone A countered Aβ42-induced cytoskeletal disruption — and moderated excessive UPR — in neurons 182 .",
      "key": "2804010da700ed2bff7c5c96aae39d614071cc3dec563277312f55ca86f482067da352da6d372a117b032d9caa11ac1c371dcbaf027029617610559cb2b842f8",
      "line": 880,
      "relation": "decreases",
      "source": 5,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " In a vicious circle, Aβ42 itself decreases IDE expression, although it may prompt its release from glia 254,259 .",
      "key": "6455aa264d97b45652a0fce055bfb9171eef09e6a97778e47947ff066c07c25c0515e04137c8a805d2dc85613db957142dac191d013d5dba9577704ea3c64de9",
      "line": 1128,
      "relation": "decreases",
      "source": 5,
      "target": 144
    },
    {
      "key": "a3ac61ee6ec4e9b3af47845dbe04b3de658393e1d87be866f3fc491ce0722391f8d21e748e8816d98859b534dff8a41ea1d7df7603199741e1d45d50c1675f96",
      "relation": "hasVariant",
      "source": 140,
      "target": 142
    },
    {
      "key": "b42ad1b8e9597c423c725b75c4086729a97204b2b559865d4a6ad337d474de0d31fcbf6f5cd1b378fab26ffaa9207436362424447e799777b4dd78852565af35",
      "relation": "hasVariant",
      "source": 140,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Mutant Htt is cleared by autophagy, but it compromises the ALN because of decreased cargo load- ing and impaired autophagosome formation and trans- port 55,56,68,92 . ",
      "key": "139fc5d5d355058f5eeb0a336317d15979948e74bfc561dd342164d74319e9817de17495d14ef9a97095452721631fe4c8eb6e3a262a49139f89cc60995d5b10",
      "line": 442,
      "relation": "decreases",
      "source": 142,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Mutant Htt is cleared by autophagy, but it compromises the ALN because of decreased cargo load- ing and impaired autophagosome formation and trans- port 55,56,68,92 . ",
      "key": "889aef078281b20a11e4ef07e8f45226a199a58ced3ce63fb07619dbc6f54eec6577456bfb2319be6572673cf30b32b583d07ab39d6ad00c91f46157e7260d40",
      "line": 443,
      "relation": "decreases",
      "source": 142,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Mutant Htt is cleared by autophagy, but it compromises the ALN because of decreased cargo load- ing and impaired autophagosome formation and trans- port 55,56,68,92 . ",
      "key": "8ed539e59144e14cb17fcdb65a8573ac9c129ddd2e414a2be31fe2cf39d3e408a3e5622d75fc6ebdb7c94dce94e5731f44293fff0fbfadb1f962c1bfe7f10109",
      "line": 444,
      "relation": "decreases",
      "source": 142,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dendrites": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Interestingly, the UPS is important for elimination of tau and other neurotoxic proteins in post synaptic dendritic compartments (a key site of spreading), where it plays a more general role favouring synaptic plasticity, den- dritogenesis and memory formation 49,52 .",
      "key": "efbdbc7f2a34b7c044d7b0b51e3d2f28d46cbc7c955837674cea04ae37a3b1284a813e7026c8cd9f680ee0abfdb016d877ccb414ec5aa28336fa44e6c497f3c0",
      "line": 208,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 68,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dendrites": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Interestingly, the UPS is important for elimination of tau and other neurotoxic proteins in post synaptic dendritic compartments (a key site of spreading), where it plays a more general role favouring synaptic plasticity, den- dritogenesis and memory formation 49,52 .",
      "key": "45d8dd947f4da36005ad63dd86674379eb7e87c81f14e4da450c7e7e5cf4830749e0724fc913cf8eca553bdde5219c8ace9418100d1173289ad4eae365d72246",
      "line": 209,
      "relation": "increases",
      "source": 68,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dendrites": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Interestingly, the UPS is important for elimination of tau and other neurotoxic proteins in post synaptic dendritic compartments (a key site of spreading), where it plays a more general role favouring synaptic plasticity, den- dritogenesis and memory formation 49,52 .",
      "key": "007e5215e5c5ddfb891175ae60ad857ef3d8a86b7ad0b81e4aa2d0dc4a4c9b53ef05dab6a535a6fdb7cd70265d72fc2c7f4c54d5d4562df243147bb076a07f5d",
      "line": 210,
      "relation": "increases",
      "source": 68,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dendrites": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Interestingly, the UPS is important for elimination of tau and other neurotoxic proteins in post synaptic dendritic compartments (a key site of spreading), where it plays a more general role favouring synaptic plasticity, den- dritogenesis and memory formation 49,52 .",
      "key": "82da7a32cd5cabbcc4d34a9e5d43dcac4846c6d3cec31c4637621eac3e7184f262d6c3d15e035ad5e49e578abd9230df412244f69f4f0fe76ccffa356f1fdf66",
      "line": 211,
      "relation": "increases",
      "source": 68,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Second, while decreases in beclin 1 levels in AD remain to be confirmed, SIRT1 expression is diminished 24 . ",
      "key": "99367b36cb81668cf7c0a10d877a2a79cf78c574a0ae5d2ed343e2b6772becc5c61af188bab2a04e2ca4e78b7323ded3d9c01c7323ff68d15f105baef406c855",
      "line": 221,
      "relation": "decreases",
      "source": 193,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, genetic mutations and anomalies of presenilin 1, a dominant negative gene linked to AD, are associated with reduced lysosomal v-ATPase-mediated acidifica- tion 40,63 , a compromised ALN and deficient mitophagy 64 . ",
      "key": "f9238efe8b9f1b69c8e812c99ab78fddb0cbbc533f94a4bf7110c4c327da5c74a92a7e57d4fedb91e82010dd760a2b998de2ea5020486cc1be746fb7a89b16ba",
      "line": 249,
      "relation": "positiveCorrelation",
      "source": 193,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Selenium deficits have been linked to AD, and thus it is interesting that seleno- methionine boosted ALN flux, from AMPK recruit- ment through autophagosome formation to lysosomal degradation, in the 3×Tg AD mouse model 112 .",
      "key": "62988ed243654e20bf2f61f2a7bab5067f8a046d7ce4e6048d6fc4394fc2fe380bed8da430c97e41ff480cb259cc29d137ae2da15624b6c496cd4d2157909bff",
      "line": 533,
      "relation": "negativeCorrelation",
      "source": 193,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " ABL1 is overactivated in AD and tauopathies such as FTD 152 .",
      "key": "24a1b6e6195ea7846ffafad4db6c044d55f57cdeb8ef559b949bdb2f57a99ca3ee0b8bf93ae40ad4fcac74aad0707a05168f587c2fb2173779a0673bb6be9772",
      "line": 758,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 193,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrum": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cerebral levels of IDE are reduced in early AD and in mouse models of AD, whereas, mirroring AD amyloidosis, Aβ42 accumulates in mice genetically depleted of IDE. ",
      "key": "d504072cdf0a984eb983a0e220ace6e11931b14bf9deba4a075a730a8ef765648528482cfd3101cbcf577b5d4da8860f01e01c712d69f2fd044cee5a4b2d411c",
      "line": 1120,
      "relation": "decreases",
      "source": 193,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Similar to IDE, neprilysin catabolizes Aβ42, and its loss in mouse models of AD and in patients with AD alike also contributes to Aβ42 accumulation 253,256,260 .",
      "key": "7a94b0d54cac381029b36c93a913bda246d4fc3830d388b185754e3f65cbb90991f8cb847c4c0a33ebff803646565fcbb125c5fd0f7405e399ced7109448610e",
      "line": 1144,
      "relation": "decreases",
      "source": 193,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Like IDE and neprilysin, plasmin degrades Aβ42 and blocks Aβ42-induced toxicity, suggesting that the decrease in its levels in AD is involved in the evolution of AD 254,256,261 . ",
      "key": "932fe32a7555bcdff016ee12ddca2cf0c1a9aa99a6046dbe31334741d259adf643be3ee59d1bdcb2473276f31c59985442a7f992836d161ce496a943631d9d14",
      "line": 1154,
      "relation": "negativeCorrelation",
      "source": 193,
      "target": 168
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Third, apolipoprotein E allele 4 (APOE4), a major risk allele for sporadic AD, is associated with increased generation and accumula- tion of Aβ42  (REFS59,60) .",
      "key": "f232824568e436967b231852bdb56f8867500a4c5dfe9b55b9fdad9bd1317aa01d9fe6a50c2291272ced8c65884607e1927b629f32e3a333d0a1a3f2030c84c2",
      "line": 229,
      "relation": "increases",
      "source": 88,
      "target": 193
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Third, apolipoprotein E allele 4 (APOE4), a major risk allele for sporadic AD, is associated with increased generation and accumula- tion of Aβ42  (REFS59,60) .",
      "key": "c3b8386e23a4f7601408adfc2ea32337fbf1aa855a7e53227dcbec14f692129d102f486fe1587e4655d5c0a198bdcf61c5b771a56c2b3a231fcdcd4f2c437c61",
      "line": 230,
      "relation": "increases",
      "source": 88,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cytosol": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In addition to decreased degradation, one consequence is leakage of asparaginyl endopeptidase into the cytosol, where it generates toxic fragments of tau 61 . ",
      "key": "a80af3e0dd7c3ce8b05ba330b10cec42602d773d2b86736ca7ecc722d69f368d3d32321ff45c2f62b9c5becda5805095f678d52da8385c124b955a85ec4c38ed",
      "line": 239,
      "relation": "increases",
      "source": 88,
      "target": 148
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cytosol": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In addition to decreased degradation, one consequence is leakage of asparaginyl endopeptidase into the cytosol, where it generates toxic fragments of tau 61 . ",
      "key": "7ba49d1db7bd3525d4196c27e78c25e7a759ae6a5febe8bb66a0ace6f3af7874752ac5475b0199d422b26f3373581acc80aac0d50b6b6c00f573a37df3d51795",
      "line": 240,
      "relation": "increases",
      "source": 148,
      "target": 154
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Finally, while physiological tau possesses KFERQ motifs and is degraded by CMA, aggregates, mutant forms and frag- ments interfere with CMA 45,47 .",
      "key": "a47758fc1310dfacdf5513810ec095f72afe4d7c1858727635936361860f27009dea32297823e8ae1e99864d0fb3557e0fbadfe0b5088ebca6b965910f54dfe7",
      "line": 303,
      "relation": "decreases",
      "source": 154,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, genetic mutations and anomalies of presenilin 1, a dominant negative gene linked to AD, are associated with reduced lysosomal v-ATPase-mediated acidifica- tion 40,63 , a compromised ALN and deficient mitophagy 64 . ",
      "key": "284f06fb651cbe1a3ab756869d61bc9b4a10fac566f0567f1363e55c4bc9ac110db331e23c27dad24869cefc4a4aad4d5bfe9c3a046b88d72a17d42f8a0a3043",
      "line": 249,
      "relation": "positiveCorrelation",
      "source": 92,
      "target": 193
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, genetic mutations and anomalies of presenilin 1, a dominant negative gene linked to AD, are associated with reduced lysosomal v-ATPase-mediated acidifica- tion 40,63 , a compromised ALN and deficient mitophagy 64 . ",
      "key": "eeba9e2f14570c0b6ea3c4d97f60ed47bef0c61e99829e8ad14292e30bc6ff99a5aa5b484506bc3bc170fe765dfe76fc70b4989b635ec51bb1e3d17d1608c3f7",
      "line": 250,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 92,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, genetic mutations and anomalies of presenilin 1, a dominant negative gene linked to AD, are associated with reduced lysosomal v-ATPase-mediated acidifica- tion 40,63 , a compromised ALN and deficient mitophagy 64 . ",
      "key": "739f82a0d30c93b2e8f078cfb245128e0899fe6d4a543032561ad311a83a691a881647c5f6f616a514b97709ff912711959d3b15c188c56663668c3d94855328",
      "line": 251,
      "relation": "negativeCorrelation",
      "source": 92,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, genetic mutations and anomalies of presenilin 1, a dominant negative gene linked to AD, are associated with reduced lysosomal v-ATPase-mediated acidifica- tion 40,63 , a compromised ALN and deficient mitophagy 64 . ",
      "key": "8f4a0a24d6f04bf8af54b1da3c9210a55d3fbb8525b6f0ce50477f3048a996074392fc36c7f79764bfd45da62efefd0b34fed45509478071b84a6c58b4518c94",
      "line": 252,
      "relation": "negativeCorrelation",
      "source": 92,
      "target": 76
    },
    {
      "key": "a2b8b0f059845e4ae4e318598e7fcf54e0cf135333ca9ad300e19ae7be549302b6e14013807e0f5fd2f00d2429f3ab759d5beb8aad79ee3abf084f13d8dd760d",
      "relation": "hasVariant",
      "source": 91,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, genetic mutations and anomalies of presenilin 1, a dominant negative gene linked to AD, are associated with reduced lysosomal v-ATPase-mediated acidifica- tion 40,63 , a compromised ALN and deficient mitophagy 64 . ",
      "key": "54036bd8cee9b8f69364b530ea2b48a970da23a63da7719cf02e837ef495b519726070a5106a01b80249be232f8d7c12afdcae7e4881462aa43e3173a2363c3e",
      "line": 250,
      "relation": "negativeCorrelation",
      "source": 80,
      "subject": {
        "modifier": "Activity"
      },
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, genetic mutations and anomalies of presenilin 1, a dominant negative gene linked to AD, are associated with reduced lysosomal v-ATPase-mediated acidifica- tion 40,63 , a compromised ALN and deficient mitophagy 64 . ",
      "key": "bcc81467af91970b7f027b560217fea2814eaae7e40c8b596ecbd0d73de2001b6c008adfd2eaf2a1d1e39ecbae11f15887ae7846bca152aaa0f549e6392b2b1c",
      "line": 251,
      "relation": "negativeCorrelation",
      "source": 72,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Mutant Htt is cleared by autophagy, but it compromises the ALN because of decreased cargo load- ing and impaired autophagosome formation and trans- port 55,56,68,92 . ",
      "key": "3813470c441fb4a84dad85748e54480863e9841871f05b1e02fa55fc5a92bc53f73288412f1f9c54142dc170700a9c5a67f3f3565376628d255bece81f632102",
      "line": 441,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 72,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fifth, mutations in APP similarly disrupt endosomal and lysosomal func- tion, in part owing to accumulation of the β-secretase- generated, carboxy-terminal and Aβ42-containing fragment of APP called C99  (REF.66) .",
      "key": "2e911c910a1299b0e9c339900c1f9811b42b1f2b33496306c4b04ee681c204a3bfebd11cf33e9841204e5f92036ef875fb44956def86265b3367be1b2e39ca80",
      "line": 261,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 90,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fifth, mutations in APP similarly disrupt endosomal and lysosomal func- tion, in part owing to accumulation of the β-secretase- generated, carboxy-terminal and Aβ42-containing fragment of APP called C99  (REF.66) .",
      "key": "4a166961f3ba3026f1b7cb97f27ba556a6cd67c6cdad63bbed0abe6121aba530382ef2fc0f62bade714a5bc5c0628deb523417385d4b166f3350accb2fcbd28f",
      "line": 262,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 90,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fifth, mutations in APP similarly disrupt endosomal and lysosomal func- tion, in part owing to accumulation of the β-secretase- generated, carboxy-terminal and Aβ42-containing fragment of APP called C99  (REF.66) .",
      "key": "6ccecf586d35fc178117625de6f30febc3baf476101c61014453782bc7d5e100c9006f0bd65474feeb0dd32ccf1e41fc64357226a1e97e719503a0f648af48c1",
      "line": 263,
      "relation": "increases",
      "source": 90,
      "target": 106
    },
    {
      "key": "f1813f708385bd7ca9d6d7aa2a0e30e78c35478c9e91d7a97338422b4e47578afb15b950ca60c0fed3f910b20817212a5009476f193d0a207a85469d7e62aeca",
      "relation": "hasVariant",
      "source": 89,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Both aggregates and mutant forms of tau likewise block the proteasome, and its ability to degrade hyper- phosphorylated and oligomeric tau is reduced compared with its ability to degrade physiological tau 3,55,68 . ",
      "key": "a6da713dcb5fcbe355aac72c82b2cdd39c9c7de43418af494818e7cd97ecb5a4cd6cf61dd1110c7de87301beb5b97f5350a1661b56c03492195a17bae0618b0c",
      "line": 285,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 42,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Both aggregates and mutant forms of tau likewise block the proteasome, and its ability to degrade hyper- phosphorylated and oligomeric tau is reduced compared with its ability to degrade physiological tau 3,55,68 . ",
      "key": "754192ee8c4cfb9efabbd2adeb1656e6eb09f6933ba6059e7a35379bb4af46dd51945a10bf1c75e0bdce3607af1552bc97493d7734f71ca01818c148e7fe525b",
      "line": 289,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 42,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Both aggregates and mutant forms of tau likewise block the proteasome, and its ability to degrade hyper- phosphorylated and oligomeric tau is reduced compared with its ability to degrade physiological tau 3,55,68 . ",
      "key": "9a5172c8adf74a6febc29b8a0b86b268cdb23801af995e75c84737560a1ac462a444b6e410fab129ee2ba21732f4971536291536c100c597e6e751e2516f6a58",
      "line": 290,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 42,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Finally, while physiological tau possesses KFERQ motifs and is degraded by CMA, aggregates, mutant forms and frag- ments interfere with CMA 45,47 .",
      "key": "d14bdfe25042cb7c13796e27ac38eb062b21f1e0d38e099424c530f833efc330efb6e9c17a69cfdea2c90c355359ea3dd5b69617795798f6b4ef84823a5cef5f",
      "line": 301,
      "relation": "decreases",
      "source": 42,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Both aggregates and mutant forms of tau likewise block the proteasome, and its ability to degrade hyper- phosphorylated and oligomeric tau is reduced compared with its ability to degrade physiological tau 3,55,68 . ",
      "key": "ca9f3ce771262ca15233c8b8b495cda7132de5e20f55f3bc7a5cd746d4e00efe3bb701a3308d0241671929950bcda6a8631c6bf4eb7938b50004edb2b6ff22bc",
      "line": 287,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 81,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Both aggregates and mutant forms of tau likewise block the proteasome, and its ability to degrade hyper- phosphorylated and oligomeric tau is reduced compared with its ability to degrade physiological tau 3,55,68 . ",
      "key": "689a8ac031c3d7a3113f73bf5e7c1a72811771891dc2ebd6fafa4fabb11764b35299528b3604abc374f1d395865410f1253c1956a937e33a2dbd7fe064190c2c",
      "line": 288,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 81,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Both aggregates and mutant forms of tau likewise block the proteasome, and its ability to degrade hyper- phosphorylated and oligomeric tau is reduced compared with its ability to degrade physiological tau 3,55,68 . ",
      "key": "e3e24574d2030598321723938aac00576c23762a7599315fc791a026c7cfe9c7b376fc98fa2025f855d00d6a097906b95ec4a802a86692810a24cd35d91b3b99",
      "line": 286,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 157,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Both aggregates and mutant forms of tau likewise block the proteasome, and its ability to degrade hyper- phosphorylated and oligomeric tau is reduced compared with its ability to degrade physiological tau 3,55,68 . ",
      "key": "90ed7b3e08b96931a65e3f73b189c2e78fdc0975eafd7aa84df5ecad32d725343f9e21ef55b8c5ba8e9998e4a8952dc35506b6d719229062de8fe56f712836c5",
      "line": 291,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 157,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Both aggregates and mutant forms of tau likewise block the proteasome, and its ability to degrade hyper- phosphorylated and oligomeric tau is reduced compared with its ability to degrade physiological tau 3,55,68 . ",
      "key": "eaa4275878fedba3c4e99994bd88f12652bbc38cbc174d7b217ad707c9f4f6a290a66b784f96a308f4ecac764b47175cf7156ba8007915d497f7191bf1fcc521",
      "line": 292,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 157,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Finally, while physiological tau possesses KFERQ motifs and is degraded by CMA, aggregates, mutant forms and frag- ments interfere with CMA 45,47 .",
      "key": "ca5a6202d8d26885f5de6908b30598c85f3e0b774628af180ce68eaf13b5034481f68d0ba1444bb084af1b77ae67ccfc5ac3679ffd0294155123dedf5ded0cb9",
      "line": 302,
      "relation": "decreases",
      "source": 157,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "First, autosomal recessive forms of early-onset PD are associated with mutations in PTEN-induced putative kinase protein 1 (PINK1) and the E3 ubiquitin-protein ligase parkin; these mutations lead to deficits in the mitophagic removal of damaged mitochondria 69,70   (BOX 2) .",
      "key": "62b9cc3a1935ca9e7afe24c6eed66e4a73b84f5ee42717b363cb67a6cc7aa76032a7ebc39c2f68ee7126343fc0e909c1ff4dc02e46a3dc24dd25db74eb2cac00",
      "line": 315,
      "relation": "association",
      "source": 167,
      "target": 198
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "First, autosomal recessive forms of early-onset PD are associated with mutations in PTEN-induced putative kinase protein 1 (PINK1) and the E3 ubiquitin-protein ligase parkin; these mutations lead to deficits in the mitophagic removal of damaged mitochondria 69,70   (BOX 2) .",
      "key": "3f6816ec7a6178a7292c39152dc324e0f055b79e59140ee8f704fcf8a15ab262bb537933b318de0d6d67f8617cdc91fdc14978f75f0c9fc31367213b9ed172d9",
      "line": 317,
      "relation": "decreases",
      "source": 167,
      "target": 76
    },
    {
      "key": "08bf67fe0b32986bfa401bccb19f8a802ef685b677066ad9e6f2c1b6793ed7fee7bbbb7b8e8a6dad71a59ca9bafc5ac1ddd4047880a36e1ee2ef886520ccc4fc",
      "relation": "hasVariant",
      "source": 166,
      "target": 167
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "First, autosomal recessive forms of early-onset PD are associated with mutations in PTEN-induced putative kinase protein 1 (PINK1) and the E3 ubiquitin-protein ligase parkin; these mutations lead to deficits in the mitophagic removal of damaged mitochondria 69,70   (BOX 2) .",
      "key": "eb4b2fcc5043c05969a1985d3a4c3b9b76df8ee112ddd1a2eebd5edbf51e0722b0cfe746360b1a3e12c504a35a6da5b49d427f6a0a72d548facdb00f4dcbfe05",
      "line": 315,
      "relation": "association",
      "source": 198,
      "target": 167
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "First, autosomal recessive forms of early-onset PD are associated with mutations in PTEN-induced putative kinase protein 1 (PINK1) and the E3 ubiquitin-protein ligase parkin; these mutations lead to deficits in the mitophagic removal of damaged mitochondria 69,70   (BOX 2) .",
      "key": "44a4b9c9fe3b32429fe99eaab25b268b559c5c1ef1f76864c9962a2c0ffd41945567ed9689331c90736d1f22f6097631973cfbbe0ad20d1cb932a4a0b9e940eb",
      "line": 316,
      "relation": "association",
      "source": 198,
      "target": 170
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Second, the GTPase leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) is the most commonly mutated protein in late-onset, familial PD. ",
      "key": "162e1d2f04eb0dcae3ce62f94dd712da7529076c108670c0bed0ff2b141c4128bde5490dedd63bc78f6fc9b678913dd0a20be9ff178296ddf3b5ad747f258b7f",
      "line": 326,
      "relation": "association",
      "source": 198,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "First, autosomal recessive forms of early-onset PD are associated with mutations in PTEN-induced putative kinase protein 1 (PINK1) and the E3 ubiquitin-protein ligase parkin; these mutations lead to deficits in the mitophagic removal of damaged mitochondria 69,70   (BOX 2) .",
      "key": "8e8318f09056eadd8874085d7daf22ceb58a87834e0b4e618af973510ac7835d045c107ef6145f54e0cb577146fd45adaa834495a9a42c505fbe9bea8a2c0071",
      "line": 316,
      "relation": "association",
      "source": 170,
      "target": 198
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "First, autosomal recessive forms of early-onset PD are associated with mutations in PTEN-induced putative kinase protein 1 (PINK1) and the E3 ubiquitin-protein ligase parkin; these mutations lead to deficits in the mitophagic removal of damaged mitochondria 69,70   (BOX 2) .",
      "key": "47cf1cfc04a5b264a8a6c7d51172bc64b24cda5612306e3cdb8b154541ff8c126da3288c8a10d9dcb65ac25afe8c8fc3d55d9f8d01e82a7a2952da9e5a5bd974",
      "line": 318,
      "relation": "decreases",
      "source": 170,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Furthermore, mutations in the gene encoding parkin and several other genes are linked to reduced UPS activity 2,56,69,79,80 .",
      "key": "07aa80fbad78bc242e4f463c1fb5552bd3a6d124d04f11fe4a3417f6f3cfc2b617ec7d96bdd87f74c5759379dae9879400aa87807f66c86412b02051a415e400",
      "line": 373,
      "relation": "decreases",
      "source": 170,
      "target": 68
    },
    {
      "key": "10487a8d22b323a87b2ef92474948fe9cbbd3497ae38566976f3685b17a3f09a26f540d1004db223ccacd9eef7e6d00a24383486bf7c3f9af7c6e962c6c86f2c",
      "relation": "hasVariant",
      "source": 169,
      "target": 170
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Second, the GTPase leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) is the most commonly mutated protein in late-onset, familial PD. ",
      "key": "9538a09a54ce636adecdd85b8bafb91f434cdf1ec8750723ee9110e93ab38e6ee6d49b27411940d3e5d2ac0d4a5d80282b7f514a20efeb83dcf300de49c705b5",
      "line": 326,
      "relation": "association",
      "source": 151,
      "target": 198
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Some of these lead to an impairment of the ALN owing to reduced activation of beclin 1; another repercussion may be altered process- ing of APP, providing an unexpected link to AD 69,71–73 . ",
      "key": "18129d703e9cb55ed1af294fb91690c8062d9e88f0a77d20bb977b54b75d51f746f87c1184ffd7cb5faa1e66b2e2b2f9b01c33148b79136f612b43edb6217f9f",
      "line": 334,
      "relation": "decreases",
      "source": 151,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Some of these lead to an impairment of the ALN owing to reduced activation of beclin 1; another repercussion may be altered process- ing of APP, providing an unexpected link to AD 69,71–73 . ",
      "key": "ae5c2f86cc8e3ae996fd3c6a0e0fd41bd254d9978a294b01016145a3ee3a3159d5fed3c3398dad922b1e0e8669c50977130416762c9b6556d874a373cce7b157",
      "line": 335,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 151,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Some of these lead to an impairment of the ALN owing to reduced activation of beclin 1; another repercussion may be altered process- ing of APP, providing an unexpected link to AD 69,71–73 . ",
      "key": "142770d54f39924c66b7cb7a7c4d910ab31da326316f6ea200cae2a2ad155748cc56d771edba92b4adfe9056899f99508c91c119ab599f3f6e4e482b0c73aa72",
      "line": 336,
      "relation": "association",
      "source": 151,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " In addition, CMA is disrupted by sev- eral genetic mutations occurring in PD, including muta- tions in LRRK2  (REFS2,3,45–47,55,69,80) . ",
      "key": "ac817914e4cf824aacdf826c2cf566a2ccaf34bf282a156e5f92285694bd5cfe91dbc3a18df0907ff6727f4092b80b1972635e4ab809f977e7c34ce40df0f4a9",
      "line": 380,
      "relation": "decreases",
      "source": 151,
      "target": 68
    },
    {
      "key": "559d9ceb76a658aa6be33e8d5730b26212596896a15dfe3a89d79a7732609fc67e355b0660f6dc0acc96a09da8acf8d93e424c282149f3f005cb4d5306c6b094",
      "relation": "hasVariant",
      "source": 150,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Some of these lead to an impairment of the ALN owing to reduced activation of beclin 1; another repercussion may be altered process- ing of APP, providing an unexpected link to AD 69,71–73 . ",
      "key": "25e858878d33d24073587a357e3f4ad303a194d466b74c458412beffbed5a5c60e2878b56f964c22155dc94a6e43385b141bcc254e34d03d4e69de41894d4974",
      "line": 336,
      "relation": "association",
      "source": 77,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Third, α-synuclein mutations, triplications or excesses amplify the ALN burden, interfere with auto phagosome formation and irreversibly disrupt the lysosomal mem- brane 1,3,44,56 .",
      "key": "64ba2b4997a1cc1f991b49cb55875dfad630191e4ae258afa8797388f263ac54123efb9b5f91e455217b631073b0eae285cd53d6994e43aabac6650e698b71fe",
      "line": 344,
      "relation": "decreases",
      "source": 179,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Third, α-synuclein mutations, triplications or excesses amplify the ALN burden, interfere with auto phagosome formation and irreversibly disrupt the lysosomal mem- brane 1,3,44,56 .",
      "key": "6e3fe467eb072589570988e9088ab802d6040a8686ab544b30e723246249ee7d5061c412592e0de5ec1b1e8b29717643fc5fff02fabfcfc133f0438202e2d5fe",
      "line": 345,
      "relation": "decreases",
      "source": 179,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Sixth, aggregates and mutant forms of α-synuclein disrupt the proteasome in dopaminergic neurons. ",
      "key": "1e4c441c5639a2ff7b41e9e1b02de8ef45f54c3bdd435d045d32084133e668ad84e47fbd85dcc8d7fdce56c28360f6cecbc27986ba691f99f48d01d11b441b53",
      "line": 366,
      "relation": "decreases",
      "source": 179,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, homozygous mutations of lyso- somal β-glucocerebrosidase (βGCase; also known as GBA) provoke the LSD Gaucher disease, which is linked to decreased ALN flux, α-synuclein accumulation and a fivefold increase in risk of PD 43  (Supplementary Box 1).",
      "key": "ae5c999785cf91a9a7a1f6ece88db81a28ecbfa85cc199235601621d14ef8914563667a669f436641de510d8bc22d45fe09b294803cf988c87acbc06c47bf2f4",
      "line": 354,
      "relation": "increases",
      "source": 137,
      "target": 196
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, homozygous mutations of lyso- somal β-glucocerebrosidase (βGCase; also known as GBA) provoke the LSD Gaucher disease, which is linked to decreased ALN flux, α-synuclein accumulation and a fivefold increase in risk of PD 43  (Supplementary Box 1).",
      "key": "fbea3a388f6e12c52827f44c3cd48d8462fd07daa2ee7d3520b29a5e4200dfdb08aad018f93422d47bd33389148c88749f535060b0265c42e9cb7ef6c24a927c",
      "line": 355,
      "relation": "decreases",
      "source": 137,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, homozygous mutations of lyso- somal β-glucocerebrosidase (βGCase; also known as GBA) provoke the LSD Gaucher disease, which is linked to decreased ALN flux, α-synuclein accumulation and a fivefold increase in risk of PD 43  (Supplementary Box 1).",
      "key": "398db5a2e863db1ff35fdaf156c598b8032b082dad3723834f15e74b7181c095b3dbbcf34b86f9adaab6663eec58aaeac7023ea2ba0a0185450bcb99628b8495",
      "line": 356,
      "relation": "increases",
      "source": 137,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, homozygous mutations of lyso- somal β-glucocerebrosidase (βGCase; also known as GBA) provoke the LSD Gaucher disease, which is linked to decreased ALN flux, α-synuclein accumulation and a fivefold increase in risk of PD 43  (Supplementary Box 1).",
      "key": "a55f7d328f591ffd871cf3fe7a6163bfabad4a4d3339ed98cfd88dcbc8597bde35a413f7f57638c1f52c5f04541b2db72c278273ff8c2b35d511aa5308c8a0da",
      "line": 357,
      "relation": "increases",
      "source": 137,
      "target": 198
    },
    {
      "key": "37ffd640dcb8e259485e2ea20e366c3fc4e58dabf60338380577853ba34afb6106cac955ae5f444aed9b7cf0a9fd02e8f6bea60ef6dadf8a28f7b5f42dc0dd52",
      "relation": "hasVariant",
      "source": 136,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Sixth, aggregates and mutant forms of α-synuclein disrupt the proteasome in dopaminergic neurons. ",
      "key": "ff149c3ab6af7281445c08379c7691379aabc29f06da66c34ca0690ed21d8f6f9098572d8ce4844faef12982034af7f514a8fbad7a9d81f31a17505432287bde",
      "line": 365,
      "relation": "decreases",
      "source": 44,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "However, in light of common risk genes such as SQSTM1 (which encodes p62) and chromosome 9 open reading frame 72 (C9ORF72), FTD is increasingly linked to ALS 82,83 . ",
      "key": "30cb30251e998b35f6124a725de6f307f0ebbb97af4b7d09a1cefb19b707632aab2f950057d7cd74a5a43beb9309d01de0f12ac53bf19f84cecf3d2596799b00",
      "line": 399,
      "relation": "association",
      "source": 182,
      "target": 195
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "ALS shares many causal genes with FTD, including SQSTM1, CHMP2B, TBK1 (which encodes tank-binding kinase 1), OPTN (which encodes optineurin) and other genes associated with deficits in ALN and mitophagy.",
      "key": "bd2af8189a988c83770a7d6879fd206d3511629c40cf45bab3c8b35066b3fb7603477213d34126c3d9e5e2b15458b99a1c98bc4dee73fb429ad544908af5beca",
      "line": 412,
      "relation": "association",
      "source": 182,
      "target": 194
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "However, in light of common risk genes such as SQSTM1 (which encodes p62) and chromosome 9 open reading frame 72 (C9ORF72), FTD is increasingly linked to ALS 82,83 . ",
      "key": "e3c44bcf5a2c2361dc31ea557e548c9135f4ed9b13379ee943cc2052edf94596931e6e3588690a5bc806aa4864efedb4838fe57f42378047178b09c494b27658",
      "line": 399,
      "relation": "association",
      "source": 195,
      "target": 182
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "However, in light of common risk genes such as SQSTM1 (which encodes p62) and chromosome 9 open reading frame 72 (C9ORF72), FTD is increasingly linked to ALS 82,83 . ",
      "key": "97d8ab8e66fa9abc2a4cfe6a50f8ed05e4b5066a904d04311c692f5f277fecefb3e1641add3638039e2fba5b4c7160afb67dbdf3e5845a3d92505157129926a4",
      "line": 400,
      "relation": "association",
      "source": 195,
      "target": 123
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "However, in light of common risk genes such as SQSTM1 (which encodes p62) and chromosome 9 open reading frame 72 (C9ORF72), FTD is increasingly linked to ALS 82,83 . ",
      "key": "5353a5a5110dfeeffbf445e75ff110aa1cd2f68d00b8a7a201157f9427a76187efcad8b83966a914eafbdad45880426c0cc1ef452b537432fcd744fef0febc77",
      "line": 401,
      "relation": "association",
      "source": 195,
      "target": 194
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " ABL1 is overactivated in AD and tauopathies such as FTD 152 .",
      "key": "ccaaca7e6a4e57e84ef9714a728ea99f677e649b306813a162000a89ab9d0e18b78496e14980be521d955b9383ab38c552b306bfc4f45ed931c3378ff6feba8a",
      "line": 759,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 195,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "However, in light of common risk genes such as SQSTM1 (which encodes p62) and chromosome 9 open reading frame 72 (C9ORF72), FTD is increasingly linked to ALS 82,83 . ",
      "key": "2685113b17f929ecad97f889131781af09c0c9b8408c91792b2f39dabccc9336e36f7894dee842fe30cb74f19cf2c190308106a35fb638019b7aa3b88f731db0",
      "line": 400,
      "relation": "association",
      "source": 123,
      "target": 195
    },
    {
      "key": "3541dbf8c0ae09acbc5d2dafbd707f9e8eefa347ee51b9a4f43aa89e5ee2583464155e136dc73d22c1796d966b9e561084c4c2a85288423be585387cc06e0f7c",
      "relation": "hasVariant",
      "source": 123,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "However, in light of common risk genes such as SQSTM1 (which encodes p62) and chromosome 9 open reading frame 72 (C9ORF72), FTD is increasingly linked to ALS 82,83 . ",
      "key": "32970d2652ea01460f0224e28d6564b4a54900a8a9404629da96d5dc3ca1ccb2d93caff72ece923b34f05463e6560e5e8c12f121e5eca522210185e6ddb2d324",
      "line": 401,
      "relation": "association",
      "source": 194,
      "target": 195
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "ALS shares many causal genes with FTD, including SQSTM1, CHMP2B, TBK1 (which encodes tank-binding kinase 1), OPTN (which encodes optineurin) and other genes associated with deficits in ALN and mitophagy.",
      "key": "165f2e5e197b8341b79c9388dad7aa730996dde718aca42dd75a5b58e967d146e7c60dd7b0b8abb6a289600ad106218009d818a206efe4e8e1dbfa346c194162",
      "line": 412,
      "relation": "association",
      "source": 194,
      "target": 182
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "ALS shares many causal genes with FTD, including SQSTM1, CHMP2B, TBK1 (which encodes tank-binding kinase 1), OPTN (which encodes optineurin) and other genes associated with deficits in ALN and mitophagy.",
      "key": "abdee6695837de88bda964b2a3c4f8d9ff55ee8cb7408bb1d2f9e6fd4e686268f12c951da3c7bd949d2e45225063194e265feaabcf48b16572039ee747fd544c",
      "line": 413,
      "relation": "association",
      "source": 194,
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "ALS shares many causal genes with FTD, including SQSTM1, CHMP2B, TBK1 (which encodes tank-binding kinase 1), OPTN (which encodes optineurin) and other genes associated with deficits in ALN and mitophagy.",
      "key": "fbd22e7dc07888271abf77b518d2fb8275a3c27173fe6f88a0cc042c6d73c090588fbdf35aca69af6560f357f42f2bdcc41294a52722bb68e11a91ca90f79669",
      "line": 414,
      "relation": "association",
      "source": 194,
      "target": 185
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "ALS shares many causal genes with FTD, including SQSTM1, CHMP2B, TBK1 (which encodes tank-binding kinase 1), OPTN (which encodes optineurin) and other genes associated with deficits in ALN and mitophagy.",
      "key": "931b3b07ce866e6e1d3dc2c05e3b95347b42938003cd1d634ac0b682b31e31fbcb546b7532a8d1c1b3185af057ec4057786fe220a1dae0c19363715db1157050",
      "line": 415,
      "relation": "association",
      "source": 194,
      "target": 164
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "ALS shares many causal genes with FTD, including SQSTM1, CHMP2B, TBK1 (which encodes tank-binding kinase 1), OPTN (which encodes optineurin) and other genes associated with deficits in ALN and mitophagy.",
      "key": "cb6535779128c88f4b9c4a22594cacfc1f8527753e52c06485eb8e258c7232f367536e280bf8be859ef3a0f6d85bc89f302dc6d695b14f8a910a6a95cf313247",
      "line": 413,
      "relation": "association",
      "source": 130,
      "target": 194
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "ALS shares many causal genes with FTD, including SQSTM1, CHMP2B, TBK1 (which encodes tank-binding kinase 1), OPTN (which encodes optineurin) and other genes associated with deficits in ALN and mitophagy.",
      "key": "f9d3cbcdba42522a27300da4df61bf12fa6bfc3aed5d01664836dfd28591da082077067f999bd68ef26a4204a967a6d01e46fbf8cf058cf60cd56591a67a84cc",
      "line": 414,
      "relation": "association",
      "source": 185,
      "target": 194
    },
    {
      "key": "450ec0f16c7ec6ca2749b9a71baf3f38094a2606a88d441b05dec5c27e7a4680a689efd81b45bcfbfca4641f71a44ed19b4bb5a31e8f5f080a94f75a8e44f0e3",
      "relation": "hasVariant",
      "source": 185,
      "target": 186
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "ALS shares many causal genes with FTD, including SQSTM1, CHMP2B, TBK1 (which encodes tank-binding kinase 1), OPTN (which encodes optineurin) and other genes associated with deficits in ALN and mitophagy.",
      "key": "75833f7e1b463d7eaad32e092dcbe523cb74fb279aedb34237f65fecfff548f5f42ee158a23dc6e29056e6831ec0d7963c9f149d92bbb35a0931f97164af79cb",
      "line": 415,
      "relation": "association",
      "source": 164,
      "target": 194
    },
    {
      "key": "b6cebba6519bed0b1c423f982bc37af00785019b4b40588201a2b33fd8904a28d3220072fffab0e74dc90dc2a40cb3fbd49251a20d29a624832737ad403616fa",
      "relation": "hasVariant",
      "source": 164,
      "target": 165
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "For example, mutations in OPTN and TBK1 interfere with cargo loading 82,84,87 .",
      "key": "8c5239ff6210fb7df190f87f9c67cbc4135ce13d21b512ee85b9d0b6528d8de16383caddf5708033aa2b680c4bca246c1391f7ed89d1471e3504d7693e29c0ed",
      "line": 421,
      "relation": "decreases",
      "source": 165,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "For example, mutations in OPTN and TBK1 interfere with cargo loading 82,84,87 .",
      "key": "e9c1341431d0ef0feb608bd610d6417ceac2ae65e470736e07a2db2890935779de708f4e5eb11ce64d7ee5ca135d5474ae34176a15303549f74e803330e0c0f3",
      "line": 422,
      "relation": "decreases",
      "source": 186,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Mutations in C9ORF72 (the most prevalent risk gene for familial ALS and FTD) are likewise linked to disruption of the ALN, including interference with dynactin–dynein coordinated transport of autophagosomes along axons of motor neurons to the perikarya 82,88 .",
      "key": "76ee6803c5d69f059b264c01ef3fd9b85824d426465c01491101ab25c53301f435806e0dc30a7a1e9fede7ea7cbed998b070c0c4211bc9e4445ebb3edc5605d6",
      "line": 431,
      "relation": "decreases",
      "source": 124,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "For example, methylene blue coun- ters tau oligomerization and promotes autophagy 101,102 (Supplementary Table 4).",
      "key": "1186297abc9f76149ec2d1019f07271cdff4dc34c2cc3b1339c816373c3143e2c13c72c93a23f4086d9840d194390f2bc86145c948b98366ede4340579bfb254",
      "line": 453,
      "relation": "decreases",
      "source": 11,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "For example, methylene blue coun- ters tau oligomerization and promotes autophagy 101,102 (Supplementary Table 4).",
      "key": "8dbe1ae3286dfb6b07a94c4ecad3de78154988f27557e786823fbb3a0506b8aa7f98a43f305395fd8de9a780b0282257ad1caa702eeaca4f0ddf6d85874038e0",
      "line": 454,
      "relation": "increases",
      "source": 11,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Other compounds that act through AMPK acti- vation  include  the  antiaggregant  methylene  blue (Supplementary Box 1), which elevated levels of beclin  1, p62 and LC3, induced autophagy and suppressed tau in organotypic neuronal cultures and a mouse model of FTD 101,102 .",
      "key": "e145eb4c02126774b5b36c179971bbb790bcd064c44f110a00b7c76c27d1262ddaa8f23d1db2f1a77b0d43ed2292ef1b33d435c88fa8c924fa7bc8bd2fd65d54",
      "line": 634,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 11,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Other compounds that act through AMPK acti- vation  include  the  antiaggregant  methylene  blue (Supplementary Box 1), which elevated levels of beclin  1, p62 and LC3, induced autophagy and suppressed tau in organotypic neuronal cultures and a mouse model of FTD 101,102 .",
      "key": "c6e73e22dc14a2d7b4fed6e24e3954c064ed16c0ba5e1793a8098149f45d0b829c3fdb856197add4bf6c74a100e66c6f22e607ae51079fb393e291701a66dcb0",
      "line": 635,
      "relation": "increases",
      "source": 11,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Other compounds that act through AMPK acti- vation  include  the  antiaggregant  methylene  blue (Supplementary Box 1), which elevated levels of beclin  1, p62 and LC3, induced autophagy and suppressed tau in organotypic neuronal cultures and a mouse model of FTD 101,102 .",
      "key": "a2d54b62f931e53691e2bef26acedffc6dd93f5bc3bdf95d1918f9870158e0d6db061bed8ad09b38ebfe9371de65e1623a7ac3d9da2f4d24bbd76328f7f2fa40",
      "line": 636,
      "relation": "increases",
      "source": 11,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Other compounds that act through AMPK acti- vation  include  the  antiaggregant  methylene  blue (Supplementary Box 1), which elevated levels of beclin  1, p62 and LC3, induced autophagy and suppressed tau in organotypic neuronal cultures and a mouse model of FTD 101,102 .",
      "key": "feb003491978ee8d8f733848f5a47a7dfd90423d8e333ae275a778937db2913d6c4b073fb5ffea742646f1966df4a3b38170a8b6fe42082e53d7438f3b1f7846",
      "line": 637,
      "relation": "increases",
      "source": 11,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Other compounds that act through AMPK acti- vation  include  the  antiaggregant  methylene  blue (Supplementary Box 1), which elevated levels of beclin  1, p62 and LC3, induced autophagy and suppressed tau in organotypic neuronal cultures and a mouse model of FTD 101,102 .",
      "key": "eca4dfd4c0421ea7d1ee17fce5d78007f0186321cd06f12a039ab8075d6b356c0cc6cf68b943dc5cd5f0ace7ea198a523f33b97e4e387696cfeb4ffb7792fc13",
      "line": 638,
      "relation": "increases",
      "source": 11,
      "target": 182
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Other compounds that act through AMPK acti- vation  include  the  antiaggregant  methylene  blue (Supplementary Box 1), which elevated levels of beclin  1, p62 and LC3, induced autophagy and suppressed tau in organotypic neuronal cultures and a mouse model of FTD 101,102 .",
      "key": "8914a982b5099c02a154ced6843d83de4b5fd12a057b737b6881b9a18010fee6fa8e74e7888be4a15b1aedca07fb7281a6e2afba8ea6afac9354206b95c77da0",
      "line": 639,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 11,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Indeed, clonidine and rilmenidine, two G i  /G o -coupled α 2 -adrenergic receptor and imidazoline 1 receptor agonists, stimulate autophagy and cleared Htt in cellular 103  and animal models of HD 104 .",
      "key": "778b64cb97db8673b10e8ed8ed424cb650cdd84355b19673d9c33baa1df58d06d06e9169fa4bceaa79554a755be286c6785ace00dc5cbfe49202ed5bc343b80b",
      "line": 463,
      "relation": "increases",
      "source": 23,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Indeed, clonidine and rilmenidine, two G i  /G o -coupled α 2 -adrenergic receptor and imidazoline 1 receptor agonists, stimulate autophagy and cleared Htt in cellular 103  and animal models of HD 104 .",
      "key": "3cfbc1b41260992c8dcdee3cf3e31e4f421a8bb585f9f0757549948880e655e0a03c38cea07e5f28dea67521f625be5e7912653316d9010a9eb0825be6d0e612",
      "line": 464,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 23,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Indeed, clonidine and rilmenidine, two G i  /G o -coupled α 2 -adrenergic receptor and imidazoline 1 receptor agonists, stimulate autophagy and cleared Htt in cellular 103  and animal models of HD 104 .",
      "key": "ac6f1e2435e358b5431644a288306fb51c04c09f6c976099cefdc1694c2863b11ccfb7d4557434b35e581c2605bbcc1c3a1d6f8fba58545e65ad63f3b8d16688",
      "line": 465,
      "relation": "increases",
      "source": 17,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Indeed, clonidine and rilmenidine, two G i  /G o -coupled α 2 -adrenergic receptor and imidazoline 1 receptor agonists, stimulate autophagy and cleared Htt in cellular 103  and animal models of HD 104 .",
      "key": "03b9f0585f3e224ce45d28a87add2e1ec2cb328d2c51b70d47f953e459b15afae62abc7f5da83b724c263011b956fec971d3be23cfa4f029a22678f92f11f54f",
      "line": 466,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 17,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Genetic knockdown of calpain 1 or calpain 2 or overexpression of their endogenous inhibitor, calpastatin, increased autophagy and cleared aggregates in SK-N-SH cells overexpressing a mutant form of Htt 103 .",
      "key": "eaa11ca8f6c280cec3136f12f4a5813f49dde9b1f70cf6aea481de6c821dfe05d96b07e18886bc3afc91ea4272a17c974f0824d369d538b53b7d221c9e63ce76",
      "line": 474,
      "relation": "decreases",
      "source": 126,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Genetic knockdown of calpain 1 or calpain 2 or overexpression of their endogenous inhibitor, calpastatin, increased autophagy and cleared aggregates in SK-N-SH cells overexpressing a mutant form of Htt 103 .",
      "key": "01ec2804e22033be297422804c3e24051e8c278771b372cd336e3b92bc9a00cf22c436344a538776e26df8e03e68bd22df32e2cbcd6be65cc247dab132a2f7d6",
      "line": 475,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 126,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Genetic knockdown of calpain 1 or calpain 2 or overexpression of their endogenous inhibitor, calpastatin, increased autophagy and cleared aggregates in SK-N-SH cells overexpressing a mutant form of Htt 103 .",
      "key": "2d827fb42ee096566994261240f18b13f9ecfa710cbbc965aec6093a296789f90b289b35a7d6fe21c243d1b68fdaea8fe8058d5c456a64bd0754c2728c40982f",
      "line": 476,
      "relation": "decreases",
      "source": 127,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Genetic knockdown of calpain 1 or calpain 2 or overexpression of their endogenous inhibitor, calpastatin, increased autophagy and cleared aggregates in SK-N-SH cells overexpressing a mutant form of Htt 103 .",
      "key": "d60ce79bba6e73eaf86697662ccb3b712ae44df8b75f344a25e403fb942b2ff97fa6c502201c81e6f3554fcc06622b5220f899b41778c8b696375d41917597da",
      "line": 477,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 127,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Genetic knockdown of calpain 1 or calpain 2 or overexpression of their endogenous inhibitor, calpastatin, increased autophagy and cleared aggregates in SK-N-SH cells overexpressing a mutant form of Htt 103 .",
      "key": "763ac3a7a51ca331eebd630ad02a9130dd56162db0825cd7bbe91e5749766ce36a19939bc60fdc91c246bdb4ac83006cc40e3f8aeb8cb03cf797466162f6e0fa",
      "line": 478,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 129,
      "target": 126
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Genetic knockdown of calpain 1 or calpain 2 or overexpression of their endogenous inhibitor, calpastatin, increased autophagy and cleared aggregates in SK-N-SH cells overexpressing a mutant form of Htt 103 .",
      "key": "5e7e8e1b9f53c1ecdd4be9e9e4d3aad89cfe17f6d7f5de8ddf21fa4c54ed97a8c5a59d574101bd49a64ecbf1448976c51733d43dff0394a1ec888e315a639eb8",
      "line": 479,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 129,
      "target": 127
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Genetic knockdown of calpain 1 or calpain 2 or overexpression of their endogenous inhibitor, calpastatin, increased autophagy and cleared aggregates in SK-N-SH cells overexpressing a mutant form of Htt 103 .",
      "key": "cbd0d07ceb936fb19ef6b3bfe18f72a116fc269ead03ab7e4c4afd9ccd09e66d3fc553935b4cd4ffa00cc33c495ce863803aa2f86068d9dd27a6cab3a64dd802",
      "line": 480,
      "relation": "increases",
      "source": 129,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Genetic knockdown of calpain 1 or calpain 2 or overexpression of their endogenous inhibitor, calpastatin, increased autophagy and cleared aggregates in SK-N-SH cells overexpressing a mutant form of Htt 103 .",
      "key": "dfaa5d7e484ff82aec62aea65cbd8a6e3bd6668fd010c02d9164cee7709680686abdab74220e4b935105bdd4cacff036e09f3ca1e8551acf7d0dbdf9c43babb2",
      "line": 481,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 129,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Calpain inhibition by cal- pastatin or pharmacological agents also confers neuropro- tective effects in other NDA models, including improved clearance of tau, α-synuclein and SOD1  (REFS54,106,107) .",
      "key": "0ab99b73ae978bbe53ae2b9ad01937e86940eafd5bf25a0158dfd6779179d0fdab863d290dbd2a97014f8e6c70b8b598616dfea5d1e50bb8d83fc99be09cdaf4",
      "line": 501,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 129,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Calpain inhibition by cal- pastatin or pharmacological agents also confers neuropro- tective effects in other NDA models, including improved clearance of tau, α-synuclein and SOD1  (REFS54,106,107) .",
      "key": "5f48122ff8781a05faaa3be7bd2a8e9fb8bf5124456b45f44e74be7e607d7e68c1d352369bd70486715df42af21ff7dc49de016a4c2a2508c2c2fda566fbaec1",
      "line": 502,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 129,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Calpain inhibition by cal- pastatin or pharmacological agents also confers neuropro- tective effects in other NDA models, including improved clearance of tau, α-synuclein and SOD1  (REFS54,106,107) .",
      "key": "efc9145a5356951a7991c8b691847789db6812d6e9fe46d9ea6ae92271a10b58d44cbb0d7ae9e773f465f0e55d20966285c7cec0529b2bd556bb4b4ce0120dbb",
      "line": 503,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 129,
      "target": 181
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Calpeptin, a cell-permeable calpain inhibitor, can also reduce Htt proteinopathy via induction of autophagy 103,105 .",
      "key": "6147fafc125fe0491c59025a45994b2330e1a24291c7b784807fc8a73c598ba23fae82ef7ae41a94a20717e731d6a4af934cd9e2aa396281334580e5eefa4caa",
      "line": 488,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 15,
      "target": 126
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Calpeptin, a cell-permeable calpain inhibitor, can also reduce Htt proteinopathy via induction of autophagy 103,105 .",
      "key": "ee8f61d914de39ed95bfda971c5b05ceb289d9ccfe45cf11febab8ac27d917de94538c2864c62c9f24937a7f22e793504adc1a67cce81af8c06b147152a1e3fa",
      "line": 489,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 15,
      "target": 127
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Calpeptin, a cell-permeable calpain inhibitor, can also reduce Htt proteinopathy via induction of autophagy 103,105 .",
      "key": "1f4575bed92e178839c884b903ef52a042aee7e3c563c8512269acb91e76ab55a97e1cc6b0fca6c90f7fd97f80adcb1db6ee061f75a3b75c4a712e3ba7b921dd",
      "line": 490,
      "relation": "increases",
      "source": 15,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Calpeptin, a cell-permeable calpain inhibitor, can also reduce Htt proteinopathy via induction of autophagy 103,105 .",
      "key": "7166f0b2e435dc9a672da011c1792de2342c7c1aa7edcdb60a8dd916b9e66f82ea4657cf86d72fb2a40444a099c39e7cbab409d48d550c44f58644b88357ad03",
      "line": 491,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 15,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The aminoimidazole derivative 5-aminoimidazole- 4-carboxamide ribonucleotide (AICAR) undergoes intra- cellular transformation to an AMP analogue that triggers AMPK-mediated autophagy 21,108 .",
      "key": "75fc6273c15a5bb0ee5b19474bb10525034fb6fea4cd10598193913e644ce8b5a8ad4c2d48256e21f27afd1d4c2b8d28f3f923d0af83b4ecd7d8fef10510b7ad",
      "line": 511,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 2,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Another direct facilitator of AMPK, A769662, elicited autophagy and reduced the burden of Htt in a striatal cell line derived from knock-in mice expressing a humanized form of mutant Htt (exon 1 containing seven polyglutamine repeats) 111 .",
      "key": "a6e41ec5bb9bc8c90e0e104a2ba24eb0a578c053c1ffd9a7fd4b0c2c99398408c3ec013638507c22b9e1083f766323bfa45f5ce3bb89a30deeb13e2c92ef8d93",
      "line": 521,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 56,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Another direct facilitator of AMPK, A769662, elicited autophagy and reduced the burden of Htt in a striatal cell line derived from knock-in mice expressing a humanized form of mutant Htt (exon 1 containing seven polyglutamine repeats) 111 .",
      "key": "e529ddc70b4535a9f82a3811db08723c86710277e61c200f76e822b44e23ab15cdd654e6b4a04956c709f3a311922ff3450cb70785e2a70427109d6b9d956e9d",
      "line": 522,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 56,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Another direct facilitator of AMPK, A769662, elicited autophagy and reduced the burden of Htt in a striatal cell line derived from knock-in mice expressing a humanized form of mutant Htt (exon 1 containing seven polyglutamine repeats) 111 .",
      "key": "937e11166d6b11290ada2ec0724c760698025262854f55a2443ab9db9b4c0b7ece93488d7ea932de8e0f8499660c7d544bc857f9d85a020428b22ad0486f88a6",
      "line": 523,
      "relation": "increases",
      "source": 56,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Selenium deficits have been linked to AD, and thus it is interesting that seleno- methionine boosted ALN flux, from AMPK recruit- ment through autophagosome formation to lysosomal degradation, in the 3×Tg AD mouse model 112 .",
      "key": "f2a9c5ca2da7789aaac1c7055b0d60345636f9b78134dc897f982f0cdf7f9ca40df9a26811d7f341a483d49222cd6f909c6a18ac3b8b11e541b6cbe9219498d8",
      "line": 533,
      "relation": "negativeCorrelation",
      "source": 14,
      "target": 193
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Selenium deficits have been linked to AD, and thus it is interesting that seleno- methionine boosted ALN flux, from AMPK recruit- ment through autophagosome formation to lysosomal degradation, in the 3×Tg AD mouse model 112 .",
      "key": "00727d6069f4548369dd544c81caec3fb515c247c752ce9174de690349de2b3b97bcd2f620e5094c0543323435d6b25f089d7170594029e5f5ab0637059d871f",
      "line": 534,
      "relation": "increases",
      "source": 32,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Selenium deficits have been linked to AD, and thus it is interesting that seleno- methionine boosted ALN flux, from AMPK recruit- ment through autophagosome formation to lysosomal degradation, in the 3×Tg AD mouse model 112 .",
      "key": "f7639ca9e5fcf6b6d751864fc62c570f83012152f1aadd12a391d340d1cc1f79e6af143d4dc6b101c348b21b78417de6363fc60b0d33929923d71ad266d121d1",
      "line": 535,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 32,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Selenium deficits have been linked to AD, and thus it is interesting that seleno- methionine boosted ALN flux, from AMPK recruit- ment through autophagosome formation to lysosomal degradation, in the 3×Tg AD mouse model 112 .",
      "key": "17d73e431ae36c24e462ad1f11a157f00b7cd77d94591038d5ec32fbf3c29482cd49e3eecc2bafd6b9da8fd3302cc7f8fdb4845849e46905b963bf5c6a28227a",
      "line": 536,
      "relation": "increases",
      "source": 32,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Selenium deficits have been linked to AD, and thus it is interesting that seleno- methionine boosted ALN flux, from AMPK recruit- ment through autophagosome formation to lysosomal degradation, in the 3×Tg AD mouse model 112 .",
      "key": "a71a4784b4c07f22e145d117d1f10ff2c2c31b8a5bc7edde5408c23fef7dfa9d4f5f09c63210303591687f90bd2f1bae58abfca0315f2910db9f04e68ff5d9a0",
      "line": 537,
      "relation": "increases",
      "source": 32,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The ‘anti-ageing’ agent resveratrol is thought to indi- rectly recruit AMPK via activation of calcium/calmodulin- dependent protein kinase kinase 2 (CAMKK2), which, acting in synergy with Ca 2+ , exerts its effects via Thr172 phosphorylation 113 . This action, among others (below), is involved in its reduction of Aβ levels in N2a cells and neurons 114  and the elimination of Aβ and Htt in animal models of AD and HD 114,115 .",
      "key": "23f50d0f976273fd02665af0d718a62eabcb075b4df8e7ce7043d9b5b0f35b435bc1f4a6d7f4651c2bfd3572fd065eeefc04df880ea845174d9f73d52ea82308",
      "line": 549,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The ‘anti-ageing’ agent resveratrol is thought to indi- rectly recruit AMPK via activation of calcium/calmodulin- dependent protein kinase kinase 2 (CAMKK2), which, acting in synergy with Ca 2+ , exerts its effects via Thr172 phosphorylation 113 . This action, among others (below), is involved in its reduction of Aβ levels in N2a cells and neurons 114  and the elimination of Aβ and Htt in animal models of AD and HD 114,115 .",
      "key": "697859bbffc195b4eeedfd69cd4dd7186ec9b5916c354128597391a9127f857659b9ca490ed30db6de734641f0db3f002dfca65d87b352f8a633a010db45001e",
      "line": 551,
      "relation": "decreases",
      "source": 30,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The ‘anti-ageing’ agent resveratrol is thought to indi- rectly recruit AMPK via activation of calcium/calmodulin- dependent protein kinase kinase 2 (CAMKK2), which, acting in synergy with Ca 2+ , exerts its effects via Thr172 phosphorylation 113 . This action, among others (below), is involved in its reduction of Aβ levels in N2a cells and neurons 114  and the elimination of Aβ and Htt in animal models of AD and HD 114,115 .",
      "key": "3fb81ea82bc391ac1b1d817c174604135124360b3a18d39ed8f64f93fff1df11f8b2cb55847f95a11d6690c7fdd9e442336330ac75fcefc9f05dc07a62201c95",
      "line": 552,
      "relation": "decreases",
      "source": 30,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Resveratrol can stimulate SIRT1 via AMPK (see above), and it also possesses an AMPK-independent mode of SIRT1 recruitment that participates in blunting the neurotoxicity of Aβ25–35 fragments in PC12 cells 160 . ",
      "key": "142345d3af6f3cce2451ece1216b4cd3b779cdd662564dfbdfbeba469443b55522ccdcc2e5652708e640b5d9a6449eab43bff849525f9f4732f928c18b351b6b",
      "line": 784,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Resveratrol can stimulate SIRT1 via AMPK (see above), and it also possesses an AMPK-independent mode of SIRT1 recruitment that participates in blunting the neurotoxicity of Aβ25–35 fragments in PC12 cells 160 . ",
      "key": "2048ceab72dd78e679a757c698f866105c1f02e81cbcf1a0f22d79d24f4bb26eb196096538b0de612f955fe6c890c47a16cd2db8802c32a076a7da61eb756c2a",
      "line": 786,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Resveratrol can stimulate SIRT1 via AMPK (see above), and it also possesses an AMPK-independent mode of SIRT1 recruitment that participates in blunting the neurotoxicity of Aβ25–35 fragments in PC12 cells 160 . ",
      "key": "633c2faa1efed87922b92bc62dbe90c08c5306e0251f0e68f58e9bf54c8ec1e0c4af7b76511b6967b60fb496bb8542a72879a4ea6f52edab83a50baae1718ee7",
      "line": 787,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 30,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The multi-modal agent resveratrol induced the expression of ATG4 and promoted autophagosome formation.",
      "key": "aeb117335575864fcc44d0e1a0583bb2af805fc4f5bf06fe83a900c4ba6e92e6b7afcf8e999e8c2b443fa861702dda9f21c47fc2250088593b8348c6769a2553",
      "line": 853,
      "relation": "increases",
      "source": 30,
      "target": 99
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The multi-modal agent resveratrol induced the expression of ATG4 and promoted autophagosome formation.",
      "key": "e2878823c241346141325d2c023f628ed75622a10b82d59c28af0378f90473a4aecaa1dac0db78ba430bdb8c6860a867124bd33d2c412b60475e6c012cc34389",
      "line": 854,
      "relation": "increases",
      "source": 30,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Interestingly, resver- atrol downregulated RAGE as well as MMP9 — an effect that is related to decreased hippocampal load of Aβ42 (REF.297) . ",
      "key": "42469ec3c71db6e34b7b40a0855194c0e1618e48f9e4063487b09d10d7dcebb06f701d198694dcd5195883b9ba97d737a5d64b0da7a9e0f2b05338589808a8dc",
      "line": 1217,
      "relation": "decreases",
      "source": 30,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Interestingly, resver- atrol downregulated RAGE as well as MMP9 — an effect that is related to decreased hippocampal load of Aβ42 (REF.297) . ",
      "key": "7ff0523402ee4ef9ade24bd717fe2772982cb462be992c92845a2faa4b10b3d602ef73d8e5884d3820dc61e95248e824df9a2590d20b8bffd090a5c90e963496",
      "line": 1218,
      "relation": "decreases",
      "source": 30,
      "target": 161
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Interestingly, resver- atrol downregulated RAGE as well as MMP9 — an effect that is related to decreased hippocampal load of Aβ42 (REF.297) . ",
      "key": "2bd5b3ad6bf0639993452d09d022bb0d9de2fc57c058063f40fe8f734b92e796b238187a7a2b9a5388d968463a2b9907ba3c4c438e5aab8610b07a7fe722c634",
      "line": 1220,
      "relation": "decreases",
      "source": 30,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Another kinase that activates the proteasome (RPT6 subunit) — and directs it to dendritic spines — is CAMKK2  (REF.227) .",
      "key": "bdd1a735258278b5df436a0954a2e47f0d5db345bc7cb6442cac6e1dd932350d089daf9622db0c3b4314ca28b2946c9cf0192ca4fe351f2b10cdda3dd767c6ed",
      "line": 1041,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 125,
      "target": 171
    },
    {
      "key": "bd9f54c37b4f9238c9f9b898ba5715f9ca484d2c0faf4399deef63a4c13414a6c272c5b527b677cf740b77ecd5fd2290fa3757e8e7b0c35fd6c15f64d54b5ea8",
      "relation": "hasComponent",
      "source": 86,
      "target": 7
    },
    {
      "key": "c99ba7d149894fe062514d55f3b73b4ae9f0ebdd98805de0ea22c95060a76c1a6be9773fe616191de6bee1461acf424d7b8602e3f9cb71b62118a6c24877f458",
      "relation": "hasComponent",
      "source": 86,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The ‘anti-ageing’ agent resveratrol is thought to indi- rectly recruit AMPK via activation of calcium/calmodulin- dependent protein kinase kinase 2 (CAMKK2), which, acting in synergy with Ca 2+ , exerts its effects via Thr172 phosphorylation 113 . This action, among others (below), is involved in its reduction of Aβ levels in N2a cells and neurons 114  and the elimination of Aβ and Htt in animal models of AD and HD 114,115 .",
      "key": "257ff4449ef6c70da7464436d06b8e09a666b8f07f4da4798736b6bf3ffb0d7868a4abfa05937d5e595336e77d591788c9a20abc47830bdad7bd45962713be18",
      "line": 550,
      "relation": "increases",
      "source": 86,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The antidiabetic drug metformin, a prototypical activator of AMPK, induced autophagy and increased longevity in mice 116 . ",
      "key": "a2a77c3dbc4dcee35909e5ed643be4aed35d437a3576b206e160af71160ba17ac0dd05d5318bc7c71386e7e7901bc7f7d32ddb620c79faad2ee01668f8844d02",
      "line": 559,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 27,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The antidiabetic drug metformin, a prototypical activator of AMPK, induced autophagy and increased longevity in mice 116 . ",
      "key": "d54c7586d197a4eabde92527a75df832467d3203028df15bbdd215c518a18f779d415c5662ce90f433451bc46a5634d46b0dea711fc3cc7537e94ac5123379cc",
      "line": 560,
      "relation": "increases",
      "source": 27,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Dopaminergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The antidiabetic drug metformin, a prototypical activator of AMPK, induced autophagy and increased longevity in mice 116 . ",
      "key": "7cc689493322d0c2ab6c4a2282ee5eb44e97e80c81f079fa5cf743df77c719dc69759a514359bdbea891dcb4cab763459bc0574c1d8b657c12d1d0d077fbd5ec",
      "line": 561,
      "relation": "increases",
      "source": 27,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Moreover, reductions in levels of hyper phosphorylated tau and Aβ were seen in metformin- treated neurons 117,118 , while it blunted neuronal loss in a neurochemical lesion model of PD in mice 119 .",
      "key": "eea650503af368a7897b69fc33fe8907772aa6950d66ba3adc4cb3b88b422e4369934607abe27931e17bee370681d8e7a044eabc290a6a3adfb12948f37ff4a4",
      "line": 570,
      "relation": "decreases",
      "source": 27,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Moreover, reductions in levels of hyper phosphorylated tau and Aβ were seen in metformin- treated neurons 117,118 , while it blunted neuronal loss in a neurochemical lesion model of PD in mice 119 .",
      "key": "59626daede311ba32361993e3c9ea0c8e7fb4e2c0aede21bc70a95613965001d6b6091b2b165320282e38a240fd58d8c31a382516643d1aa5872db0ddeb5cf1b",
      "line": 571,
      "relation": "decreases",
      "source": 27,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Moreover, reductions in levels of hyper phosphorylated tau and Aβ were seen in metformin- treated neurons 117,118 , while it blunted neuronal loss in a neurochemical lesion model of PD in mice 119 .",
      "key": "b16ae92630d92635d041b9edb71e6db961b68ecc70825e809af8dccdef36b3154562cf7da3bf6027d6be687e9f3afd0677dfdbfd7cf009fcb15734e6b1c7d525",
      "line": 574,
      "relation": "decreases",
      "source": 27,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The di-glucose derivative trehalose inhibits the sol- ute carrier 2A (SLC2A) family of glucose transporters to promote AMPK-induced autophagy and reduce neurotoxic protein load, although it also exerts other actions downstream in the ALN 4,120 . ",
      "key": "5284d16958ccea0cdcdcf5c7159bb419479a0a18d0779baf3a3a7684ebdabb902536a66149171e082b293446f4ffc8ab4fe1d1e55df60d417ab103e72a3f3acb",
      "line": 584,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 4,
      "target": 176
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The di-glucose derivative trehalose inhibits the sol- ute carrier 2A (SLC2A) family of glucose transporters to promote AMPK-induced autophagy and reduce neurotoxic protein load, although it also exerts other actions downstream in the ALN 4,120 . ",
      "key": "de654642c9dca482f4ddcfda598c05fc90d1b0f503c7ba4d9c40cdb90955601d825880158b85d9ee7cc5b02f9b2d0604b986f500cb6eb50b5ef701b82857e3b1",
      "line": 585,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 4,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The di-glucose derivative trehalose inhibits the sol- ute carrier 2A (SLC2A) family of glucose transporters to promote AMPK-induced autophagy and reduce neurotoxic protein load, although it also exerts other actions downstream in the ALN 4,120 . ",
      "key": "7214f9c4279074b04ab7e0771c6930b11eb0bfbf6ca35c78bb8382367b875386c960bf0e92c7956418dc86dc8e6995152cc905d655e480a42dc4f8dbb647d480",
      "line": 587,
      "relation": "increases",
      "source": 4,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also proved effective in cellu- lar models of PD, HD and AD 121,122 , as well as in mouse models of HD, AD and tauopathies, where it cleared aggregates, reduced neurodegeneration and ameliorated motor and cognitive performance 123–125 .",
      "key": "7760653e96a9b7d1b8ac7a8f6ae9f94338160d4c4fb143ca880652ea7b721e8a8e698382caebaf588d745c04f2ec0e99b951ed2c79c458e933aa6e045cf3ba16",
      "line": 596,
      "relation": "decreases",
      "source": 4,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also proved effective in cellu- lar models of PD, HD and AD 121,122 , as well as in mouse models of HD, AD and tauopathies, where it cleared aggregates, reduced neurodegeneration and ameliorated motor and cognitive performance 123–125 .",
      "key": "2952a33e052651dad6650956d4796f73e1330b515ee1151e668d4d532fe64be6be85dbf7994a2a0cfaec158fd167b4c28c9fc3d6651c55be812a4f61f3f9af14",
      "line": 597,
      "relation": "decreases",
      "source": 4,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also proved effective in cellu- lar models of PD, HD and AD 121,122 , as well as in mouse models of HD, AD and tauopathies, where it cleared aggregates, reduced neurodegeneration and ameliorated motor and cognitive performance 123–125 .",
      "key": "58d99932ab8719cde98bf956072dd382f7edaddf2e075952401f51430e030885d4e9a8ecdb41d4372e69b4993773c96e5ed02e9f5d359df111825bb355d4a936",
      "line": 598,
      "relation": "decreases",
      "source": 4,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also proved effective in cellu- lar models of PD, HD and AD 121,122 , as well as in mouse models of HD, AD and tauopathies, where it cleared aggregates, reduced neurodegeneration and ameliorated motor and cognitive performance 123–125 .",
      "key": "085d0832c6555f3965553437064316ca94f977e6c36faa7a18694243170da7b5e4d6559264cd0291ea39a7f918a8bee8a1347a46d21a094ccfc7cf18489b8783",
      "line": 599,
      "relation": "decreases",
      "source": 4,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also proved effective in cellu- lar models of PD, HD and AD 121,122 , as well as in mouse models of HD, AD and tauopathies, where it cleared aggregates, reduced neurodegeneration and ameliorated motor and cognitive performance 123–125 .",
      "key": "b9cd065ce3d9dad46693f3499a0f95b451996970a25adc1106fbcbf896ddc0b394d47a0cfd8182ad53afa9d343a83bc55054cec9d1b1f3d4b2b2feef68593d34",
      "line": 600,
      "relation": "decreases",
      "source": 4,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also proved effective in cellu- lar models of PD, HD and AD 121,122 , as well as in mouse models of HD, AD and tauopathies, where it cleared aggregates, reduced neurodegeneration and ameliorated motor and cognitive performance 123–125 .",
      "key": "120241f1520e289ee2489a307b3a3ee98bb545d4d56778470c8fa6fd77d87bb570bcda2a2e3d35fc813511b32ff1515478a0a6ad314c80d599a3ddb22d630d1d",
      "line": 601,
      "relation": "increases",
      "source": 4,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also proved effective in cellu- lar models of PD, HD and AD 121,122 , as well as in mouse models of HD, AD and tauopathies, where it cleared aggregates, reduced neurodegeneration and ameliorated motor and cognitive performance 123–125 .",
      "key": "987ea60d279810201064a9bf295e10473002bba9201beccd4f098d520907b3d499428d18c4e82423cc9195025fc9c6d4883769e7276828f9d38f05264db0cc75",
      "line": 602,
      "relation": "increases",
      "source": 4,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Lithium ions inhibit inositol monophosphatase to deplete inositol triphosphate.",
      "key": "010a0cf1500fe29b2fbd9900e8fe984315251d10f8b2d85971739e41732ac06633162e4951fb5feb99c66cac78d91a9e782f9b1e9d0b097d970fef8cf3442c81",
      "line": 608,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 10,
      "target": 145
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Lithium ions inhibit inositol monophosphatase to deplete inositol triphosphate.",
      "key": "72fd15744c11b5248e8ccbd71affe8f5e905841f87a9728edb4a2eb1a340f3fd4d1f47b4706574a4b340a5cbc7d8fe1798f391778c22ac3fd285bc188e52fe7b",
      "line": 609,
      "relation": "decreases",
      "source": 10,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " This mechanism may be involved in its promotion of autophagy, reduction in cel- lular levels of α-synuclein, SOD1, Htt and tau 126 , ame- lioration of motor function in a P301L mouse model of tauopathy 127  and slowing of disease progression in SOD1 mice 128 . ",
      "key": "1b72e32a013e9244267a678530bae06d15797208bd0dda11760b48b85b198972e43906d4eaca04072dda343ef79721a611a5409b3884f03603b910ff38c5e778",
      "line": 619,
      "relation": "increases",
      "source": 10,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " This mechanism may be involved in its promotion of autophagy, reduction in cel- lular levels of α-synuclein, SOD1, Htt and tau 126 , ame- lioration of motor function in a P301L mouse model of tauopathy 127  and slowing of disease progression in SOD1 mice 128 . ",
      "key": "c9000bb6aead85e51d1def13e72362dd56f4f2d5c58e9eef53109ba6d341b3565b44f135aeb3b83a0885101126bb2d86e37b111ea8183b945dc7eec553b7e6b2",
      "line": 620,
      "relation": "decreases",
      "source": 10,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " This mechanism may be involved in its promotion of autophagy, reduction in cel- lular levels of α-synuclein, SOD1, Htt and tau 126 , ame- lioration of motor function in a P301L mouse model of tauopathy 127  and slowing of disease progression in SOD1 mice 128 . ",
      "key": "f74ca2cc96b82893d39d7df659cc1bdab3a3ad8be2e59e39968fba3e72532fca917c39c6cf7cabf87bdc0f67c805ba5b9009d89e30d70a170c3318d275c4f57e",
      "line": 621,
      "relation": "decreases",
      "source": 10,
      "target": 181
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " This mechanism may be involved in its promotion of autophagy, reduction in cel- lular levels of α-synuclein, SOD1, Htt and tau 126 , ame- lioration of motor function in a P301L mouse model of tauopathy 127  and slowing of disease progression in SOD1 mice 128 . ",
      "key": "ccc75c22bf6522b1df2cc283bf851d4572e3ceb2bae6cfd6ad428236418d5cae935fe4ebf55f23df65cff3e310f2fc53f04414c6c6997bc965ad5d704ccbbc7a",
      "line": 622,
      "relation": "decreases",
      "source": 10,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " This mechanism may be involved in its promotion of autophagy, reduction in cel- lular levels of α-synuclein, SOD1, Htt and tau 126 , ame- lioration of motor function in a P301L mouse model of tauopathy 127  and slowing of disease progression in SOD1 mice 128 . ",
      "key": "d00c56109a9c3f32098b1d5ad0f32a6572e028d8962329e1436989de00045023d12d507bff4c1a98fef46e4a7e65c4553e8517d85191afa9b4097d5a6eb165ff",
      "line": 623,
      "relation": "decreases",
      "source": 10,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " This mechanism may be involved in its promotion of autophagy, reduction in cel- lular levels of α-synuclein, SOD1, Htt and tau 126 , ame- lioration of motor function in a P301L mouse model of tauopathy 127  and slowing of disease progression in SOD1 mice 128 . ",
      "key": "7e444b985d7680045cc82d66106e26564869e6b58041e51e73fec5b8bb300c4162048740c29b6908443d8fc2f5b75aa7f93848daadce7a555b34d3ac33907387",
      "line": 624,
      "relation": "increases",
      "source": 10,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " In addition, calcitriol (the active metabolite of vitamin D 3 ) elicited AMPK-dependent autophagy in a neurochemical lesion-induced model of PD 129.",
      "key": "822b5bcc05c130028d406a9fa09a91ea2f49212c056f75ca903dc23c51db48981643370ee24a0a43e534391e4787f2a8b53eb883eedc9c45649d428304f19682",
      "line": 647,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 20,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " In addition, calcitriol (the active metabolite of vitamin D 3 ) elicited AMPK-dependent autophagy in a neurochemical lesion-induced model of PD 129.",
      "key": "8cc2ca151307d4c3f8ff31b0cfb54f46c794fc0c16ae1324cd2d2672a1ee85ea46e8c39cb8aca5602ca5d86aac576d2c7daa6c42cb60ed6b7ac9424a0ab9eb8b",
      "line": 648,
      "relation": "increases",
      "source": 20,
      "target": 74
    },
    {
      "key": "d3e829e84b6fdb3aed6b62a324ca452aac5154c2dbff9f2c5c873b7b278a9ead1842e2250a5fcac9361be9eb1c826955ec7a50ff3f8db2492a77ec9aefb356ee",
      "relation": "hasComponent",
      "source": 82,
      "target": 33
    },
    {
      "key": "7c53dea8304d4f83c50c292c4fcada380f4aba3c329a97dc1d836b59960cff9caa8f3a0f6e76c534059dd943c5acfbfebc4fd2f5da2ebd90cdb7c7b02b43806a",
      "relation": "hasComponent",
      "source": 82,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "This kinase is classically inactivated by rapamycin, which binds to the modulatory protein 12 kDa FK506-binding protein (FKBP12; also known as FKBP1A).",
      "key": "c74c89847ae64a14af3d287f4e59d7bd46636896018a318cd8bd8e5bef147fb26f1be1b21bfe5618a67fa8edf7ba00b189b31a29a0d2fc1f2143fdde5115bb61",
      "line": 664,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 82,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Enhancing auto- phagy with rapamycin reduced levels of α-synuclein, FUS and Htt 130–132 . ",
      "key": "aff54300cd2e67cfb57a7442b958a77548d68060a52cb0696a8b3b17795b956ff8bed35dd8219e02ff85c5b5b9c7ae7563cdad6c85e851e55639b0e0d0826b11",
      "line": 671,
      "relation": "increases",
      "source": 33,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Enhancing auto- phagy with rapamycin reduced levels of α-synuclein, FUS and Htt 130–132 . ",
      "key": "8c746e194f033bdb1921c4b78f405d6918f95d9dc602633e9158eb53b88a953e470380a798ae62d8625f4a01617d27ec9fbb8433eb8471e6ee4d6cb324c4baa3",
      "line": 672,
      "relation": "decreases",
      "source": 33,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Enhancing auto- phagy with rapamycin reduced levels of α-synuclein, FUS and Htt 130–132 . ",
      "key": "e7cf42abb3b0cf07e2dd6528bf02c04c65d2de292b3535d5e3c9d8551717c4867e903f080c830e80a4633c5ed99c248dc292813db4ac71e6ae49b141d14f266e",
      "line": 673,
      "relation": "decreases",
      "source": 33,
      "target": 135
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Enhancing auto- phagy with rapamycin reduced levels of α-synuclein, FUS and Htt 130–132 . ",
      "key": "746a7680e1983dc43be6357da2745a5894843526e9baf13e55c6e07b4ef3eefb6ccf568f20eb408fb07ae0edb85500ca21e1ca6ae271e163dc2ec008f06893a9",
      "line": 674,
      "relation": "decreases",
      "source": 33,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Likewise, temsirolimus reduced the accumulation of phosphorylated tau in SH-SY5Y cells and P301S tauopathy mice 137 .",
      "key": "0b4f6a24bec17ba73527b15db77a0636f1a7c04fa1544d12c48a004eb503dcbbf71c4e55daa1546bb1f1e38b47d62ba4ecfe42a40c2ec77aa650eb95df216b83",
      "line": 681,
      "relation": "decreases",
      "source": 18,
      "target": 156
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also removed cellular aggregates of mutant Htt and improved motor performance in a mouse model of HD, reduced α-synuclein aggregation and afforded neuroprotection in a lesion-based model of PD and depleted mutant ataxin 3 in a mouse model of supraspinal cerebellar ataxia type 3  (REFS133,138,139) . ",
      "key": "72a770003bdfc396e670e299023a06ca7c63a4690159c822d7322cfc95004349486da1704ec2341cdd37e38d3f19fd4df1e3666f231fcf0d866209ba3daa07d0",
      "line": 692,
      "relation": "decreases",
      "source": 18,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also removed cellular aggregates of mutant Htt and improved motor performance in a mouse model of HD, reduced α-synuclein aggregation and afforded neuroprotection in a lesion-based model of PD and depleted mutant ataxin 3 in a mouse model of supraspinal cerebellar ataxia type 3  (REFS133,138,139) . ",
      "key": "bac2546f993486547821039331022bb371d2409d939406585385aa9262635969e753244dfef2a41b3ee24db8dfc40981e16793d5d51b1c1461b34ea35135aff7",
      "line": 693,
      "relation": "increases",
      "source": 18,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also removed cellular aggregates of mutant Htt and improved motor performance in a mouse model of HD, reduced α-synuclein aggregation and afforded neuroprotection in a lesion-based model of PD and depleted mutant ataxin 3 in a mouse model of supraspinal cerebellar ataxia type 3  (REFS133,138,139) . ",
      "key": "08cceb3818b976e2b355514971ebcb8fb837b12e6768f500a4a8738f49b9bfef574aea8b1b3d3b41e2eab5a2d2144aeaedbf49441ff2ea2f618025a2b7841a78",
      "line": 695,
      "relation": "decreases",
      "source": 18,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also removed cellular aggregates of mutant Htt and improved motor performance in a mouse model of HD, reduced α-synuclein aggregation and afforded neuroprotection in a lesion-based model of PD and depleted mutant ataxin 3 in a mouse model of supraspinal cerebellar ataxia type 3  (REFS133,138,139) . ",
      "key": "faf07bbdc3a695fbcaded1867128ac32a504a1cc7db179babcbacbc9cc2c79db5901373e18832dc22fddda695a5c546ff98cf7ddb17edf4d707068a6fe0429fd",
      "line": 696,
      "relation": "decreases",
      "source": 18,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It also removed cellular aggregates of mutant Htt and improved motor performance in a mouse model of HD, reduced α-synuclein aggregation and afforded neuroprotection in a lesion-based model of PD and depleted mutant ataxin 3 in a mouse model of supraspinal cerebellar ataxia type 3  (REFS133,138,139) . ",
      "key": "99bc0d73e43f25e6f015ebc7b2668b1797f3e47d7b127e2bbe1f22e542b22598365f36d70d0c8a9e34bbee8c56e1c3b027bfa238105fc4f22604699b88c4a7d9",
      "line": 698,
      "relation": "decreases",
      "source": 18,
      "target": 117
    },
    {
      "key": "426e29e4ab315349eba3b0afe904ceed54ac988e8ae3fa0e02f1c5f8b529746830ee2d096c7e585164200e069c05a35155ccd24c5ea57869128e6deedbfefd3d",
      "relation": "hasVariant",
      "source": 116,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The natural product curcumin induced macro- autophagy and protected rotenone-treated dopaminer- gic neurons 141  in addition to accelerating the elimination of mutant α-synuclein-A53T by repressing mTORC1 in a cellular model of early-onset PD, although it also exerts other actions such as inhibition of p300-mediated pro- tein acetylation and of aggregation 142,143 . ",
      "key": "fa7bce5d87e48c469f558dd98c360ff1e80fe0734f77e47904b2bbe5ed72ef15225344aef23905e8e95e601ae0f20bf3e7c179ed3e5ac4d93fd243614de198e8",
      "line": 709,
      "relation": "increases",
      "source": 24,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The natural product curcumin induced macro- autophagy and protected rotenone-treated dopaminer- gic neurons 141  in addition to accelerating the elimination of mutant α-synuclein-A53T by repressing mTORC1 in a cellular model of early-onset PD, although it also exerts other actions such as inhibition of p300-mediated pro- tein acetylation and of aggregation 142,143 . ",
      "key": "a8f0a375032e3c299611e1ca09eab93129af0257f1ea608a81a7fdac8b6ae4df05fa10b052c96e89c7a13f9f2870595058f4aa79d44332a906ba99fddaa213c8",
      "line": 710,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 24,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The natural product curcumin induced macro- autophagy and protected rotenone-treated dopaminer- gic neurons 141  in addition to accelerating the elimination of mutant α-synuclein-A53T by repressing mTORC1 in a cellular model of early-onset PD, although it also exerts other actions such as inhibition of p300-mediated pro- tein acetylation and of aggregation 142,143 . ",
      "key": "c3e255c7c836ac938189e8a15fe079ce3db41dfa708b316ffd47cdcdcaf3512d7754e4fed5ed1f1de61ed8286aacd4b6fb238b17ff4c87eaf8fa11fe0406ff90",
      "line": 711,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 24,
      "target": 180
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Pro-autophagic effects of curcumin are reflected in improved function in cellular and animal models of PD and AD, as well as reduced levels of α-synuclein aggregates 144  or Aβ and tau oligomers 145,146 .",
      "key": "83a2e6cb260b5dab02961205ec0951155c7344afc876d40ca37a16fe011ed49f4f0e5640e0667b47c375c2f7a6174519aadd0e9afee6217b695a146745376f50",
      "line": 720,
      "relation": "decreases",
      "source": 24,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Pro-autophagic effects of curcumin are reflected in improved function in cellular and animal models of PD and AD, as well as reduced levels of α-synuclein aggregates 144  or Aβ and tau oligomers 145,146 .",
      "key": "2848cfd99b13fa18ce80ebec75bd384e535e8685687a81fba83d0a810af1b7fbb474b5a117349b12c683a0b1071ae50e0fc7b67a623ad619b0999ca255495573",
      "line": 721,
      "relation": "decreases",
      "source": 24,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Pro-autophagic effects of curcumin are reflected in improved function in cellular and animal models of PD and AD, as well as reduced levels of α-synuclein aggregates 144  or Aβ and tau oligomers 145,146 .",
      "key": "a5951185488d56dd366fe77adb25ea2bbe3d530a88731f52cba0024a855d0fa1dfde0adc4d74a9fc2347bd7aec9dd094cb1b128a50c037d3cf328850d29a24a1",
      "line": 722,
      "relation": "decreases",
      "source": 24,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Moreover, the flavonol fisetin stimulated auto- phagic degradation of phosphorylated tau in cortical neu- rons via mTORC1-dependent activation of TFEB and the cytoprotective transcription factor nuclear factor eryth- roid 2-related factor 2 (NFE2L2) 149 . Fisetin also reduced Aβ accumulation in an APP/PS1 mouse model of AD 150 . ",
      "key": "d8f6f4209448ac929b8388ad5ecf009e61258577c2d9ee44d4e50ee2997c189195e10fc1c83a13c20cb5a576f4753ff1657eb1b355f58c011f29ab6df58c2057",
      "line": 739,
      "relation": "increases",
      "source": 25,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Moreover, the flavonol fisetin stimulated auto- phagic degradation of phosphorylated tau in cortical neu- rons via mTORC1-dependent activation of TFEB and the cytoprotective transcription factor nuclear factor eryth- roid 2-related factor 2 (NFE2L2) 149 . Fisetin also reduced Aβ accumulation in an APP/PS1 mouse model of AD 150 . ",
      "key": "c6e982bdca2323eb3318460796fa720cf5e740b722d940138b980c2d8df7d12779930e551a3664a29ae44b255497ad2285e5e0177b117cb7b5d0efd9fd4d721a",
      "line": 741,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 25,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Moreover, the flavonol fisetin stimulated auto- phagic degradation of phosphorylated tau in cortical neu- rons via mTORC1-dependent activation of TFEB and the cytoprotective transcription factor nuclear factor eryth- roid 2-related factor 2 (NFE2L2) 149 . Fisetin also reduced Aβ accumulation in an APP/PS1 mouse model of AD 150 . ",
      "key": "6864911b09afb0d3be12ba6f9b53bb83d1796ad1c2dc944fff3dd6e32086e75eb16726f83c95b7807abfe75b821cce4174719d00a9dea6341d99e1b7dac033ed",
      "line": 744,
      "relation": "decreases",
      "source": 25,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Tyrosine-protein kinase ABL1 is a proto- oncogene that  negatively  regulates autophagy,  partly  acting upstream of the RAC serine/threonine-protein kinase (AKT)–mTORC1 axis.",
      "key": "f5359a6c4380c530eef809ebbabc436186bffe89a6ee439b05623e37c3bbe9d8ad0bf457ce2ae30ec04c3a12dd0cf8af7c72f76aced0e6b3c52d4387922e2910",
      "line": 752,
      "relation": "decreases",
      "source": 107,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Inactivation of ABL1 with brain-penetrant nilotinib conferred neuroprotective autophagy in mouse models of PD 153 .",
      "key": "a1433b897b71c761607a7b65755462d97ec634d2168b27f65fd77a5974a85a00d6b8382b4e35c808924dd1a97a5b9ef2f81660577049de52903d3f7d21590291",
      "line": 766,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 28,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Inactivation of ABL1 with brain-penetrant nilotinib conferred neuroprotective autophagy in mouse models of PD 153 .",
      "key": "eb055b53948fed105f52e7a5f15814a59b87f250b585f06b40096276745207114cffedb38eaeeb14623b96ee5eba9f8f9e5b8562b31bc3632729a8e8e76128de",
      "line": 767,
      "relation": "increases",
      "source": 28,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Inactivation of ABL1 with brain-penetrant nilotinib conferred neuroprotective autophagy in mouse models of PD 153 .",
      "key": "47bb0dcd51fc38ed31ff663e2a635f705655abe98816bb160298e784051c10fc3e55862d6481f0cc6588ae2567bc5ea1e4dac432a26b90067cff44b459699919",
      "line": 768,
      "relation": "decreases",
      "source": 28,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Activity of the deacetylase SIRT1 declines with age, partially owing to limited availability of its co fac- tor, nicotinamide 24,56,156 . ",
      "key": "ad769bb7c1b5315d2a56e601a0cc69b916a472bc6c22f5a1639cb4b13afe5bfc09344cd96640081552f2e42d9002a477399d0dd57bf3f0b0c01ebe699dd27408",
      "line": 775,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 71,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Activity of the deacetylase SIRT1 declines with age, partially owing to limited availability of its co fac- tor, nicotinamide 24,56,156 . ",
      "key": "b0353660e61b07e7f2a90cee264afda5cdbd2dce50406349753fc487c50fc45b72ecbf04d7f2d2a70005fe4fd6e0c570845cd74728c08969679b50a2ddd25303",
      "line": 776,
      "relation": "decreases",
      "source": 71,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .",
      "key": "81e044c14b5955a91d29acaa4eab1e022603eb6f7b939c078530735c04eac43baf96dd422ef4ca66f1f8d3cae41cd181fe3d15fb6eca9e83c6433d9d58ef2609",
      "line": 797,
      "relation": "decreases",
      "source": 22,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .",
      "key": "b3c406e6ba71404926c47a5d58c02e898343f1a21f6fd74148785222fe760bb7cb9a2884112ffa523fe3112123f4b14c12e302fd59a5e4a95559264f967adcfd",
      "line": 798,
      "relation": "increases",
      "source": 22,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .",
      "key": "c434153524c55d777e950d88fefe735faff54bb4962890fc3c51947e69dd48a99c7970016c4b4c5eaa57c36129de41765c6a162cf0dc513ff42a25b973e42c2a",
      "line": 799,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 22,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .",
      "key": "4a5097d1c4a94c9bc9702594f0ecd7c91b9564ef19f8910366a712c159406f0b2b773809a2492ff2b85d6e0147e7d0740414f216175443e603b68396ce282ad8",
      "line": 800,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 22,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .",
      "key": "c43b6227b14eb54df92a6bd205ec888e49074888e5ec768317924b6343326c1a30ddb84e64dced6000bee5178bfbd7059d4e6f6868adf7d4516062c41af0f20b",
      "line": 801,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 22,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .",
      "key": "44c8813fb9b840a5ac311097df6e8962e7ce6af508884bb9e80b70b0dd6c064564d5539346fefdebfe40ce2bce2d5eb4d6f08176ac21e8b3ada2bd8cb88fec97",
      "line": 802,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 22,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Lysosomes": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .",
      "key": "a63f8e52b36d86e0497ccc71007f48b7f61620b61b4357f24c2ce25ff5151effb1ca9d96c2fc65f4c673f8889abcfe3c75865a353b3aa619de1e6381ce4c5a1c",
      "line": 804,
      "relation": "increases",
      "source": 22,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .",
      "key": "4f8e8047d2c2b638e34a51a6f97e1209a584088ee79e636e28930fa0f22bb5c22c80f27f8390f6efa863e83331121c20aa84558ed3fd5d2cd865eda4f215f9a3",
      "line": 806,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 22,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol (a phosphodiesterase 3 inhibitor) clears Aβ42 from neuronal cell lines by promoting autophagy, upregulating beclin 1, ATG5 and LC3, downregulating mTORC1 and inducing lysosomal cathepsin B; these actions of cilostazol involve activation of SIRT1 as well as upstream Tyr172 phosphorylation of AMPK 108,162,163 .",
      "key": "440f37713ae90e82775eaa5d96fc254a2282f51513d177abb597936b5369775788eebe639e9eabcfc5131d38d19a83bee751522052046511bd1fe0cdc5d8a414",
      "line": 807,
      "relation": "increases",
      "source": 22,
      "target": 98
    },
    {
      "key": "ed4078e46bb64a0b78abf9a0cc4c28557347378ba6e2da269b0f74d9d9a3476e105da3378d0a6f3d79b947c3c83c8451a9e04baa1dc827ad3466fe9d5edf21a0",
      "relation": "hasComponent",
      "source": 87,
      "target": 22
    },
    {
      "key": "3a26646d9da62c5bafbcc2c10be2dcb75f16465236e3e0ceb3751f1e69beadcee9753b1231f03fd8d6f4d340b3723b768be06767a4fadda453c13dbc664dcba6",
      "relation": "hasComponent",
      "source": 87,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol improved cognition and reduced levels of Aβ42 and hyperphosphorylated tau following intra- cerebroventricular injection of Aβ25–35 into mice 162,163 .",
      "key": "fc1cd4ff880034cfb9dd8bac081da564e881669a7a07d8df2a8080556d703a674b59ff8ca744e5da4da876c3ce20beb12296915fb550c379a94d4929e053c87d",
      "line": 814,
      "relation": "increases",
      "source": 87,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol improved cognition and reduced levels of Aβ42 and hyperphosphorylated tau following intra- cerebroventricular injection of Aβ25–35 into mice 162,163 .",
      "key": "f3b9ac7892e0ed8ac80ffb6c0b8246f0e2f8720040b450dfc994695076e914461efa2b6dbfa208c478bf257ce8226c07709d6f5e78ff7615ca3734b729a5bc4f",
      "line": 815,
      "relation": "decreases",
      "source": 87,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Cilostazol improved cognition and reduced levels of Aβ42 and hyperphosphorylated tau following intra- cerebroventricular injection of Aβ25–35 into mice 162,163 .",
      "key": "3599efe1819f4c789dcec75785d46e2d3ddeecbba0d587424af86f31fca7b68ca60479d6bf74b101a93d2415f1ef0c0428ef8cd2a92b1d378a635d8fe6eb9fe7",
      "line": 816,
      "relation": "decreases",
      "source": 87,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Spermidine inhibits the acetylation of ATG7 and histone H3, while induc- ing beclin 1 via blockade of its cleavage by caspase 3 (REF.168) . ",
      "key": "58764262e5a452c4a4c08b378ca563f01a0bb60f10fe75846e47d145047e4cab44f87ad2d085f1f80efbbe0ccf83205aa562ab7bf94c19f81154e2a5fb768de7",
      "line": 824,
      "relation": "decreases",
      "source": 35,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Spermidine inhibits the acetylation of ATG7 and histone H3, while induc- ing beclin 1 via blockade of its cleavage by caspase 3 (REF.168) . ",
      "key": "3dd940a6751c443fb3df9a1647d9d2b8e1af738fda0f20b901a70ac519d5e54a8948029c037c76d6b8f9f19b9bcc162252a3afebd34afa553667219f52d62643",
      "line": 825,
      "relation": "decreases",
      "source": 35,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Spermidine inhibits the acetylation of ATG7 and histone H3, while induc- ing beclin 1 via blockade of its cleavage by caspase 3 (REF.168) . ",
      "key": "35a37e2985ee99ddad914d859f4ab66e4871b3af408414b3aef20a80c730ed5e3000dd18686dc0379be47bb99774df939cff5d6f941535809ebf1fe7e56f3cd1",
      "line": 826,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 35,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Spermidine inhibits the acetylation of ATG7 and histone H3, while induc- ing beclin 1 via blockade of its cleavage by caspase 3 (REF.168) . ",
      "key": "30f8e4b10925defe1cea5f49af9105f15921abfd4a2b8385738eb83ec5d5231f2b22bebc3b4facd162770a70af444cb43a59a80e074536b2091de8a8f5eb286f",
      "line": 827,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 35,
      "target": 128
    },
    {
      "key": "1ec00482458ab8ea4f0eddc7be162883ab426d528c6d3c5c3a7811c2518faf3ed6e80e486c28823409406fb73d4963d9b669145e7991814209eeb3372cf9d483",
      "relation": "hasVariant",
      "source": 94,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Spermidine inhibits the acetylation of ATG7 and histone H3, while induc- ing beclin 1 via blockade of its cleavage by caspase 3 (REF.168) . ",
      "key": "83d75648a0288a826c1de55e89f66e9ceab838e70e2dffbcd3ea69eea7ebb8225aa0d63997e0e47642da8bd2622a567eec01750de9ff770bbec9d97d4ff31e68",
      "line": 828,
      "relation": "increases",
      "source": 128,
      "subject": {
        "modifier": "Activity"
      },
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Spermidine inhibits the acetylation of ATG7 and histone H3, while induc- ing beclin 1 via blockade of its cleavage by caspase 3 (REF.168) . ",
      "key": "f99451641bc1d273c3ab7ae568eb7ff6456558b2f5d8ed496dd998b074e27844b72a920d0c46d0a1db41ad26114b39afbb3a4024a1f3bd108ec3b87f30cecf8a",
      "line": 829,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 120,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In addition, the plant-derived alkaloid isorhynchophylline upregulated beclin 1 independently of mTORC1 and promoted autophagic clearance of α-synuclein, although its precise mechanism of action remains to be clarified 175 . ",
      "key": "ec5902fc0badd8a489f01974a24f215d66010aebec786780d3f249ed48cae4da12a485c22996a35d9d93f7ec434d5f4640f201a775257e5d3e03f6a4a618749c",
      "line": 838,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 16,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In addition, the plant-derived alkaloid isorhynchophylline upregulated beclin 1 independently of mTORC1 and promoted autophagic clearance of α-synuclein, although its precise mechanism of action remains to be clarified 175 . ",
      "key": "1fb3fdc03f33b0eef855f4bb3fd161d16006144e48e0869c823398f90323cf832cfad131d5d80e4244894210c69e45573b68eda3ec5efefcbaf8771999f2a385",
      "line": 839,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 16,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In addition, the plant-derived alkaloid isorhynchophylline upregulated beclin 1 independently of mTORC1 and promoted autophagic clearance of α-synuclein, although its precise mechanism of action remains to be clarified 175 . ",
      "key": "e572c561cc939545d91a6f968ac17df4d8d514e8e08dba7bf6199c68183ae2eff91382145747cd400e04392b34a53b5e4586a299ee576006535c3b8e650d4e9c",
      "line": 840,
      "relation": "increases",
      "source": 16,
      "target": 74
    },
    {
      "key": "791b3b7d9000cae879a8cfaeef4b174c7b43d5373271642337dc05c8e06596f438fcc7d50c342014f69b8f7b91840f5495dc3936aefe85cd12139ddbbca9bae3",
      "relation": "hasComponent",
      "source": 83,
      "target": 118
    },
    {
      "key": "0ea82cb76064783063a003a33f461754dfbbfede1de26a13b4f967cfc1688f6b1d599ff553f2aac4c5f9f47f6124398729e01e5918237537cb9b749676a9b31e",
      "relation": "hasComponent",
      "source": 83,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Disruption of this Bcl-2–beclin 1 complex is an alternative approach for promoting autophagy, as achieved in mouse fibroblasts by the BH3 mimetic ABT-737  (REF.177) .",
      "key": "f738224cb6cb29a2a7455615020661d71bc57a09f0288aa9ab3b813d137af198033417595a9286080fa69fb2a6e47fbdd8b4010245749eb90060b778387cce16",
      "line": 848,
      "relation": "decreases",
      "source": 83,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " An unusual approach to augmenting autophagosome formation is represented by the brain- penetrant autophagy enhancer 99 (AUTEN-99), which blocks myotubularin-related protein 14 (MTMR14, also known as Jumpy), a phosphatase that inhibits the phos- phoinositide 3-kinase (PI3K)-mediated generation of the autophagosome membrane  (FIG. 3) . AUTEN-99 aug- mented autophagic flux in isolated neurons, increased markers of autophagy in mouse brain and slowed neuro- degeneration in D. melanogaster models of PD and HD 181 .",
      "key": "49ef3981625c03cc9033afd1703de3686a7cc97ec02e94c1e0664c23ee3eeb0b140f53c0bae712010d042c6cbdd851bec7979f41e87c24c64726a49828c67b21",
      "line": 868,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 52,
      "target": 162
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " An unusual approach to augmenting autophagosome formation is represented by the brain- penetrant autophagy enhancer 99 (AUTEN-99), which blocks myotubularin-related protein 14 (MTMR14, also known as Jumpy), a phosphatase that inhibits the phos- phoinositide 3-kinase (PI3K)-mediated generation of the autophagosome membrane  (FIG. 3) . AUTEN-99 aug- mented autophagic flux in isolated neurons, increased markers of autophagy in mouse brain and slowed neuro- degeneration in D. melanogaster models of PD and HD 181 .",
      "key": "b11a5f74f1875d462644847af6c400f9120276ad2078fe78174f7b18de6d5f330af628b18c10390fbcc40fa5a860c04ec8b6af96ff0984aae749e2d5b4c0c6b7",
      "line": 871,
      "relation": "increases",
      "source": 52,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " An unusual approach to augmenting autophagosome formation is represented by the brain- penetrant autophagy enhancer 99 (AUTEN-99), which blocks myotubularin-related protein 14 (MTMR14, also known as Jumpy), a phosphatase that inhibits the phos- phoinositide 3-kinase (PI3K)-mediated generation of the autophagosome membrane  (FIG. 3) . AUTEN-99 aug- mented autophagic flux in isolated neurons, increased markers of autophagy in mouse brain and slowed neuro- degeneration in D. melanogaster models of PD and HD 181 .",
      "key": "ff95809f3cdf55a2c421720ff6594e4e5baa9f32d6f727bae3d8347fb623d749ad6b01f154977c29c4b40f106c9b786cee1ad5ca3ade84dbf62f628a75aa612e",
      "line": 872,
      "relation": "decreases",
      "source": 52,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " An unusual approach to augmenting autophagosome formation is represented by the brain- penetrant autophagy enhancer 99 (AUTEN-99), which blocks myotubularin-related protein 14 (MTMR14, also known as Jumpy), a phosphatase that inhibits the phos- phoinositide 3-kinase (PI3K)-mediated generation of the autophagosome membrane  (FIG. 3) . AUTEN-99 aug- mented autophagic flux in isolated neurons, increased markers of autophagy in mouse brain and slowed neuro- degeneration in D. melanogaster models of PD and HD 181 .",
      "key": "c22d454b95871e16db3ca955b67442f8e65fa95079e62b32a125d0f538fe13ca6c7efaa8e70f1027fbb213a23e6045aebfe857c1a8e2799775a48ed717f7be4f",
      "line": 869,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 162,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " An unusual approach to augmenting autophagosome formation is represented by the brain- penetrant autophagy enhancer 99 (AUTEN-99), which blocks myotubularin-related protein 14 (MTMR14, also known as Jumpy), a phosphatase that inhibits the phos- phoinositide 3-kinase (PI3K)-mediated generation of the autophagosome membrane  (FIG. 3) . AUTEN-99 aug- mented autophagic flux in isolated neurons, increased markers of autophagy in mouse brain and slowed neuro- degeneration in D. melanogaster models of PD and HD 181 .",
      "key": "434fc19585e1a8e5707386b4c17f2e961e68f04ff0d87c147f3bbfadf7244742f7a29784a748d91020af32e222f01a6eb2bb7273312ce599766cfebc0531f2b3",
      "line": 870,
      "relation": "increases",
      "source": 102,
      "subject": {
        "modifier": "Activity"
      },
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The microtubule stabilizers paclitaxel and epothilone A countered Aβ42-induced cytoskeletal disruption — and moderated excessive UPR — in neurons 182 .",
      "key": "af47cd58cc44b9aa2eed9fbb7feecf755582d03db8f500c7da7d7abcc899f46eeb30e24191941795046a9b9e507255e5c105f7a792d338a1d1c829e3427e895d",
      "line": 881,
      "relation": "increases",
      "source": 29,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The microtubule stabilizers paclitaxel and epothilone A countered Aβ42-induced cytoskeletal disruption — and moderated excessive UPR — in neurons 182 .",
      "key": "db00c29b95406d6f024a1d5093a19d1d4841627632365e54fd2152be2ac7b1ee53de02063fac4c40ff6a95244be62d6b7d65c9057f108ac2710498b5dd4e6ed7",
      "line": 882,
      "relation": "increases",
      "source": 8,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Furthermore, epothilone D countered microtubule disruption and cognitive deficits in aged P301S/P19 AD mice 183 . ",
      "key": "463b0b3355efff6ca146c50b56364d59ab39326dc7887bbd57261b2fb52aa9ca9b129f7996816609cba102fac9e616a10f78fdaf4400f12c3e1a1b6ed7c1288e",
      "line": 889,
      "relation": "increases",
      "source": 9,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Machado-Joseph Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Furthermore, epothilone D countered microtubule disruption and cognitive deficits in aged P301S/P19 AD mice 183 . ",
      "key": "38695c734292bb3432666f0b863d7d1b84f3af7c4d7e29511485bdc093f58fa79f6633b7b40449cac3a279dff6aba129356bc29da996e69120a2700ab63aa2d0",
      "line": 890,
      "relation": "increases",
      "source": 9,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true,
          "Frontotemporal Dementia": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Interestingly, genetic or pharmacological activation of RAB5 countered neurodegeneration in mouse C9ORF72 models of ALS and FTD 187 .",
      "key": "75a54e0ab4785d42b1749bdfe560cf9b6c65883fbd0f698d5bcc060dcbab3bbaf98793daccad28a44ed1cee4a6720f8db772e454f97ddb94f0559659ec4a265d",
      "line": 898,
      "relation": "decreases",
      "source": 173,
      "subject": {
        "modifier": "Activity"
      },
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Second, the TFEB inducer 2-hydroxypropyl-β-cyclo- dextrin promoted the acidity of lysosomes in neurons 190 .",
      "key": "7d72c970e497c819790663e11646d8a390493b7ca90826c8a7d4bfe812caebade2cff507c603b6d710be27f315b763732b5711f2342d0db4082cfb6b3c024e46",
      "line": 906,
      "relation": "increases",
      "source": 51,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Harnessing TFEB by 2-hydroxypropyl-β-cyclodextrin promoted clearance of proteolipid aggregates and α-syn- uclein in a cellular model of PD 195,204 .It also augmented the elimination of Aβ in a Tg19959/CRND8 mouse model of AD 173 .",
      "key": "5208bd84ea8241a10c464cb9c94b4884bd1711613e9e7799ed8e23e551b2f89a7fd69b7ad126474a9ee6e28ecd3eb8a5955140bc4380671e5dec7b33befc6d7c",
      "line": 969,
      "relation": "decreases",
      "source": 51,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Harnessing TFEB by 2-hydroxypropyl-β-cyclodextrin promoted clearance of proteolipid aggregates and α-syn- uclein in a cellular model of PD 195,204 .It also augmented the elimination of Aβ in a Tg19959/CRND8 mouse model of AD 173 .",
      "key": "5aa9e8b7ad06390be86a7d04f2c74b30fef860e36bdd0234fac375bb49fb6213afb93b8cce633f151dde647be8e8d738212ed7581d1742f90b64c732a62a3f83",
      "line": 971,
      "relation": "decreases",
      "source": 51,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Third, acidic nanoparticles such as polylactic acid and poly(lactide- co-glycolide) increase acidification  (BOX 3) .",
      "key": "2d008f5834fdb21cab217d8d516afd1db924702eb092e808f9cc8865b75b0e19160839a7465da356e1cb2e43e079ffb183fccbafbef1c6f3d9bf980ae0b85140",
      "line": 913,
      "relation": "increases",
      "source": 13,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Third, acidic nanoparticles such as polylactic acid and poly(lactide- co-glycolide) increase acidification  (BOX 3) .",
      "key": "469cf259a449a378fd1db8b7d3b4c27e726c1b141bb11e8e49fbde756efc6197f6d9bd140fb05a759f92e489e72255b270132c253827f05b8ae39597165bbf52",
      "line": 914,
      "relation": "increases",
      "source": 12,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, activation of the lysosomal Ca 2+  channel mucol- ipin transient receptor potential channel 1 (TRPML1) with a synthetic agonist (ML-SA1) increased lysoso- mal Ca 2+  release, lowered pH and promoted Aβ clear- ance 191,192 . ",
      "key": "a06cdbecaa5fd196d25c3d783b64ff6e7700111dcbb79f4ae564b642b649da12aa5d4fa5f7e87d3e05f968cd7e6214b429adaee685feda6ee1e5e016c71650cf",
      "line": 923,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 53,
      "target": 158
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, activation of the lysosomal Ca 2+  channel mucol- ipin transient receptor potential channel 1 (TRPML1) with a synthetic agonist (ML-SA1) increased lysoso- mal Ca 2+  release, lowered pH and promoted Aβ clear- ance 191,192 . ",
      "key": "faea856e99edf404123f4faa7a727884818973421d022b79ea1f92e15c00e6e6fe98a51433d62859845463d297fb605c00a668acda36a95d7f941f27e7ddec6e",
      "line": 924,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Lysosomes",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cytoplasm",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 158,
      "subject": {
        "modifier": "Activity"
      },
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, activation of the lysosomal Ca 2+  channel mucol- ipin transient receptor potential channel 1 (TRPML1) with a synthetic agonist (ML-SA1) increased lysoso- mal Ca 2+  release, lowered pH and promoted Aβ clear- ance 191,192 . ",
      "key": "695972aed93624c953f3fad7e6e498b97d8d9733603f4bd0967a3858fc1d562041c31626ad5b1b57985eea4f054ef3d90ab815f997239372df83185ed58408ad",
      "line": 925,
      "relation": "increases",
      "source": 158,
      "subject": {
        "modifier": "Activity"
      },
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Fourth, activation of the lysosomal Ca 2+  channel mucol- ipin transient receptor potential channel 1 (TRPML1) with a synthetic agonist (ML-SA1) increased lysoso- mal Ca 2+  release, lowered pH and promoted Aβ clear- ance 191,192 . ",
      "key": "e8dfd11dc49f3c8cea2d1abd09061bbce39f73c4aa0347fbb56c1e9994ef9e4293f837fa6f0e1cb150bc12be1d1a3916f90071f996e60ebdd16699dc06d9a7c5",
      "line": 926,
      "relation": "decreases",
      "source": 158,
      "subject": {
        "modifier": "Activity"
      },
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Indeed, clioquinol countered disruption of autophagy by chloroquine in retinal cells, reduced Aβ42 accumulation in CHO cells expressing APP and mutant presenilin 1 and diminished amyloid misfolding and aggregation in Tg2576 AD mice 196,197 .",
      "key": "fcfe3813ec04efc0f43843ff8c3056b93413ebf53942fea9c390e1d5149efc0f9c63f407bdbd8de46d3ab9b6ee6ad63c139631227cb149ba6df2d000d25fa5fc",
      "line": 935,
      "relation": "decreases",
      "source": 21,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Indeed, clioquinol countered disruption of autophagy by chloroquine in retinal cells, reduced Aβ42 accumulation in CHO cells expressing APP and mutant presenilin 1 and diminished amyloid misfolding and aggregation in Tg2576 AD mice 196,197 .",
      "key": "3ecce1c7b57ef29698f183f5b572ef115fcc700cae6f40064324dec11afcb627ba44f094b4ac3b4d4f0abab963fe05df7ee00beb4d1117ba4984509c4af62642",
      "line": 936,
      "relation": "increases",
      "source": 1,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Indeed, clioquinol countered disruption of autophagy by chloroquine in retinal cells, reduced Aβ42 accumulation in CHO cells expressing APP and mutant presenilin 1 and diminished amyloid misfolding and aggregation in Tg2576 AD mice 196,197 .",
      "key": "661b0c648a92afdfc77360e21d16832022e8792991b1fc7dc5e3fd48aea471603db03b6711d3ee6e1e3978fb883f17bab5d4b6b3a30f905f8f09e891c3d972d6",
      "line": 937,
      "relation": "decreases",
      "source": 1,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Indeed, clioquinol countered disruption of autophagy by chloroquine in retinal cells, reduced Aβ42 accumulation in CHO cells expressing APP and mutant presenilin 1 and diminished amyloid misfolding and aggregation in Tg2576 AD mice 196,197 .",
      "key": "c45c550e52676a33fbb3786eb421d613e31c46fdb751dd287b732692961b958d8d221decaff976269f7e8901a577e5947b248ad07ba4f5ac8fd2c9a3038707ef",
      "line": 938,
      "relation": "decreases",
      "source": 1,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It increased expression of βGCase, normalized autophagy and accelerated degradation of α-synuclein in a stem cell model of dopaminergic neurons derived from patients with PD bearing mutations in βGCase 200 . ",
      "key": "df9661cc1f8365699086172a2474715d7d67c7572a02716a9721abaa159cfdc888c2f66bd41e0c081a861cb15a0f06bd4fe471d3f829398df17be1270ad5306a",
      "line": 948,
      "relation": "increases",
      "source": 19,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It increased expression of βGCase, normalized autophagy and accelerated degradation of α-synuclein in a stem cell model of dopaminergic neurons derived from patients with PD bearing mutations in βGCase 200 . ",
      "key": "519e52e4e903938cc0969948f4581f890f997c6024eaf27f3cc273433983fff77aa30d9d65797bcb1f12ef1a09491ccf4a29075444e38996b51f8a34730db330",
      "line": 949,
      "relation": "increases",
      "source": 19,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " It increased expression of βGCase, normalized autophagy and accelerated degradation of α-synuclein in a stem cell model of dopaminergic neurons derived from patients with PD bearing mutations in βGCase 200 . ",
      "key": "73f812f9966bcb8c285c581c3233714a5b34427aab1e26593e6493b8b0605ca493554c08c5c1668cd250b8cbcadd662502c4e1a84ca576bfee2e477c834a9acd",
      "line": 950,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 19,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Ambroxol, which also decreased ER stress in D. mela- nogaster 201 , reduced α-synuclein levels in overexpress- ing, transgenic mice 202 .",
      "key": "3313b29e03e3942e803d016d9646788a05eb6cb0c70e08ae688094c0fcbd817f15d4d4cc7bdf5c18df5d8c04b913dabddc1b62a581b442809ce01b55371a2263",
      "line": 959,
      "relation": "decreases",
      "source": 19,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Ambroxol, which also decreased ER stress in D. mela- nogaster 201 , reduced α-synuclein levels in overexpress- ing, transgenic mice 202 .",
      "key": "daf62d7c654e12c95804fed87bf2cf70288839a46686698c3fe2ed9f43e3ba9e9c539d3f2fda1cda4511ad50455bda80d518ac712b16410c4b7d0d291c59a9be",
      "line": 958,
      "relation": "decreases",
      "source": 19,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "One promising agent is the hydroxylamine deriva- tive arimoclomol, which increases the activity of HSP70 by augmenting transcriptional activity of HSF1  (REF.210) .",
      "key": "5e7032b31ea6d4e9d2639b30ee2d8d5c0b79fecfc884cac0ad5750024122ab163ad4bea34b245e88f83d69425d13c46b469d245bcc1fa2f85545c412234fc797",
      "line": 984,
      "object": {
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 58,
      "target": 139
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "One promising agent is the hydroxylamine deriva- tive arimoclomol, which increases the activity of HSP70 by augmenting transcriptional activity of HSF1  (REF.210) .",
      "key": "a84602d88767fbf48febea2feb62976b6b4f5ebc92d083049fd1dead9776be8575bcc267f6f851df65bc280724531acedaabc1f13a0b50c55c2ccaea2972beba",
      "line": 985,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 139,
      "subject": {
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 101
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Among compounds that inhibit HSP90, geldanamycin promoted elimination of both hyper- phosphorylated tau and oligomeric α-synuclein in cell lines 219,220 . ",
      "key": "741703f31b222876560ce51c2f03fa80cdda2b5aa232514566284614b1c2bd215d6ff90d732540024db14f69cc9e129233320ef549a8957f98185b351b058ee2",
      "line": 993,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 26,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Among compounds that inhibit HSP90, geldanamycin promoted elimination of both hyper- phosphorylated tau and oligomeric α-synuclein in cell lines 219,220 . ",
      "key": "1858f44872f8b1090944f99fc9149722b262117fb7a8f5faa0a8b83b408ce74d3af6566626c35732f58be04ab66d4cfe33deb7606f80ed98031008ffca166e41",
      "line": 994,
      "relation": "decreases",
      "source": 26,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Among compounds that inhibit HSP90, geldanamycin promoted elimination of both hyper- phosphorylated tau and oligomeric α-synuclein in cell lines 219,220 . ",
      "key": "a9bb784e9696adaa5a27437881395210ecf10a7584d2b9b8e4f8412de4772e04c98dd3ce71c6d921085ce83477db7a7255f8682c05a20d9fa6ac504df974ea06",
      "line": 995,
      "relation": "decreases",
      "source": 26,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The less cytotoxic analogue of geldanamycin, 17-AAG, has improved brain penetrance. It decreased Aβ levels 223 , improved memory 224  and lowered tau in transgenic AD mice 224 . 17-AAG also reduced α-synuclein oligomers in H4 cells 220 .  ",
      "key": "95c4b12c299c52d160a69c31e9e03cd20dcbe16486f124108d890163f01496e0e4e39ce4f1ee19ab1847411975fca324983fd953dfa6c76cd0a514f3bfd68c98",
      "line": 1006,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 36,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The less cytotoxic analogue of geldanamycin, 17-AAG, has improved brain penetrance. It decreased Aβ levels 223 , improved memory 224  and lowered tau in transgenic AD mice 224 . 17-AAG also reduced α-synuclein oligomers in H4 cells 220 .  ",
      "key": "6b7d0e896b8b26930482f778166c991d2a29c0d30cd6f068315f22876fbe280746b4260e9d3cd4819a235d9ae874bc03db8fdf29197b4f49f5ff8d704e500a5f",
      "line": 1008,
      "relation": "decreases",
      "source": 36,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The less cytotoxic analogue of geldanamycin, 17-AAG, has improved brain penetrance. It decreased Aβ levels 223 , improved memory 224  and lowered tau in transgenic AD mice 224 . 17-AAG also reduced α-synuclein oligomers in H4 cells 220 .  ",
      "key": "ff4b77411d7060b73c9c50e85d980aa27566b7ae4ec2d89f4f2343feacdcea55a4d14a96c8d28d8c88636e7a5a1cadcafa24cdb0c33d3bf949a0722ad02b8694",
      "line": 1009,
      "relation": "increases",
      "source": 36,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The less cytotoxic analogue of geldanamycin, 17-AAG, has improved brain penetrance. It decreased Aβ levels 223 , improved memory 224  and lowered tau in transgenic AD mice 224 . 17-AAG also reduced α-synuclein oligomers in H4 cells 220 .  ",
      "key": "9c4596f1eb23492b41de9178d643c4734767b827277c303e17daa1c1b076f69156fdd986471fb9d566bfaeae1b3a8e11d6ee9124b14848baf9af4c1ad8c43d0a",
      "line": 1010,
      "relation": "decreases",
      "source": 36,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The less cytotoxic analogue of geldanamycin, 17-AAG, has improved brain penetrance. It decreased Aβ levels 223 , improved memory 224  and lowered tau in transgenic AD mice 224 . 17-AAG also reduced α-synuclein oligomers in H4 cells 220 .  ",
      "key": "c234f971089d34e0fdba8dfba1e0eca2a37fe9f7e54c27e0f6d35fe0d711ea1dff8af904fc636827abf3725b5a3c60ab06dc6e269b87b5ff53029483bf9171ab",
      "line": 1012,
      "relation": "decreases",
      "source": 36,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Another HSP90 inhibitor, HSP990, has shown promise in lowering Htt aggregates and improving motor performance in two mouse models of HD 225 .",
      "key": "50e27d1267a66ae8341629b6cdaa979ab918ba633d389d451e635cb11fc9034f94bc318579bd51abf186b5fa4ef8d277cb606c418884452c2226cf1efadd9474",
      "line": 1019,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 55,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Another HSP90 inhibitor, HSP990, has shown promise in lowering Htt aggregates and improving motor performance in two mouse models of HD 225 .",
      "key": "d6e0b139100886ce67acbd14905634f95c80c1e23ce36ca477e4f9408003bfe2a2bcec72bdbfc9399b68258dc4dca33d4087c3a3b5bf303aa956c6286022eba8",
      "line": 1020,
      "relation": "decreases",
      "source": 55,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Another HSP90 inhibitor, HSP990, has shown promise in lowering Htt aggregates and improving motor performance in two mouse models of HD 225 .",
      "key": "62f6aa5aef2879020cee034e9868977a430d21f16f32db82936f443c82ab01cb6ee8f216a5862fa9268a5860c1c3838e539fef5532dac72086f2b9eb8bffcbd7",
      "line": 1021,
      "relation": "increases",
      "source": 55,
      "target": 197
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Chronic administration of CGS-21680, a selective agonist of the AC-coupled adenosine A 2A  receptor, restored proteasomal activity in cellular and murine models for HD via PKA-mediated Ser120 phosphorylation of the RPT6 component of the 19S subunit 231 .",
      "key": "1e2eab5d7c9288f05d46382b5a7dab24601e4b908e88a929c7a8b61de58726a081f84968ef52fbbe435f5da0e873da11354cad1858a9af7df0b5048efce1b82d",
      "line": 1030,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 54,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Chronic administration of CGS-21680, a selective agonist of the AC-coupled adenosine A 2A  receptor, restored proteasomal activity in cellular and murine models for HD via PKA-mediated Ser120 phosphorylation of the RPT6 component of the 19S subunit 231 .",
      "key": "a4f427e4da181c929dd0f1a83a7b390063801f07ca5b008fb17e7827e6f96f774d781afccf484a035e3aa830ab9e940dac8d1716a40f57c27ad97394a9e0418b",
      "line": 1031,
      "object": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 54,
      "target": 103
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Chronic administration of CGS-21680, a selective agonist of the AC-coupled adenosine A 2A  receptor, restored proteasomal activity in cellular and murine models for HD via PKA-mediated Ser120 phosphorylation of the RPT6 component of the 19S subunit 231 .",
      "key": "8d8cd511f73c1da3103a8c9bd017027bb9f6a2ef61feb1d6a0c68c3ae115415129a57cf92464b3edb42d6db266cfbd44161c062c0bf2d784dd93ed2ab71b55b8",
      "line": 1033,
      "relation": "increases",
      "source": 103,
      "subject": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 172
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Chronic administration of CGS-21680, a selective agonist of the AC-coupled adenosine A 2A  receptor, restored proteasomal activity in cellular and murine models for HD via PKA-mediated Ser120 phosphorylation of the RPT6 component of the 19S subunit 231 .",
      "key": "dd80df356b0621d12eb0890ef41fdb2409bc92cd526a502a8a313c070cd6325555e3679e5cc6857e57d29e2ebb9e05615df907262bca9491b81991e70587ca5e",
      "line": 1034,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 172,
      "target": 81
    },
    {
      "key": "9462b1dcf55c4c430836f407713e5ad33c19ade7c9ed609a5560ba4e7f7fbc2d70ddc1dd8ab4e59fb8986c8085eb515dafe225a5d41bf9abdf31516e6cf231a4",
      "relation": "hasVariant",
      "source": 171,
      "target": 172
    },
    {
      "key": "c05d6c8bebb65c0e8ca32e6640f6b80139f11bcf51f80f32f6a0670e8997430d1a6abb170cda02b988f9762106c45c2fbc3e271a610b61d4cf0e314d54dbb7f7",
      "relation": "hasComponent",
      "source": 84,
      "target": 122
    },
    {
      "key": "f03694e909cb32fef936d36f041b136e06b2b50ceddc4c0ced1aa1415ec8b8fa200ed533ce6252a7b71da4fe9b8e3f8ca1c7da0eec9f4f348e586347443ce090",
      "relation": "hasComponent",
      "source": 84,
      "target": 181
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Third, cellular inhibitor of apoptosis 1 (CIAP1; also known as BIRC2) specifically binds mutant SOD1 and drives it to proteasomal degradation.",
      "key": "151b1ea2bf2ba653d9b737b2749eeed60645f14ec459351d8c25114b83358ba84430777f939bc9b355f7bc9498e3820c5bda1661c1b895ebb1babe884f01d01c",
      "line": 1048,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 84,
      "target": 181
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Nonetheless, overexpression of LAMP2A accelerated CMA-related clearance of α-synuclein and afforded pro- tection of dopaminergic neurons 45 , and several routes to potential pharmacological exploitation exist. ",
      "key": "5f5e3cc06da872046d676a1ae1502680c46d7c1451de33661e83157b65eb7e811f21d72f9930af22998079c38a0cda5d15fa7ed2f457eee9de027ccb6983484d",
      "line": 1065,
      "relation": "increases",
      "source": 147,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Nonetheless, overexpression of LAMP2A accelerated CMA-related clearance of α-synuclein and afforded pro- tection of dopaminergic neurons 45 , and several routes to potential pharmacological exploitation exist. ",
      "key": "677407e50e44bbf4e201f108e4b777cf85e0bb5313ca3c45d8c5447947e9f58fdfa743443dce6c5c4d6549688b54b5497b7fc201900cc1cec665b98eccbbaee4",
      "line": 1066,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 147,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Supporting the relevance of sestrin 2, it has been shown to protect dopaminergic neurons from the neurotoxin rotenone via AMPK-transduced autophagy 247 .",
      "key": "ec21f34b7e8b1ccca1144c8c5de075722aae6b17079361ef2eadc476278705ef5ca688a8efff06b40798d501fb16a0ba790e3a11eb56fe3e664835b81ae895aa",
      "line": 1085,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 174,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Supporting the relevance of sestrin 2, it has been shown to protect dopaminergic neurons from the neurotoxin rotenone via AMPK-transduced autophagy 247 .",
      "key": "b2c83d7e210749d27e002d11c5be749a35de7604a7e57810f2793f4c238c04227e25f013c6b9410125d8024e64d9c726d13e945a8fe63ef15d822dd0f23335e8",
      "line": 1086,
      "relation": "increases",
      "source": 174,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Sestrin 2 over expression also prompted mTORC1-dependent autophagy in cortical neurons in a presenilin-knockout model of AD.",
      "key": "bb377cccdfb08872db572612eadd5a3ac01312e30d16d40ff59c2f15f2eb790bce18fbfe9995277b8648b130b2d30d196d1c1cab72d0fd27e024e296aebe56ec",
      "line": 1094,
      "relation": "increases",
      "source": 174,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Sestrin 2 over expression also prompted mTORC1-dependent autophagy in cortical neurons in a presenilin-knockout model of AD.",
      "key": "74469dee0fdcc53a27b38b4b83f35bb1bca63f1e4e4ab0ae4d66025d69117ff18148350092182f37e8ed659e6d9b4e64f98bef750acf8d9d3dcf44a6558b8a18",
      "line": 1095,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 174,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Aβ42 and amylin (a pancreas-derived, AD-associated protein found in brain) are substrates for degradation by IDE, which also irreversibly traps Aβ42 and α-synuclein, preventing their aggregation and promoting ALN and UPS elimination 259 .",
      "key": "e3df73410260c5becc4d64549255683694ebe509959b289e66405d0b6fc51efa5b3fefd3adf2b2ea7c43bb1e1c168dfb0dab830b98f8bdfdf1d61e841db98f6d",
      "line": 1106,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 144,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Aβ42 and amylin (a pancreas-derived, AD-associated protein found in brain) are substrates for degradation by IDE, which also irreversibly traps Aβ42 and α-synuclein, preventing their aggregation and promoting ALN and UPS elimination 259 .",
      "key": "cce44a01dc6fcba8d1c94f9a5b18bf9701af0591e138b374b0758f75abc976df3265bcae4f6c22e0da0794af321b05c968e9593acb8e30d72315b3c08f937a8c",
      "line": 1107,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 144,
      "target": 143
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Aβ42 and amylin (a pancreas-derived, AD-associated protein found in brain) are substrates for degradation by IDE, which also irreversibly traps Aβ42 and α-synuclein, preventing their aggregation and promoting ALN and UPS elimination 259 .",
      "key": "e01c30054a3a7cef298d6b244dcf90ff1b33c2a8ee7bcaffb32ba43bb327ae8b1a0c1f28b7caa8805f38c9ca4571a83ca48da7dad94fd674bcd20c0e6ba1b269",
      "line": 1108,
      "relation": "decreases",
      "source": 144,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Aβ42 and amylin (a pancreas-derived, AD-associated protein found in brain) are substrates for degradation by IDE, which also irreversibly traps Aβ42 and α-synuclein, preventing their aggregation and promoting ALN and UPS elimination 259 .",
      "key": "c4fcedcbbfa8bcebb5e196cd1dd0750b6af80544cfa890599422ec735c0abdb15794c594864e79e99122bf8ea4a6f878378d8b5544dacf5e734cca812783f4eb",
      "line": 1109,
      "relation": "decreases",
      "source": 144,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Aβ42 and amylin (a pancreas-derived, AD-associated protein found in brain) are substrates for degradation by IDE, which also irreversibly traps Aβ42 and α-synuclein, preventing their aggregation and promoting ALN and UPS elimination 259 .",
      "key": "a1a59f6e4faa090d51fe33beb9d9062ea3136b605c2e54c88b99e68cf4a48839f06ee4b9ccb70dab4fd340fec7e5f1e398de9fced40cd1cd761586092c30c6fd",
      "line": 1110,
      "relation": "increases",
      "source": 144,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Aβ42 and amylin (a pancreas-derived, AD-associated protein found in brain) are substrates for degradation by IDE, which also irreversibly traps Aβ42 and α-synuclein, preventing their aggregation and promoting ALN and UPS elimination 259 .",
      "key": "1146fa90100c4fb20e23099a9b8e690a60c400f23a3cd6b17cbbb2730cfdaaecab112ebf3459cc3a1248876d1b7a39dcba5a410b1f1e42f0b59837d7028eb5ca",
      "line": 1111,
      "relation": "increases",
      "source": 144,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " IDE also degrades and prevents the forma- tion of α-synuclein fibrils 259 .",
      "key": "333087cc1ec1d3b83211b1223b623e5a4cba06b53af786b2733e55e74d0657c2e8779ba45817745292f2900601bfcb1d33d1d18ed345e5266c596085cf8ccd5a",
      "line": 1134,
      "relation": "decreases",
      "source": 144,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " IDE also degrades and prevents the forma- tion of α-synuclein fibrils 259 .",
      "key": "e293bf7f06840a124e950fa2d804f4a419e6dd2aac01854a57f8f3fd5918e1b1f9dba88459d80bfdeaab103b0259e94bb1ab760c9234fe567fba3bf7e25372d6",
      "line": 1135,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 144,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Similar to IDE, neprilysin catabolizes Aβ42, and its loss in mouse models of AD and in patients with AD alike also contributes to Aβ42 accumulation 253,256,260 .",
      "key": "4682ded5d1da7cea864ff0021d812c1a5a8dadc4fb8136b984a356d08026b22115ca6b5d6b03a85db4de73637b2e8dea644e7c9b40deea1bf06c923dd114ff85",
      "line": 1143,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 160,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Furthermore, expression of progranulin in the hippocampus of AD mice reduces the density of amyloid plaques by enhanc- ing the activity of neprilysin 281 .",
      "key": "feb541b2d78aa74cb45b3e857f3182680e02c3cd38dd9348896bf3edb2a21ad315beb2b11a895417975f072bf7b2572852867c3493ecf17f1c9659d0fa053835",
      "line": 1198,
      "relation": "decreases",
      "source": 160,
      "subject": {
        "modifier": "Activity"
      },
      "target": 199
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Like IDE and neprilysin, plasmin degrades Aβ42 and blocks Aβ42-induced toxicity, suggesting that the decrease in its levels in AD is involved in the evolution of AD 254,256,261 . ",
      "key": "acd3084a4934bd7d49b8b799b17d80a27a8ee753fd30e7264b661b9b5eec7f57baf7076ecef23c4a3e6e16c59024ea02e49014afc8c0d51a294fc402ac53fd16",
      "line": 1153,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 168,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Like IDE and neprilysin, plasmin degrades Aβ42 and blocks Aβ42-induced toxicity, suggesting that the decrease in its levels in AD is involved in the evolution of AD 254,256,261 . ",
      "key": "a87b818131b15daf28b8fb8dec6569e4aefde508e8d68c237fcea186a134f9c38d22355f3b3295d906600dfb5484c2b995064ca7f22d457c056368fd061bf795",
      "line": 1154,
      "relation": "negativeCorrelation",
      "source": 168,
      "target": 193
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Plasmin also degrades α-synuclein to retard intercellular spreading 262 .",
      "key": "d93e50337a33844bdbc3efdc7c0d2d80c324b6a8d4c1806a7fa1808c187c06bb8a57715900ba5b870ea102868864925537faa39db284806623161c67d46098e8",
      "line": 1160,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 168,
      "target": 177
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Finally, the extracellular and intracellular serine protease neurosin (also known as KLK6) cleaves α- synuclein. ",
      "key": "8479bc34714d6b25d9374037a549ff309c9bca0d3e827853e6b552f6ce14dc9c028eea47457ba2b15f1f92d1cb78e910b9c24448b1b282669ecce79ee7b643ae",
      "line": 1167,
      "relation": "increases",
      "source": 146,
      "target": 178
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "8df397f8da3803fdf37d4f482a884fb8928969871644ceb7da866c61e2e6f02f3eee89941aef815ccd8f7840cf0c436b52771297e46fba6f89a757f279c26a3f",
      "line": 1177,
      "relation": "increases",
      "source": 0,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "934fa4f46c3e944b2d3caada90f085273b86355ea16a34b2f541ba422b1bbe495091144853bc44ca735aa4228072fbaab5e16a11141da1bd0818b25c6f25af2a",
      "line": 1178,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 0,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "77ae0f04c9cca31b51220fa4241389f91687959a4589ac947c16ca668def3e42b84a37410737f312308acbc8f55818fd8f973b0fc2bd1d58e91d7f33e040eecb",
      "line": 1179,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 0,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "357f995b0a8e69f09bda417525aaffa0ea5c6ca3814adcc062a9ebb3e7cd5a44b6e9c46d74fa3eee4c30b750c77149e950f8c5c813f19bccd4f1fdd0b529c519",
      "line": 1180,
      "relation": "increases",
      "source": 0,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "df66911a832405f06844a4c3f9c91c705bf326648e3255d87601a7ea520fcf4720cfca72300fb6573ba3a10bba309724082f966f77f78607af646e6352f09b64",
      "line": 1181,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 0,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "84262869d174f69f8358a4cebf54427949316e3b57cef37b0d1aef0a51e8d9744f9560fc388996229429b0187a6300da8936820897c8d6972a1133cef4a02432",
      "line": 1182,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 0,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "97a058fb6b301fa1a5ed9725f582e4a35ccc8243ea41ae519878e81578888abfebc7ff14d4517b44d44ddabff244e82e0009a790b83b3d245d0401ab23bce4d1",
      "line": 1183,
      "relation": "increases",
      "source": 34,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "4665b05b5dd37014ce17bac7f24c58dc4e815d4558867ea6af4b1a577a99d87be84fdba00ee1da17a1e859d8db593f2af56f7a1733cb7313aae406bea1cfe7c2",
      "line": 1184,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 34,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "0041453f3de88fea97aa86b3058aa7a4ab372876fe92a19da5ffc72ed010d1baf94c7408b0ebd2df1881f81befe5cfd740399aaa0f0641dc72fc258fbe38d6ee",
      "line": 1185,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 34,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "96daf1a395e633a25065f2df816b3ca4b9f8971fbff0cd2728ce95b02aa0722ddcf2e29eb69ea3f885181d0c694a086d91c9ab80f839d7b5e3e6e0e949064b31",
      "line": 1186,
      "relation": "increases",
      "source": 34,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "8289341b97541b17badbdd4faeedee7cd1cb25639785eff436833b5752b73a32700688f80e7cb31ce9d3ce85aae58f5747f523a79326645800be59678a441ee7",
      "line": 1187,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 34,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "In regard to pharmacological manipulation, substances such as epigallocatechin and somatostatin promote the expression, secretion and (allosterically) catalytic activ- ity of IDE and neprilysin in parallel with an increase in the degradation of Aβ peptides 259,280 .",
      "key": "828508f9f3f0664ef84f2b1f6dca5a2f9bb2f57f7431cef58d6b3b6bd469cc0916cd73dea64db195e9f55aaa41d3809a6053eaf2018d9db698e2415efd69d6c6",
      "line": 1188,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 34,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Furthermore, expression of progranulin in the hippocampus of AD mice reduces the density of amyloid plaques by enhanc- ing the activity of neprilysin 281 .",
      "key": "4c2646652f344c6390ed49b9226c534694861f8d3067455f8761ed13ae82ad8cb2ee24c207fc72aca540bce08dcf1a55033405f6d1e0545a4157b288351873c8",
      "line": 1196,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 138,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": " Furthermore, expression of progranulin in the hippocampus of AD mice reduces the density of amyloid plaques by enhanc- ing the activity of neprilysin 281 .",
      "key": "5c1b29444345a70d39356529d9f3e6ddca8248e8b4707c76b7aad9406d791cecd37517682522790c766f87c30ee023a8082a40777e9214b902baadc1df6acd8e",
      "line": 1197,
      "relation": "decreases",
      "source": 138,
      "target": 199
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The antibiotic rifampicin likewise promoted Aβ42 clearance by induc- ing BBB-localized LRP1 and P glycoprotein 1  (REFS273,292) . ",
      "key": "961a09cb277a916c096e719e13bd7e41faf7999653d80ec9830912cd8e393d8a53a2b7193221d0fc64a6264a54ff30edb19fb1ad110a0105099d7b553e59f64c",
      "line": 1205,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 31,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Blood-Brain Barrier": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The antibiotic rifampicin likewise promoted Aβ42 clearance by induc- ing BBB-localized LRP1 and P glycoprotein 1  (REFS273,292) . ",
      "key": "e22fdfa36b0e034e07ff9ff54725f256228b0bce40795a0e6043258da0da0bba0545eb9711d2c12063305e8e1b1f30a46ac1bdc3cecc36cd0c4d1f4ca15e9955",
      "line": 1207,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 31,
      "target": 149
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Blood-Brain Barrier": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "The antibiotic rifampicin likewise promoted Aβ42 clearance by induc- ing BBB-localized LRP1 and P glycoprotein 1  (REFS273,292) . ",
      "key": "d789b4d063577caa525b6b09c5b52b749c85203005e0a73acfe47a8dd522eaa6a35ba2d5c3319811dbd65a10d3e6c1efebf5f96169c2d50cc9db7bd8c6a063ef",
      "line": 1208,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 31,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrum": true
        }
      },
      "citation": {
        "authors": [
          "Bezard E",
          "Boland B",
          "Corti O",
          "Duchen MR",
          "Eskelinen EL",
          "Henriques A",
          "Kroemer G",
          "Levine B",
          "Louis C",
          "Mallucci GR",
          "Martin OR",
          "Millan MJ",
          "Mochel F",
          "Mollereau B",
          "Nixon RA",
          "Pastores GM",
          "Rubinsztein DC",
          "Spedding M",
          "Yu WH"
        ],
        "date": "2018-09-01",
        "first": "Boland B",
        "last": "Millan MJ",
        "name": "Nature reviews. Drug discovery",
        "pages": "660-688",
        "reference": "30116051",
        "title": "Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.",
        "type": "PubMed",
        "volume": "17"
      },
      "evidence": "Activation of aquaporin 4 channels on perivascular astrocytes to aid the glymphatic elimination of cerebral Aβ and other toxic proteins is a potential strategy for stimulating clearance.",
      "key": "bfdfaddb41ee33346a810ff009a252e667cc485f07e55324384d9e23965bedec927db2633a8b1ac17e433ac5a3d6666d4af4df66b279ea7c07fedebcb75ac72e",
      "line": 1230,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 112,
      "subject": {
        "modifier": "Activity"
      },
      "target": 6
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"(-)-epigallocatechin\")",
      "function": "Abundance",
      "id": "a751c0197e991726a31b49409be04e06aed3a27e3e1eb4f5e1a1bc98c4fe86d250a35969a5d56f619eb462ebb09e0f533f4f73b47ef024a5897514600e94d7fc",
      "name": "(-)-epigallocatechin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"5-chloro-7-iodoquinolin-8-ol\")",
      "function": "Abundance",
      "id": "f8ed1ff5a8997280c4f5061a8ee3e76de5f6a270ebec3a5e0fc3dd5209782a497f7bf24fbaa72e52cd145db996e634099b9f3034ddc04832cc3cb5b801bbc5dd",
      "name": "5-chloro-7-iodoquinolin-8-ol",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"AICA ribonucleotide\")",
      "function": "Abundance",
      "id": "48287cad69e8d1b924134a2e1c6a90b050fba03093b968811d048fa46a7b3673a0c633e7a144abb6f9ad4a4a885d72c08fc2892316df2689a1ce73ddd1dd55ef",
      "name": "AICA ribonucleotide",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"NAD(+)\")",
      "function": "Abundance",
      "id": "987ff63bde605a81a696f249bdec60f49a30a25cf77be765d547c38dc291c2080cd3a90fb8fcb3043847732a20a7e62f72d13b291f0e8e8f96b2553140a03693",
      "name": "NAD(+)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"alpha,alpha-trehalose\")",
      "function": "Abundance",
      "id": "00d23a5366dc32175e6cb3cc67e05507114bbdfacc64422f8d232cfc9d1b794abe1e5f039f3067f5b05ac88a719c31c5e8d42d0dc7da73b809bea49996d2d11f",
      "name": "alpha,alpha-trehalose",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 42\")",
      "function": "Abundance",
      "id": "c2da54109c90719396dfdfb558be74582b8522863849a50f3f5029b7d60f4d53df3cfa1a97b787e760a2f74ea1f74012eb49273beeded42a2873d788953b4a13",
      "name": "amyloid-beta polypeptide 42",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "function": "Abundance",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
      "name": "amyloid-beta",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "function": "Abundance",
      "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9",
      "name": "calcium(2+)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"epothilone A\")",
      "function": "Abundance",
      "id": "740628a24ce9146547f0ff04581e9268551971157ce86daf880f6e36f55a19d41dc5163cefa580da9deee3f143239ef819c4a43f6062706f3ad74e51401a4bc5",
      "name": "epothilone A",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"epothilone D\")",
      "function": "Abundance",
      "id": "6c16894dc6965d68e5700365a2715865dd2da1b6d6ec20974c6134ef6dd6c08f6f609d006456a6088eccef09ca866122a453604459252d95d2bd817951facfbd",
      "name": "epothilone D",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"lithium(1+)\")",
      "function": "Abundance",
      "id": "943c096f03634b7dbc23b20c0b3cf2392d0f373b19fef3d18bbcce7b2c99dbfe759397ec294f186cb6876052de3e7177d8da019fea173f99f26c1013dc1cfd99",
      "name": "lithium(1+)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"methylene blue\")",
      "function": "Abundance",
      "id": "bc17e9a0bb9e81081bd8fd81201449228e606bb9013e59ebf8a144c733531a8fbfe4e53776b79be7832ae7ea593e80a36ccc93367f04919f6241c7f32ab8e9f7",
      "name": "methylene blue",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"poly(D,L-lactic acid-co-glycolic acid)\")",
      "function": "Abundance",
      "id": "47ff16e9d330df9839feebbb412b2e616625455035677dd2bc8507bff317d153157edb0b58912730788ba1941ba87faecc521b317dc23ed453429dd54a49532c",
      "name": "poly(D,L-lactic acid-co-glycolic acid)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"poly(lactic acid) polymer\")",
      "function": "Abundance",
      "id": "a43add38928ddbafd94b4e0479fafbe0d32d2ec9eac8ba6050cf6da91952a9ac41d89fe4a4302b12d61f7f1d484a7e483780cf9d281ee653d9f6a574c6f00b80",
      "name": "poly(lactic acid) polymer",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"selenium(2+)\")",
      "function": "Abundance",
      "id": "7222c0157998e3d519c155111af1834b75866e9109d1548dbea3a87fba685712ddee1bda6e582ddfc91e86250248cc6e5e3f343cade6b2fc87659b668992b71a",
      "name": "selenium(2+)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Calpeptin)",
      "function": "Abundance",
      "id": "c735e976fcc8edf50d2f49f3fd29ea21583e44a8ad7f172d19c9f4540614b607c533492aed97bd756c8f083aa4d40bedd9949b9bd0e885e55d3db7d6629f87f6",
      "name": "Calpeptin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Isorhynchophylline)",
      "function": "Abundance",
      "id": "7c4671fea666b35164e254a45c79431cc8b619b959c291d246dd4dffb9b2c413d0d4c4364a3543b90147e0ea6611907764c5df32cb6723a98e82bb274dfe9571",
      "name": "Isorhynchophylline",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Rilmenidine)",
      "function": "Abundance",
      "id": "83194215e7c627d85dbcf19e4b240f338c3346b757dfd87a7dda0e9cc396c03a4299d6ab274ccd892f90819a4ae0e06a143ee9241d22d933066c06b6796d25d0",
      "name": "Rilmenidine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Temsirolimus)",
      "function": "Abundance",
      "id": "6eb519f2ad4d46a6ed4151fc8fc609049b5a772cad25e88cf9c625d12370b056fee390606fd6d862c7544e539a500c9c5a0fc4eba471ccc4f90bb74e9f603024",
      "name": "Temsirolimus",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:ambroxol)",
      "function": "Abundance",
      "id": "e7f3b8bfb12ec03ceb800c38c99bd78a701467ac0c990cf4a1a8a43fa5d4766d949642a4a7bb7c6ba45594346cd130c361750e663e66d8bd1761372f24a8a3b3",
      "name": "ambroxol",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:calcitriol)",
      "function": "Abundance",
      "id": "798ec8751ddb5f7af4af24c449ac17f5fe3e2859995ac49deaf82102cc233521700210da3c6e536fdfd54632b862b5bde8c98b325901bee3d3bc2e43b4a48973",
      "name": "calcitriol",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:chlorohydroquinone)",
      "function": "Abundance",
      "id": "a00e9ba4b60a8b0c37b2771fc99d873de3633900939cbc819a154293d5bce9693e7fb78f7b022fcf66dbd341586818180c53a4cbed36092f6479056055e1f812",
      "name": "chlorohydroquinone",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:cilostazol)",
      "function": "Abundance",
      "id": "9a9fc863375a0a8fb0f267c2c120528f381f2060312a574cf5a9d9c205f9530144f95335f491adec62c9337983ddce2b1f32ede9421bc887ccaf3349403116c5",
      "name": "cilostazol",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:clonidine)",
      "function": "Abundance",
      "id": "66336b9c01ed7fc2a1af1d6bbfb76568720729730cacf26da77497edd8286dcdee6e14e961bfda274495447398a8eb854434332aad930928d075a139a21039e6",
      "name": "clonidine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:curcumin)",
      "function": "Abundance",
      "id": "a784cb1e1965d09b2812ceaada10e172836399f6b72ec8154a36346d212255f49d8ae319b42578ea1c29fe7b4f04e3396e963011eb98b928bfd624dfd7fa8787",
      "name": "curcumin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:fisetin)",
      "function": "Abundance",
      "id": "3ab39f7b405275faa8f2e23152d2ef329d80fcd8bc9d37c776a5f748eabeb49faedb5abef49569a294dde08c8eaf26533589e015699431116d421fe159d51b0f",
      "name": "fisetin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:geldanamycin)",
      "function": "Abundance",
      "id": "495a46f0ccb373f38cd5fc5172590ae53a0619efd473182ef38981d4f2d7d2e6631c171ef484aac26e3891e0d5ef27e716420629b6f3c62aed15ac224ad41430",
      "name": "geldanamycin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:metformin)",
      "function": "Abundance",
      "id": "8e168527ae6f3d001318f64311463a40ace1c41edb9de6f8a7763dbd9c4d9637ed7f886451804e6d45214868ad615fd57c3d6fb052bb97c661b4affe8ee2b50b",
      "name": "metformin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:nilotinib)",
      "function": "Abundance",
      "id": "dce4b6a89f80e9b917216ca36d4a06ddc8e2e4c5ff6850cd0be465adaf752d50f6866eeac9ed90f458f2b2af446849c9955bee3814b792bd7c7b86dc36504c3c",
      "name": "nilotinib",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:paclitaxel)",
      "function": "Abundance",
      "id": "a74b9c461b771479e411ffae5b88f3a0863ad0d470c0e4d15c86a6a25308ca080e6a086d6e7acaf0a69ba2847910a3b782cf5c8b22efc9e3a7705b70235901b0",
      "name": "paclitaxel",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:resveratrol)",
      "function": "Abundance",
      "id": "545daa8c15363de2760fcbff1fa1c472c83bfc4fa06d5cfaaaf1259fab8d6ac783ae0bdf7ae00fd6f6e0c5c7541242453b6423c657fbd723321fbcfb5bf953f7",
      "name": "resveratrol",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:rifampicin)",
      "function": "Abundance",
      "id": "6486178dcf738c50bf7cc5492f947e1d135f6ca83824c5d7f76add5b1afc9d111422fb9dec0f4304677cd15454a15b3846752eb9fcd1bfb22eda5f506d83ff95",
      "name": "rifampicin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:selenomethionine)",
      "function": "Abundance",
      "id": "a3d573663519ce2db1d029a5eb4e581c51bc2e26acec9268fbe0e37532f2592dfda79948f5ad2badb580cbdcc46f1aa911117d17df2b68dfd712637d54b890eb",
      "name": "selenomethionine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:sirolimus)",
      "function": "Abundance",
      "id": "102b031a00eed78fd9e5c4236defb90a8995463980f9060493bb5fd3159a3eb666cbb2b6a33a213c749a2b279ef6d149796b4f0b568e03b82eb5c89b0da77426",
      "name": "sirolimus",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:somatostatin)",
      "function": "Abundance",
      "id": "39f4b04de9cd83da835a91e87eeb06033998ce10ec82d66e2b2baa7d3576cbf6d148a2fedcac401db0bf0a9abe7c4253663ce4effead38790b6cdc1c064100b1",
      "name": "somatostatin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:spermidine)",
      "function": "Abundance",
      "id": "c5669c5840ae40443ab83d78df4ca9ff1d38f500b79f510b21317d85dd69f851cf932c95c03ef0495062eb9b069ed6876aa09514f378f83bd41e288e405764aa",
      "name": "spermidine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:tanespimycin)",
      "function": "Abundance",
      "id": "409d39722f4d5c9457a215c12a920d2bf82d03e7f143571a2ce44293d3b8a741f96f61f35a43f0580f6588e3a11c62fc1888fcdc048311e8b3180dc20f703944",
      "name": "tanespimycin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(GO:\"autophagosome membrane\")",
      "function": "Abundance",
      "id": "77a348de11ddaa40f417c21935647695d6b3c195cba87acd3ee782bb6a1a9adf851d8e76cb7be9c4324e34f7cab8b60e473704792765406159eaf1078a69d135",
      "name": "autophagosome membrane",
      "namespace": "GO"
    },
    {
      "bel": "a(GO:\"lysosomal membrane\")",
      "function": "Abundance",
      "id": "22f87f0f6d1bb93b4244cc9722aaf3cda04176ecca58e8e25984d9c825adecabe3e4b596ff608ab9aaaca5fe0613642241a8ca9be318540ea9b63fd210d8ffbf",
      "name": "lysosomal membrane",
      "namespace": "GO"
    },
    {
      "bel": "a(GO:endosome)",
      "function": "Abundance",
      "id": "e257a197ce506c1416421c57409537d935e3a61f455577121f5c3176153a5cbb8c227a4f2a567bc4eacaf845ea9f0a1cfbdc4e829dba70bdf9352b5b915a6490",
      "name": "endosome",
      "namespace": "GO"
    },
    {
      "bel": "a(GO:lysosome)",
      "function": "Abundance",
      "id": "61127e1e0a936d98ae38713263a7c5700a82083baeb5fb6c51025ddad10d280fd86e7d30ebfbabc384f77b08ddda66aae47116fd775ab82c25480f68fb78b46f",
      "name": "lysosome",
      "namespace": "GO"
    },
    {
      "bel": "a(GO:microtubule)",
      "function": "Abundance",
      "id": "0c753f37efe0eb149a47a1dd700eda093a03b462374275c68480b6aed3be0f81aa9793a179dfd97f8e0834f1fb9be4b4a6cff2165b176d9e8a8744f5e0d5bc2c",
      "name": "microtubule",
      "namespace": "GO"
    },
    {
      "bel": "a(HBP:\"Tau aggregates\")",
      "function": "Abundance",
      "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7",
      "name": "Tau aggregates",
      "namespace": "HBP"
    },
    {
      "bel": "a(HBP:\"Tau oligomers\")",
      "function": "Abundance",
      "id": "d4ceff8aa5a5d05770aaa29b828d003b85d64e7e5337c6624b7c5a84111845897462b589e7b259b0eed6bcfc63f34cdaf1f9b988c788804799aea026d8731d98",
      "name": "Tau oligomers",
      "namespace": "HBP"
    },
    {
      "bel": "a(HBP:\"alpha-synuclein aggregates\")",
      "function": "Abundance",
      "id": "4ffe86a09eab120b36e016ef7b19c9d01be6656ede07fd078714196fcc814ae0586e60fc52bb1a087f53639ba2004c175d46d511472d216e386711c2d05dcb21",
      "name": "alpha-synuclein aggregates",
      "namespace": "HBP"
    },
    {
      "bel": "a(HBP:\"alpha-synuclein fibrils\")",
      "function": "Abundance",
      "id": "e7d37ca7db3a392fb57741b397c3d2a199341ad03918944c91543eee061dbff1f594f28a341323fa8d0501bcbb8aa00baf48f75c055a2cb8e62d899d73cbc101",
      "name": "alpha-synuclein fibrils",
      "namespace": "HBP"
    },
    {
      "bel": "a(HBP:\"alpha-synuclein oligomers\")",
      "function": "Abundance",
      "id": "64c75f85509685303ba078d6cd796e192c764fd9b8dbc7486d4eea94b534574fa9d0ab0c588872bd8abb5d8fbea1c82f593ba18dffe002cc6e8fee2ef0131af8",
      "name": "alpha-synuclein oligomers",
      "namespace": "HBP"
    },
    {
      "bel": "a(HBP:\"amyloid-beta aggregates\")",
      "function": "Abundance",
      "id": "1d739f6eba3532950fc068e81f7aea675ce76d42a049b5a301ad8bccf2f503d6c2a79c9d417d4d35cc760c340b5db2513536b3c420156a92bda3605be3537740",
      "name": "amyloid-beta aggregates",
      "namespace": "HBP"
    },
    {
      "bel": "a(HBP:\"amyloid-beta oligomers\")",
      "function": "Abundance",
      "id": "a0fc661406161db12bdd89333a13d0ee89b3aa089d5eb16676962cae3efd25d4d3dd6e593dbcaebf5fc0c26f9c8c070a98f2ff0fb94a0d52412c0fa0bf6c5b3b",
      "name": "amyloid-beta oligomers",
      "namespace": "HBP"
    },
    {
      "bel": "a(HBP:\"huntingtin aggregates\")",
      "function": "Abundance",
      "id": "b002c83453fb9ff3e295ad07a36f9afee91ab00c52c321dee1b31e9b1ae80e79109adf64b9b235ba967d89545d80f66dbe86856bd4751018f2e0bf2c07ff477e",
      "name": "huntingtin aggregates",
      "namespace": "HBP"
    },
    {
      "bel": "a(MESH:\"amyloid beta-protein (25-35)\")",
      "function": "Abundance",
      "id": "27179ccb1680ada81aea0e2559b0fd6b5e25fddd805f1c005c521ca672e3d2e04619d93fe52797aeb0903971bb8148e5449cd64d6a6043a169b92bcfc795424d",
      "name": "amyloid beta-protein (25-35)",
      "namespace": "MESH"
    },
    {
      "bel": "a(PUBCHEM:129688311)",
      "function": "Abundance",
      "id": "3ebb15ae6f068b8aef189d44f1174651d03ea78dd0b453b3b0f87279a31b389feca2cbdf5e650bc67e0cc3a31c63e3609ba8f09364020504cb40203fc971c44b",
      "name": "129688311",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:16240819)",
      "function": "Abundance",
      "id": "7db3729ae0557bc2a65888ccb667cacf52974e98f1af8ff03c34353e43ca7274923d3736a88008fdd611b2e1d4ac5f4e1a99cc90639153cde28aef4308c32934",
      "name": "16240819",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:2880983)",
      "function": "Abundance",
      "id": "f9a81d5c848338416e352ed3788ba0ab129d35adc6e74e30eaacae66e892b33f939206de83701ed7fad64fb25b53320aff5a79cefd7a58c4aad78cb1d2c9ad85",
      "name": "2880983",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:3086599)",
      "function": "Abundance",
      "id": "810718c39086e1b2a0bd06c360228cd3abd44d2f6fbd2120451a00dd682219146e62be8679f4448e9234cc76ca4b5d42ce44ba4531904103a5cae4f65fd4949b",
      "name": "3086599",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:46216556)",
      "function": "Abundance",
      "id": "7ce8c53a32b5bf477885d79774a535fee1af3cedaf5b3dd191887fc0fe9bbed610115ca2b4d54ffa6eaf2776c28cce8134b65e30baa25ac7d674ea058e2b13d8",
      "name": "46216556",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:54708532)",
      "function": "Abundance",
      "id": "a8a08939ec9f12fd8da9ea98cf89af53bc7dfa4bdcca1c0163dd4fe563eb46345742ba3c6f1bff7af77ab2b011329a7b00fa5fbc546ac142b2b9cc032774caa0",
      "name": "54708532",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:55310)",
      "function": "Abundance",
      "id": "a29e1a6f9fd19ae71cc13d97fd41dce556dd9c6e068e4dcabe2024205941944613304f57399874667f197d3b2b18e78bb3acd740dee6a89422f66e7c7d4d3c01",
      "name": "55310",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:9568077)",
      "function": "Abundance",
      "id": "f287ed92a67536c1ea1610d4a8e8166210ed667ae2095cadf530db25903f2d755d5790217ef61c3e3c655aaade81b26ec88c2cf9cb7082c4103acdee9fd655e0",
      "name": "9568077",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "bp(GO:\"autophagosome assembly\")",
      "function": "BiologicalProcess",
      "id": "c89c44d07abdeace0ea42e4bf8d32258af4c2a8d95d7b9c27cd0306d2efe69133503f24a6fd40784a4d845f7e0c1a6b0ff04bb029ae9a91dfc8ef483dd4f55c5",
      "name": "autophagosome assembly",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"cargo loading into vesicle\")",
      "function": "BiologicalProcess",
      "id": "201c74629c0d77a607433db7ea34aaef4e8d05f3126394592ce5d58d8f1482c9a5d0c7fefac5b8e0136d1cfc0928c87759aec8bc9121e665f4b674ff6d7cfbe7",
      "name": "cargo loading into vesicle",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"chaperone-mediated autophagy\")",
      "function": "BiologicalProcess",
      "id": "1becad934ecf26ef0dbbb6985a45169a688cfeb4825fbe7b3534fe465a70623a05fbff45ee7812a49cff207a8c0fdfbb7a9f2083bcbeb7f609f31b3d9d0ca6b0",
      "name": "chaperone-mediated autophagy",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"dendrite development\")",
      "function": "BiologicalProcess",
      "id": "d9195ac27ba820ecd414c0bfe277919b1a49fa0a53337f10e07e7c897717cde878361c3ee425e5801813d28fb5c074f5097d013e74ada63caabfa7a1030b54aa",
      "name": "dendrite development",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"lysosomal lumen acidification\")",
      "function": "BiologicalProcess",
      "id": "f543d033dabf209a695ddf6e8922531d1ca11b234c44b480f8ea3875f83e43ffbd62bdaa59eb1274d79ce54560c5d93b46290c54c3277ec672a9d59976bafa95",
      "name": "lysosomal lumen acidification",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"lysosomal microautophagy\")",
      "function": "BiologicalProcess",
      "id": "ebf63bce2fe4d0be72b29e0ad3cb85aabbc171d84b1b0d023f116cf6694c3d0c5e06dddd30d4faefc95eae4e53eb7094d9522a4b5a78a7d04b212e32700898a1",
      "name": "lysosomal microautophagy",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"motor behavior\")",
      "function": "BiologicalProcess",
      "id": "181472b7f9a4b32696b87492619020f88bad9e24f439e97158614801e3fb1dda434c97b95c252baa65a43ba7d78eecfca26f91f6a5295d37b21e6873f04a73f6",
      "name": "motor behavior",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "function": "BiologicalProcess",
      "id": "ad7c90f2bc746a5118759fd1c8857478c02207d574a26faaac9d6e4d6fa4661d8d87446139db0024a4011aae26027d3cabdfba663aec0ac0a8242868efb81dcd",
      "name": "neuron death",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"proteasome assembly\")",
      "function": "BiologicalProcess",
      "id": "e56a9bd4b71cb9d4e7060bb2323283cadfc8cbf2dad1e0ace0539972d194bf1d1c98c39918f2515ee98e38edd69a61f7487cf77c70b3797e69c8dadd1399913d",
      "name": "proteasome assembly",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"proteasome-mediated ubiquitin-dependent protein catabolic process\")",
      "function": "BiologicalProcess",
      "id": "e31884054bf49e8c01cd68d025871de0290da5ccc81a412fdbd2a8926cf48c1aeaeeb16165f6d77ef1a7f647fdb4623057028cc40cadb2e5e4eeb5c45e00ae56",
      "name": "proteasome-mediated ubiquitin-dependent protein catabolic process",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"regulation of synaptic plasticity\")",
      "function": "BiologicalProcess",
      "id": "903846a9cf9209815f6dcfe040df50ed6f55896865a72567e9c38cd2dcf71773d60453fcfefaf38dc2933bb0c524d73f2b9c10afe99231cbd86c56860a8197da",
      "name": "regulation of synaptic plasticity",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"response to endoplasmic reticulum stress\")",
      "function": "BiologicalProcess",
      "id": "5fe897eab892da6b4bbf879af4bd343aa38a7f71abf55f0bbc7df5c1d1163ec36b675abf62ca57521de4c08bf1b23a8b051a1e20bd19d7372df3bc1e24a90af1",
      "name": "response to endoplasmic reticulum stress",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:aging)",
      "function": "BiologicalProcess",
      "id": "e656a7a9b8877eca28efc8bcece0149b9f17b643e48c2ae605fb3977fb925968220ed9a29a1649919bd2bdbfd43e6cd082182ead002a6eb840cd3f1e4f57d213",
      "name": "aging",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:autophagy)",
      "function": "BiologicalProcess",
      "id": "f1a3202be460e565f65c1445ee061e99f63cc05f9ab70c5d4d8d93ba180d6a94f65cb8d1ac6c5ba53c0a4d2e153db32135e6a0bffcfdfd4d84e6727594a70b0a",
      "name": "autophagy",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:cognition)",
      "function": "BiologicalProcess",
      "id": "8d73f2caa1c473289d5f37cbdd4ad391a120cdbdf2356b373070c2a7b2bc0c785eaa620782fa2dd947c666100f0a169e81f35864f359cadf3e1550962fcc4127",
      "name": "cognition",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:macroautophagy)",
      "function": "BiologicalProcess",
      "id": "568e5f70e05a1543c9a1d54019c461ab0802ff3556801ad06f2231e0687a80f2cbd21d12f808f5d72752f7cc8c484e0b32d830256321af323cfd08b1b63cc765",
      "name": "macroautophagy",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:memory)",
      "function": "BiologicalProcess",
      "id": "87795d00588bdf77d28229ad379d58f00922f6339902a803d0672cc15e669269f8fe50785b2851e1e82046f4e1e49920534ec68c0b6911bea5a1b838dbc999cd",
      "name": "memory",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:mitophagy)",
      "function": "BiologicalProcess",
      "id": "4aaab5eeba08d2187abe1f18604897bde37a4bc61d183903b25e78b40ac7c98f4a567cce3031ac17c35dbe9e821502e794ba33a5204cb73f9228917027f3d6bb",
      "name": "mitophagy",
      "namespace": "GO"
    },
    {
      "bel": "bp(HBP:\"APP processing\")",
      "function": "BiologicalProcess",
      "id": "cfc9433284818feeeee20158891cf4f5b802c0ba463538840e389a3a97739446bff7305190f4a55ff4f6b3667531d853072705d9596122d30d2fc382eb77720b",
      "name": "APP processing",
      "namespace": "HBP"
    },
    {
      "bel": "bp(HP:Neurodegeneration)",
      "function": "BiologicalProcess",
      "id": "96f5a3bbd33a722b2760c6448efdaabb70ed3e96434c786a9ad70ca7eb89b9585204c9e8df72a4ab1b5c7f617a36f919bde50523c31467d62a4842b479ddd805",
      "name": "Neurodegeneration",
      "namespace": "HP"
    },
    {
      "bel": "bp(MESH:Longevity)",
      "function": "BiologicalProcess",
      "id": "5696b94cf48f5b91fe66f456a9a51f751fa960b09b6c8502619034246671b9bb36644fd7e84bac6693c1beaee142bc3cff1045021070ece93aa1c2b41d5740c8",
      "name": "Longevity",
      "namespace": "MESH"
    },
    {
      "bel": "complex(GO:\"lysosomal proton-transporting V-type ATPase complex\")",
      "function": "Complex",
      "id": "453f415274c83776e43073ae1a76c4ede09df7ba5ac9381d528ecaff2cfe25e31503d2a9fa85f19aeb867622a493a7ffe39d49cded738eb5f6b02380d45e799b",
      "name": "lysosomal proton-transporting V-type ATPase complex",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"proteasome complex\")",
      "function": "Complex",
      "id": "5deb6bcfdcfa66f95c4979205b8144cf23a26c8da492c2d4b71750a7f8e440a3d40a37452d67ccbdccfba2bd5cea7bf1bbba3d66e18875bae3fd8abd8d3d68f4",
      "name": "proteasome complex",
      "namespace": "GO"
    },
    {
      "bel": "complex(a(CHEBI:sirolimus), p(HGNC:FKBP1A))",
      "function": "Complex",
      "id": "8dcdb78499fdda688b360a1e364ec94dbd707b6ff1c7f811b4caceffd042cdb22d2254fee13169cd63c789318c6e6a0cd4b398730f1d19d3c09b180e1cdbbcde",
      "members": [
        {
          "bel": "a(CHEBI:sirolimus)",
          "function": "Abundance",
          "id": "102b031a00eed78fd9e5c4236defb90a8995463980f9060493bb5fd3159a3eb666cbb2b6a33a213c749a2b279ef6d149796b4f0b568e03b82eb5c89b0da77426",
          "name": "sirolimus",
          "namespace": "CHEBI"
        },
        {
          "bel": "p(HGNC:FKBP1A)",
          "function": "Protein",
          "id": "5d459428cba61445afcbcff9f74aee2fa9a7d2693c853075ae9abcb46149a6277cd5f2de3eece57b9529bdbad094243894b73c2734ef5a2437348d567af8e4d6",
          "name": "FKBP1A",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:BCL2), p(HGNC:BECN1))",
      "function": "Complex",
      "id": "cb3851f1c877390e38ec7a37ab2495c08365263ea80446d45a999dae7ce681c25da081dda7b01966c19ab9ea7cb1bf79d1ce926c761ab8223d320b911ebc6d45",
      "members": [
        {
          "bel": "p(HGNC:BCL2)",
          "function": "Protein",
          "id": "b25decf9a9958e757d163c2d365729a1f86914126328ab0aabc90b2c29eb3a4617cd266432c4459745e2a1cd10176488cd1ba102d74f3869d82ad68257204b06",
          "name": "BCL2",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:BECN1)",
          "function": "Protein",
          "id": "ce5e6cfc287bf6d0e84facb5b47e9a27acc7790b28ca4e133b28be3d5e182582aeb37e2a9ed8c867ec8bebff972f5132a6ef26bfd08dbf95abd402d24504486d",
          "name": "BECN1",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:BIRC2), p(HGNC:SOD1))",
      "function": "Complex",
      "id": "16d1b6a01c3ca7a6049abfc4e49695be6278190dbb69ff6c1d683a2507d2c28ca783db8bb76248948d2d9590bec972ef78be94688f24a9a8caec5faaddd69c3e",
      "members": [
        {
          "bel": "p(HGNC:BIRC2)",
          "function": "Protein",
          "id": "2497e171918fde1f45d0532ace107a3b41ef0816e23859671bf814252dc90c74dbcd5866a44680fa02e2c7243db8f11f37aaa1af7bebceebcfbe9a1114281209",
          "name": "BIRC2",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:SOD1)",
          "function": "Protein",
          "id": "7bebe84ddc870a4ceb70828bba41ec797b861126138342942eb8124edaef94657501d4b9c4a69876b38e0fba2ff4cd5a91b560173b73723f03809ed503e90e98",
          "name": "SOD1",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"NAD(+)\"), p(HGNC:SIRT1))",
      "function": "Composite",
      "id": "753b899b2e895c505160b083bc4b4845f3d4b5074c7e2e870fc7716d45a378f6460adb720df58a7ea9d2221da16770a8d111e8ab4e33b165c02a9b28d20d8bec",
      "members": [
        {
          "bel": "a(CHEBI:\"NAD(+)\")",
          "function": "Abundance",
          "id": "987ff63bde605a81a696f249bdec60f49a30a25cf77be765d547c38dc291c2080cd3a90fb8fcb3043847732a20a7e62f72d13b291f0e8e8f96b2553140a03693",
          "name": "NAD(+)",
          "namespace": "CHEBI"
        },
        {
          "bel": "p(HGNC:SIRT1)",
          "function": "Protein",
          "id": "f8ae229ccf59eb0423431200e2fa1cf7719362512511880bbaa90df7dcf8590b8bd54bdd49b275529304bb7a982202caedda5bb0c8fcad07f6890aec3fb8f7f1",
          "name": "SIRT1",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"calcium(2+)\"), p(HGNC:CAMKK2))",
      "function": "Composite",
      "id": "483a70aaaec6734043eae63e2ae84e05af94cc1537e60c3513acf3db3e3e310caca178ddd5095b947a9f0b92dcad7086acb313ead82b6ed32aec49e2e7c3291d",
      "members": [
        {
          "bel": "a(CHEBI:\"calcium(2+)\")",
          "function": "Abundance",
          "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9",
          "name": "calcium(2+)",
          "namespace": "CHEBI"
        },
        {
          "bel": "p(HGNC:CAMKK2)",
          "function": "Protein",
          "id": "87bb83ad6f18004d9d8e5f7eb81e5fd2e702d341f3a687a4f6810f56cb1a5ff0b3035d491674c328fe99d331277247996774e9a8ff0fe0f5689ce7ee225559fb",
          "name": "CAMKK2",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:cilostazol), a(MESH:\"amyloid beta-protein (25-35)\"))",
      "function": "Composite",
      "id": "ee370a2ca529a14a109a7a05ae40341d325569e3eca57da8bd44d6050e41dcf53a3558dde84721bb3c35b8586ef85ac62b9f0a3b859d57756dd91a47f2cff469",
      "members": [
        {
          "bel": "a(CHEBI:cilostazol)",
          "function": "Abundance",
          "id": "9a9fc863375a0a8fb0f267c2c120528f381f2060312a574cf5a9d9c205f9530144f95335f491adec62c9337983ddce2b1f32ede9421bc887ccaf3349403116c5",
          "name": "cilostazol",
          "namespace": "CHEBI"
        },
        {
          "bel": "a(MESH:\"amyloid beta-protein (25-35)\")",
          "function": "Abundance",
          "id": "27179ccb1680ada81aea0e2559b0fd6b5e25fddd805f1c005c521ca672e3d2e04619d93fe52797aeb0903971bb8148e5449cd64d6a6043a169b92bcfc795424d",
          "name": "amyloid beta-protein (25-35)",
          "namespace": "MESH"
        }
      ]
    },
    {
      "bel": "g(HBP:\"APOE e4\")",
      "function": "Gene",
      "id": "04016d02eb722dd432653575a2fdb39cb6e4abd7f368a02ecf500f45d1b4425cc1d6bc18e60417e0e0cded5967e9c097527bd3898ae21d2292f411b6d3240ae9",
      "name": "APOE e4",
      "namespace": "HBP"
    },
    {
      "bel": "g(HGNC:APP)",
      "function": "Gene",
      "id": "b0c972ce318230ec034b96a29f2c9eb3fa32c869d5e9c638cdcaa908769ae5ff5cabc371877c4355af3727c7f5baf19cb604ed0283769cdb29d3bc43f375dd43",
      "name": "APP",
      "namespace": "HGNC"
    },
    {
      "bel": "g(HGNC:APP, var(\"?\"))",
      "function": "Gene",
      "id": "1866bebf4b1fa1c88c3a165a5c7f2f22e87c268272d835dad5bf43fc435a1b19c1bfe3490ce974f1258653a3acfa503df1c1c01d81ceca921044b887bbe7622c",
      "name": "APP",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "g(HGNC:PSEN1)",
      "function": "Gene",
      "id": "a41476b93b2676ab2057f762b596676213ddc3f1c34b7d8cd614e03d06776bdb81f3f29884a6abd0ca53b180983c74565339434b096f85b668798185abc92501",
      "name": "PSEN1",
      "namespace": "HGNC"
    },
    {
      "bel": "g(HGNC:PSEN1, var(\"?\"))",
      "function": "Gene",
      "id": "c25ff74c45df969be8a565ef6294983772d87355c966b8bb9d4b47a5c925c28241f5ddddaa655327219fffef72637a27ff332b8a487cdd9b0632f5f9ea2c2b4e",
      "name": "PSEN1",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(FPLX:\"GPIb_IX_V\")",
      "function": "Protein",
      "id": "b584d29a3f22466c9ad9248bc606ee678015a63da235f575b7600f5df634cd6c848f6bbe1f477f0540d22c0b08eac82be40f8d71ec0afc528ad1b0c7b9ee57b9",
      "name": "GPIb_IX_V",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:\"Histone_H3\")",
      "function": "Protein",
      "id": "8459666ba97818c6473cf7825adb746c69dbf60d63dfe78459e6921906ad9af910cc8ae669d68ef437ceb3627966d734f6d931bdcc1cc6af0994fce05223c07f",
      "name": "Histone_H3",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:\"Histone_H3\", pmod(Ac))",
      "function": "Protein",
      "id": "c1e7735e43c9f6e920ddd1470354685315354324070018b6a4e9bad43bd9a15d6166a17ae51ba64d3f4b4de7aa953725f0ad1fc40ffffc3c8c361c7248206371",
      "name": "Histone_H3",
      "namespace": "FPLX",
      "variants": [
        {
          "identifier": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:AMPK)",
      "function": "Protein",
      "id": "131d91a9caa5cdbc7b28605571e134fa945e7705a05cb7d6e238dbb6268ca89c9ea06d040b41f3d5dc7803109910aa78cc4504a4e5408bfe08c5b1a32300a499",
      "name": "AMPK",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:AMPK, pmod(Ph, Thr, 172))",
      "function": "Protein",
      "id": "2069b14ec85b6715bbbde7972dfcac6ae128adb05e6e52e4a1c99bb968e6975b622b28908912d088a58c9b255a46ac215c775100d4534fb86467314dc4688b5c",
      "name": "AMPK",
      "namespace": "FPLX",
      "variants": [
        {
          "code": "Thr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 172
        }
      ]
    },
    {
      "bel": "p(FPLX:AMPK, pmod(Ph, Tyr, 172))",
      "function": "Protein",
      "id": "5dc552a6d5e21de5efa74847a89fbce584bc16451e902e33070d07de093668687a5817127530c12bf504d08f9634f4230e15d1088ea4e68987cfebf9ad313341",
      "name": "AMPK",
      "namespace": "FPLX",
      "variants": [
        {
          "code": "Tyr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 172
        }
      ]
    },
    {
      "bel": "p(FPLX:ATG4)",
      "function": "Protein",
      "id": "1414e5180d5761269edfc087f10fd024c5e2f19e5186cd7e8efdb67815916476afa66680fb42104503766d9de4fd3026557c2a162a2b50df73c69a318c101b0e",
      "name": "ATG4",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:HSP90)",
      "function": "Protein",
      "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245",
      "name": "HSP90",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:HSPA)",
      "function": "Protein",
      "id": "c293d8f843520dae6cba835a86c0e958d54d4dad9658a8281d9540b21d8e39272f2548fe5c429cd97d5d9a3755643b8dc346c2aecf00d7d53ab3914574cbf62d",
      "name": "HSPA",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:PI3K)",
      "function": "Protein",
      "id": "9c014e2c23b6343e5d523dc9679591bfbed4d6273b4d4ad038d610936aedfda6d7545dba4655f7ea5b44a70eb5eb4d507ec2476e767a8429a1e0e6a7cddfba7d",
      "name": "PI3K",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:PKA)",
      "function": "Protein",
      "id": "a312e28f30d661eb58c0cc3c07cda6812a6290acaa1b8c513be7a895fe1b15f1feb278ee6095359cd3e44eb43cf1864de0fd70d89d3cbcc5b18361fd31276f17",
      "name": "PKA",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:mTORC1)",
      "function": "Protein",
      "id": "a1c299171aad616f24329a91ca82660e0205dc2da1b10758111e4a1dfc283c68f49134e8b0987b93bcaa6c92fceb45567212a78013bae1639af5468de9caa508",
      "name": "mTORC1",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:mTORC1, pmod(Ph))",
      "function": "Protein",
      "id": "36fac628a1345509d1684c24469ee01363dec8c8567b041199554f9c4010cfe622fd93812f97ff440b54533173c13120ffe96f61882451e1ef612a36cb48775a",
      "name": "mTORC1",
      "namespace": "FPLX",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HBP:C99)",
      "function": "Protein",
      "id": "ecd0e896c2b7c13b0ca7d44c11240fe6e04eef70ca47abbe4c9ebd9bcce91b91b4dd25b5989e92be9d490e1ee7717e972c3d9e348cc8544276f51d96aef6dee6",
      "name": "C99",
      "namespace": "HBP"
    },
    {
      "bel": "p(HGNC:ABL1)",
      "function": "Protein",
      "id": "d2c9c266b57718f71c9b5ea0da0e48ba77dbe172cbc7dc550631f8c9a9540767992c47b332bd0760ed1959c3b0e4a073a3f52d2cdc4985f132d91eb43e6ca027",
      "name": "ABL1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AGER)",
      "function": "Protein",
      "id": "7e397a005d17551ff46539ab6c2a5709d61f6e6a34c53dd914d2390a36fe3641cb438c1f1e5a08095695db19ea9e931449ec027bd08e3cdfafaf5acad2a74f4d",
      "name": "AGER",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AMBRA1)",
      "function": "Protein",
      "id": "bb9df7b2856258d7cce158c2a7eeee9011e44e6f45a1074ebaed9676eb1355cee0ac28c6ca899b73726776bee0f981a34498e3bd37210dc19966896cbc887261",
      "name": "AMBRA1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AMBRA1, pmod(Ph))",
      "function": "Protein",
      "id": "dae3ac2c86b6d7e1adcde1799ed8143c00096eedae16c6bf40d3e3b337d8c221cd9151786c5abda36881642cec3406fe22fde4ad9d953efb6d1ab71caa5d25cc",
      "name": "AMBRA1",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:APP)",
      "function": "Protein",
      "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc",
      "name": "APP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AQP4)",
      "function": "Protein",
      "id": "0606ef8ed985759822e11ec738204b0ab3ff978e467bf381822f25b4eb41bde5af34489f01630a3a0048d02371239aa624807dd6a76b3a7a82476bbfa2e595cd",
      "name": "AQP4",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ATG5)",
      "function": "Protein",
      "id": "796fc85ea300a051d7a5019196a2a35b22641ecb30a90d9cf9ba8478f166f9c68c516a6bf5b9c3455cee4b636946dda6702b161b17b47f787529e6b522054227",
      "name": "ATG5",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ATG7)",
      "function": "Protein",
      "id": "e060e1208409a2c3f0c97bc03a100796791496efc59addf2d1c06c55bdd7758ebcd30a42619961a62a1c657252d703a0b37e8c34ef4bfea3878d342c3e780183",
      "name": "ATG7",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ATG7, pmod(Ac))",
      "function": "Protein",
      "id": "9ab404b7d8da016e8043fa92d17a134cffd1af561462edbf669b39727ca282659b0c82acb475d8822d87cc93bed043dab1a53825b70b50dbabceed2603ee5fc9",
      "name": "ATG7",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:ATXN3)",
      "function": "Protein",
      "id": "c6102d230a5c67109dd4fd3cfaa57f2745158769d72caa5add04724e9dfe725c935bb1ec09338262f4184baa34fb990c7287982726308939a7f9e77987c33b64",
      "name": "ATXN3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ATXN3, var(\"?\"))",
      "function": "Protein",
      "id": "9e8918c48a453eebb4a96a2a82cf99b62141fd37ad8f5abb3e24c048f89f4488c2347cd31c13a6f640ed0d314af16dafef04268ae8af09caa989e9e15e8311b8",
      "name": "ATXN3",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:BCL2)",
      "function": "Protein",
      "id": "b25decf9a9958e757d163c2d365729a1f86914126328ab0aabc90b2c29eb3a4617cd266432c4459745e2a1cd10176488cd1ba102d74f3869d82ad68257204b06",
      "name": "BCL2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:BECN1)",
      "function": "Protein",
      "id": "ce5e6cfc287bf6d0e84facb5b47e9a27acc7790b28ca4e133b28be3d5e182582aeb37e2a9ed8c867ec8bebff972f5132a6ef26bfd08dbf95abd402d24504486d",
      "name": "BECN1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:BECN1, frag(\"?\"))",
      "function": "Protein",
      "id": "0ec9bfeda44096c2ea67b6b02ba82c713f39122de8380a50aadec75f749278ce11b51ceaf1c73af8910bb9657bcf383401147ffbf121f72ec166aa71f6b3aab4",
      "name": "BECN1",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:BECN1, pmod(Ph))",
      "function": "Protein",
      "id": "a20babd8be890da2fecbea6f60fd812062f0b2c885add32776f2bb0335735ec1f4045f3aabb3b1c740aa8939015721a729e18327fea218e8ae383b7303777ca4",
      "name": "BECN1",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:BIRC2)",
      "function": "Protein",
      "id": "2497e171918fde1f45d0532ace107a3b41ef0816e23859671bf814252dc90c74dbcd5866a44680fa02e2c7243db8f11f37aaa1af7bebceebcfbe9a1114281209",
      "name": "BIRC2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:C9orf72)",
      "function": "Protein",
      "id": "7576a0f619e1a05e3eb85612509bfcf1d4b4d9f7ebafe6416b108bf4587cdf93f9b4a2172f265fe026089624704c5da0ee9659fd71bae5edbb980b1e8ae5a029",
      "name": "C9orf72",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:C9orf72, var(\"?\"))",
      "function": "Protein",
      "id": "ca5b3b2b240dbc33f442e7fc07d5a44c1bdd4367a272a1b01027c74b1d04f5aa434949648d5fe38675c201449011fd69693e807b8a8b122a99d9c8d90fa23614",
      "name": "C9orf72",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:CAMKK2)",
      "function": "Protein",
      "id": "87bb83ad6f18004d9d8e5f7eb81e5fd2e702d341f3a687a4f6810f56cb1a5ff0b3035d491674c328fe99d331277247996774e9a8ff0fe0f5689ce7ee225559fb",
      "name": "CAMKK2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CAPN1)",
      "function": "Protein",
      "id": "e77ed047fcece0e1fe3ebe2adb423ca39419743d7990c02066f8bb4362e014d568960bcb90e4196c6a2e1d0616a2935e5d555d4c0d498b2158aff604520b88ab",
      "name": "CAPN1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CAPN2)",
      "function": "Protein",
      "id": "5d33610961d00e08089b773cb9b5b79d46e447260d26b436301a046c895b159cece1b6c68a8bf73656671dc1ca8078df383540358827413423582245e5695c0a",
      "name": "CAPN2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CASP3)",
      "function": "Protein",
      "id": "3fc355e7c574083fad31aa9edc5d5685615c49fd58885c2fbd439371619da84fbe274bd3325695ab21c912b5ea592d8031ffa114a9147908170dc187400ba74c",
      "name": "CASP3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CAST)",
      "function": "Protein",
      "id": "3afb30b427838c76f2f867065b7420d6ccc5518df2f743d1853a873230fee59634e8b6ac0e88c187e55473e8e4ccebffab4d00756a01bd572f4e4a081743072a",
      "name": "CAST",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHMP2B)",
      "function": "Protein",
      "id": "1c2e1f0965db9bbdbfec9a85cd20c4086ea6ad011dbdd5aebafe1dbd71f718a726ec9763f5589f9520b51b4eb24c8c0fb1ec419620c89188e4f8c6e5f7de2f46",
      "name": "CHMP2B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CTSB)",
      "function": "Protein",
      "id": "770e5c1dacf84a7f13d61edc8b73235143273ea3811f8076af71ae88a96ca93d99874731416edb99f2d91b8d8a06d86f8ca6ab848261f03a60af0657f4838168",
      "name": "CTSB",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:FKBP1A)",
      "function": "Protein",
      "id": "5d459428cba61445afcbcff9f74aee2fa9a7d2693c853075ae9abcb46149a6277cd5f2de3eece57b9529bdbad094243894b73c2734ef5a2437348d567af8e4d6",
      "name": "FKBP1A",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:FOXO1)",
      "function": "Protein",
      "id": "8936a3f3af1bf11ad1cdcdeec428d1775217bc3c531007715fe9f6e2573130d087b67d5ba60916ae33e89ca2bdc53ee6a19fd541c4eca98e6a0eb6da2056f99a",
      "name": "FOXO1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:FOXO3)",
      "function": "Protein",
      "id": "ef39b1767b4b288db06c4eb45dad940ffd0429431f5aeefa14cbbc242037a7e669c23ce963ba1fedd10015027d3d6ed583223a12b362694b032860eb65625556",
      "name": "FOXO3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:FUS)",
      "function": "Protein",
      "id": "e4b4249edcab1c0f6d3f0ec038a9212bc2c15993ae13022339d0e6372b454bbacf764bdb4f0491042df2bef0aed7f28810984e99dfaa6aa6e26153565d2ec2e4",
      "name": "FUS",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GBA)",
      "function": "Protein",
      "id": "3c9621df9e39d495fc6d50fe4943ed5a5d6624533ac6ec4d4f1bc71a840d04d5ac167d194883b84817dbb5b6d72e346159800ddad51ce882691886963b8fc796",
      "name": "GBA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GBA, var(\"?\"))",
      "function": "Protein",
      "id": "478b169599f1f650d7065d0b6e84e9be1ce0c99c75a3a408ad948e9dd8bb784af04ba857e9c2adc21cf2a0c0356932f3779460d6f0f643451f3d1cdd806cd7e6",
      "name": "GBA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:GRN)",
      "function": "Protein",
      "id": "0b2f60d7ea92b74982a0fb4d2044bf8161bcbbf507e371b757615e030441bb1d3ee853563016c5aef12ab9a4ef834730d7980169db2a0d81a9bf65c5ab3979f7",
      "name": "GRN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:HSF1)",
      "function": "Protein",
      "id": "f14348a34dab846dcd69f4e44f9229a90bd3a44e5ddbcef4331d61dc959cb6e1aec7c1210063cb9d6f140de4ab55d0aa21cd9176aa9a75bd97939f364145b7b6",
      "name": "HSF1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:HTT)",
      "function": "Protein",
      "id": "f3dac0d39a258f730f45800014166f0cd6e8002b0bd1f9be6aefa0958d84dc3a67a48721743405568d2c7942ea831f7bdc6cdcc7a990bb1a7d5161351e6e67b0",
      "name": "HTT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:HTT, frag(\"?\"))",
      "function": "Protein",
      "id": "4ec113a2b89660b05ec358e5e4063e08e3ef3ebae53d7f43d7c36579ca67aa43d18fdab068a58ad7b66507ce9725de81651db33f8a08c03af1146a5f40dae779",
      "name": "HTT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:HTT, var(\"?\"))",
      "function": "Protein",
      "id": "ecfea6b35e9ef56154b1f7d1255c3ae63e48c14c262428a01170245d2ffae3786b0b2439c3b2b1f6abf506d5ff2a338d6de2d7a2c18ee7defc89d51c50e22f75",
      "name": "HTT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:IAPP)",
      "function": "Protein",
      "id": "af296c823a76faec9da05cd12e8702294398d57cff749c8e73273ab3973b3a3e0f926116535d535d585e1aeece77a47463542ed85991790bbe1cc835378aa333",
      "name": "IAPP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IDE)",
      "function": "Protein",
      "id": "ef40c2282a9443979f4a3a31bbd42f8d713281448c6551e853da09d253ebc0bfe8c17ea3042707bdf539f2c0921898b22e8ce3af7a86ec859c803801af7d8ce5",
      "name": "IDE",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IMPA1)",
      "function": "Protein",
      "id": "3d879df00abce74f83f527422544c03179ead1fc60c1d4f5dbdb1c056b7fe3d20de78b6ed9029c35ae8a4586ebb0ddefaa3880cfba01203ad932a482cbf331ee",
      "name": "IMPA1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:KLK6)",
      "function": "Protein",
      "id": "d5516c119a2f5729f62545d7f4d6eedd4b9464fc3ed4c63ddf9ce3d79cccaace0e833fe34316f5ea276487b30ad6ef034e3d9c794170ff7b5ffd585648b5223d",
      "name": "KLK6",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LAMP2)",
      "function": "Protein",
      "id": "972593cbc51140f55ab0c64199eaf4012d3f070e18044705595c6e87379fe2c6e733263398a2ab4af48d1fa74d5e02ed02097d67e9a8b2813bb72277a21753f5",
      "name": "LAMP2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LGMN)",
      "function": "Protein",
      "id": "ef6b2f269d550a6f1cdcb973775512e6dc0e5eb1618fbc6d1761dd321578470b6b8f88fb981b787596962da172527597c44cff88c0f9923e357e74dc5bc02eb6",
      "name": "LGMN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LRP1)",
      "function": "Protein",
      "id": "aba7c0e940b52c981e1639b0cd828988284d900b0893f15eaf8ed67a6809f7be343505b702440a71be4c53beb05bee18c776c6beeea2ec601f7a3144a8eb7547",
      "name": "LRP1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LRRK2)",
      "function": "Protein",
      "id": "f96ead302c9d5f0deee787cbc3ab3b9a683a4c41955ca6520d12263f2bfbc9810e87220fbe1c64675505d5e699f6e802c656ce2a11fb5936f0670423987e141e",
      "name": "LRRK2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LRRK2, var(\"?\"))",
      "function": "Protein",
      "id": "ab7199f12ef0216eeb929b6b277fd719a2f6f2108951dbdbdf92abb78166d530eff86cb5e15fde14d6b63264f50baabce3e60586291614de05eae4138e82669a",
      "name": "LRRK2",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAP1LC3A)",
      "function": "Protein",
      "id": "696720fe445fd05f8ee69df577c1eb30a03353ea55fa2d483f9b533222cccec6a8edb971af1b1296bd3514c9546a59e158162797ceb5d4ef8937bfee4600a06d",
      "name": "MAP1LC3A",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "function": "Protein",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
      "name": "MAPT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"?\"))",
      "function": "Protein",
      "id": "dbb6f012a2089a4aba22816c6af55e328ad7261bf5c68b09cf51c936ce08952623b5fd262df2f3e63b49c4a7807fef1d3ecc66350b87678d3cdcce92fbdbaf4e",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(HBP:hyperphosphorylation))",
      "function": "Protein",
      "id": "ede67fb639f29861d91976fefa16d8279b53ae13a659f35d70ed12e01bf3f339ffcf701fc54c7c4e908fee9902c02aac3e0022dcae5a7afa217ed2d4dba133b0",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "hyperphosphorylation",
            "namespace": "HBP"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "function": "Protein",
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, var(\"?\"))",
      "function": "Protein",
      "id": "40a1fcd2e6b4af4d7f275f7ffae5cd34aff043c40297e912ed0e45c5a645d1abe2b717042d39ef0fd11ffa06c96785d31a8c7af123db21c2162d4e6ab59b9729",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:MCOLN1)",
      "function": "Protein",
      "id": "484c18954a6916d0fb504f59bc79527cbec6d356027a968a978e4cce118ce69563a827a6f5a7f625790d89c8daafc80fb58440b8c49de43ca178e83c5ab46669",
      "name": "MCOLN1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MEF2D)",
      "function": "Protein",
      "id": "02de141ae00c7cd70ec2b08319d73861c390a607b270573f09f5a0beb8fa38cddad1d0d68d9c968fd588298c4f683fee1d9c7021d8aa147daeca07c858fff8bd",
      "name": "MEF2D",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MME)",
      "function": "Protein",
      "id": "8495cf2e994033c3769854828c023757130813a9381008860adb2cc801bf37359fe1a6b0b00d3b9ef95d354e2e2dd1383299cd272d751421c61fc1eaa151af30",
      "name": "MME",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MMP9)",
      "function": "Protein",
      "id": "8fe636fadbffa82d6204b08f82973c63c9f603b4de9d10db707b7a6978c7c86c8a9c4a31d16caa3480ffd334bf56d8f856a8639c32e2fce7764ef4decafd6bef",
      "name": "MMP9",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MTMR14)",
      "function": "Protein",
      "id": "6219b2e0b7b7d8f083f1c7df11ff1fe0226752ad4140e192e8856f5e4b27658e52c340d050be0923140f338c5684170e4b9085fd45722f4980f9ba87aeaac01a",
      "name": "MTMR14",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:NFE2L2)",
      "function": "Protein",
      "id": "f707e81d79f55da8c33a4f0fad8eda52a2960c3256f2cd831a5d51542d824e4ed26a18f97cebba93ca1b75239d492efaa0acefa07f5cb15dd98f75c9078ac249",
      "name": "NFE2L2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:OPTN)",
      "function": "Protein",
      "id": "e533668363c7e475cd6353082ecb40172ce946a694ee93f57f70b487e1ac211dcf8e1a9d1492669631ad1873845990ae920408449f469db796c46ab2bbebfb55",
      "name": "OPTN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:OPTN, var(\"?\"))",
      "function": "Protein",
      "id": "2d3980d88740b5514ac6cc6b3666fdfc1d895029770a06b4d55c3baec886bf1857e7021567b51d6cb3c5fbb64470a7538b5dc97b1a6b6b10cc0d638f35d86418",
      "name": "OPTN",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:PINK1)",
      "function": "Protein",
      "id": "f3a64ad7e973fe716cd12a5eb3305cd6e8845c0fc44d94e8fb988020de36f2d3ca54aa66530d7ba8dd40f329ebc0a9dd989a0965aa8728b1360d011f5298ac1d",
      "name": "PINK1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PINK1, var(\"?\"))",
      "function": "Protein",
      "id": "fbca930524238cdedcc7e274f59038e6202419386823fc2300febc982079f0f822367fece8fbde433eab3644321d01f1036865907a5120d43b2e3b2de3ab9deb",
      "name": "PINK1",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:PLG)",
      "function": "Protein",
      "id": "2db47be178228ce075b822632739ddafb7d4171b0d5a4c84af9489146cf2e82e1e1e11e32935524bc95b9083e2233767afc78b989c9f544dc6fbaed77742dba7",
      "name": "PLG",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PRKN)",
      "function": "Protein",
      "id": "c129e31246d9b635f2d39f8a0d20e11d29724b9888bc1c35e5b5f5eb721f42a8ead8ccee052e21a3c178f79c19d2fecb3360bd35d0a89f449b2d05af14ae324f",
      "name": "PRKN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PRKN, var(\"?\"))",
      "function": "Protein",
      "id": "18bad2008a5318b2ac88e39192c1cdc3930229cde4d1875cba179e0c144b7ee324191837819b0e6294790388cc7e202eca06b5776e5def8f36b099e366069eb1",
      "name": "PRKN",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:PSMC5)",
      "function": "Protein",
      "id": "68b6a3f825f86a74a991817048b342f0c1ec8c891f18f740919a3b7ade04e7844e8218b589124bab528c497bd4364b61e13d80e8b243ddb86e775a064f0b44d5",
      "name": "PSMC5",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PSMC5, pmod(Ph, Ser, 120))",
      "function": "Protein",
      "id": "a79b296eef79ba4926357ccadaf3bf40b89e900ce3654c93f69ebb5a5242447036fb8a5ec4e0c4ccc61307fe7cc195147403e7cfca0457c395000d68b6714838",
      "name": "PSMC5",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 120
        }
      ]
    },
    {
      "bel": "p(HGNC:RAB5A)",
      "function": "Protein",
      "id": "9ed8ca3851da7f03fc1479c502d152b264193c44ab5647c073985b3fe814db730dcb15e208232900e0d007c139d4c153488fb8cf0b3e5e90389e2a1512f2c225",
      "name": "RAB5A",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SESN2)",
      "function": "Protein",
      "id": "c82810fc4546d2a0787415c22ba794ff51da93db00ddac88c96d98870c1b6aceb9390ad7459eb47f843aa999fe2f61a2a0e50b9843f3adc8b89270aad1891680",
      "name": "SESN2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SIRT1)",
      "function": "Protein",
      "id": "f8ae229ccf59eb0423431200e2fa1cf7719362512511880bbaa90df7dcf8590b8bd54bdd49b275529304bb7a982202caedda5bb0c8fcad07f6890aec3fb8f7f1",
      "name": "SIRT1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SLC2A9)",
      "function": "Protein",
      "id": "6db07e70374e82eae934e261fb24e067e9b451b61e78f3349d573f37012e80d85b66ab7ccfd80c12f77f6a9e68454dd660a0c3b77d0f808cdd4911ca5785b4b3",
      "name": "SLC2A9",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SNCA)",
      "function": "Protein",
      "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3",
      "name": "SNCA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"?\"))",
      "function": "Protein",
      "id": "bf9106f403a6987552600db2eb76426d8e6dd196bb7e943ee82c95c60bc16afc2f1357237011d6844ead86a4f9d0e78ec162ab52e3fc901d3baf8fb37e86ce01",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"?\"))",
      "function": "Protein",
      "id": "0d646c2b44d28c4acc9f9df1e5691d8250fda5b35ec7b7818be264cf143fdd8a975666a0e67d14bea4130c53464dfafa710e2c65f54a7fdc0151fc726740f440",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Ala53Thr\"))",
      "function": "Protein",
      "id": "d2068443e7a690d5d02ecf646516124d655e615c8f4a7c320cad114af8b6cb752bcdb98e8973c053690af90c8cb72d8d4211d4f8f1314c79c1aab0bbd385c692",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.Ala53Thr",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SOD1)",
      "function": "Protein",
      "id": "7bebe84ddc870a4ceb70828bba41ec797b861126138342942eb8124edaef94657501d4b9c4a69876b38e0fba2ff4cd5a91b560173b73723f03809ed503e90e98",
      "name": "SOD1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SQSTM1)",
      "function": "Protein",
      "id": "8cd06d93cab875a139eae92082f11af5ad651146fabba6fa298a46f2cfda5bcb2bccf9dec8cc73067f5c11595d8eeb288f5c13f6a56dd316b54d108e5e66217d",
      "name": "SQSTM1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:STAT3)",
      "function": "Protein",
      "id": "3127bcd18ece964c797c6ae9fcf716d99ad750c12e3f8121f817efbbedc60af9639294ab059c32ef6101cef3ccd9abc934d90dc7ccdbe6dc3604773782f7bf97",
      "name": "STAT3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TARDBP)",
      "function": "Protein",
      "id": "96048ed5d196081ca480607e30326cb8bb474db3177bfdeea242002c3c7a4681b51247acdfdd0a3ae600face27455ed0e62e9c750e79b240b8e7418150b92963",
      "name": "TARDBP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TBK1)",
      "function": "Protein",
      "id": "f47324f7cb1a2f60144d4bd700e88b416bc18f129d19354e4a5f1be5a23054e8397da2a1cf4eee18b52286aeb373c31ffe91dae4b754abd816d22ee267277619",
      "name": "TBK1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TBK1, var(\"?\"))",
      "function": "Protein",
      "id": "63d2030fb3c478048f601976747c5688d5f5c48078ab9b98bdf3a77ab16bab3775210073965843dc39d01029db954fc8624687ba20aaf0cf229e2f434503b0b8",
      "name": "TBK1",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:TFEB)",
      "function": "Protein",
      "id": "d2586deea41500a6ea7755a94475bef3e256337b994748bb58034e8a43261cfea2cf38bc85241d08d9e06bdfc15b92df32297bceb6a3bf8848c3f2d6878b030b",
      "name": "TFEB",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ULK1)",
      "function": "Protein",
      "id": "fc3e3ab3b7db4794a30372ce336d985e205c7275af8e16e283c3645e6dadac503ad2acfc1fe8112c4a2d0787bd72ffd6c348b836bd9a797756d01ffa2a1b3cdb",
      "name": "ULK1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ULK1, pmod(Ph, Ser, 317))",
      "function": "Protein",
      "id": "c546638e00f76cb47e006030ac3eae61317b875bb225e7c2aef03103b16f8dfbd69c8bac124049b5f8072c9d3c4e7999e7ebb37b26f99461f8589d91e9f4f849",
      "name": "ULK1",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 317
        }
      ]
    },
    {
      "bel": "p(HGNC:ULK1, pmod(Ph, Ser, 757))",
      "function": "Protein",
      "id": "dcc021f7fa3ea895d9c1efc4ec0748e937b5bc371934898355cfd73fd03be0b28a8454e4549bc79754f664e30950e1ea250eecae358f714c5d5c0fcbea9b1d93",
      "name": "ULK1",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 757
        }
      ]
    },
    {
      "bel": "p(HGNC:ULK1, pmod(Ph, Ser, 777))",
      "function": "Protein",
      "id": "3f9b2e360417c46ff6fbefaf7434730774d73b42306cc172ed67dd7f08af1f63572c229dc968c5349622782a4fe13068f53f9fabd7119b093608463d2a49f6c0",
      "name": "ULK1",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 777
        }
      ]
    },
    {
      "bel": "p(HGNC:ZKSCAN3)",
      "function": "Protein",
      "id": "845a1a98cd6737cc9e17fcdd039da34144fcbf4f9bddacb558cf359bcf261b1daeccfddf9ecdd831b25157e619cffd3c77b44800ffeb69b89f60d3b30129808d",
      "name": "ZKSCAN3",
      "namespace": "HGNC"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Amyotrophic Lateral Sclerosis\")",
      "function": "Pathology",
      "id": "5e56d7b5172af0ae281c2f920b132d7b2263ae5eff7b0f1c9a22347914d8c169c79314aa7738c7e68cf75fac198de894bff58cb9fd4a0cb95ab434310fa07daa",
      "name": "Amyotrophic Lateral Sclerosis",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Dementia\")",
      "function": "Pathology",
      "id": "65b349369f9bedd1a6220b3923747475397a886cb45f96f65e9aad66d695cfd560911459bd006d087e0ee4cbf06d8829549b3e32854fe68093e2b5834049d726",
      "name": "Frontotemporal Dementia",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Gaucher Disease\")",
      "function": "Pathology",
      "id": "79c6993864c8647a7db395ddf267dffec84acf873339b6e3fef49551dfdc896471826838a240a2db981205d12cb4c4499c007bddba341ab2322daca6ab52361f",
      "name": "Gaucher Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Motor Activity\")",
      "function": "Pathology",
      "id": "02fa1b20782328b40c24bcc0cff0b4ded4dba3b1e6bfd22a69d94400d2b97e0592b0c361b908443ab4ae3eab4b2f2df00df6e6630502fecb3d4f5740867e549b",
      "name": "Motor Activity",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "function": "Pathology",
      "id": "d7f039170f83b3fcc27595412f3b0352cd1fe95f8481a2b1144ce311ac81bb5f0087a0a7e682f498d193e00b8e8fb29908a6e0b8e23da5ef349aeeb4723b9be0",
      "name": "Parkinson Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Plaque, Amyloid\")",
      "function": "Pathology",
      "id": "888c33ecabc995942e605aace0106831b95c6e6d4eb99ee4ac4c1de25ff7c58c0cb67b5e941c2d3f3a399aada51a34de03850a43011389d2ab7dae07536cea30",
      "name": "Plaque, Amyloid",
      "namespace": "MESH"
    }
  ]
}